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Jamieson, Daniel P. Ph.D., Purdue University, December 2013. Continued Progress 
Towards Efficient Syntheses of Cephalostatin North 1 Analogs.  Major Professor:  Philip 
L. Fuchs. 
 
The cephalostatins and ritterazines represent an intriguing class of marine natural 
products in both structure and biological activity, and the progress towards the synthesis 
of high valued analogs with a focus on process orientated methodology is described 
herein.  Included in the pages to follow, is the further advancement of the ‘Red-Ox’ 
strategy toward the highly efficient synthesis of 25-epi-14,15-dihydro-North 1, Chapter 2.  
A short review focusing on the earlier efforts toward the main synthetic challenges of 
North 1 analogs and the lessons learned to propel the efficient stereoselective synthesis of 
anti-cancer spiroketals is presented.  The development of a new ‘Plug and Play’ 
titanium(II) alkylidenation approach for the synthesis of α-functionalized spiroketals is 
presented in Chapter 3.  Highlighting the new strategy, is the process efficient synthesis 
of the a key enol ether intermediate as the gateway to the synthesis of 26,27-dihydroxy 
North 1 and other spiroketal analogs.  The use of silyl triflates for tandem one pot kinetic 


















CHAPTER 1: INTRODUCTION 
1.1 Steroidal Anti-Cancer Natural Products 
Man’s pursuit for the great chemical weapon against the multiple forms of cancer, 
a family of diseases that know no bounds, has continued the practice of relying on natural 
products for lead compounds.  The use of natural products for the remedy of many minor 
afflictions and even much more aggressive diseases can be traced back to ancient times. 
For most of the rich history of medicine, lead compounds were almost exclusively 
isolated from terrestrial species, whether the sources were fungi, bacteria, or fauna.  The 
ever increasing incidence of cancer and the continued need for a practical cure or even 
highly effective drugs to retard the progression of the disease, led to an expansion in the 
search for more sources of natural products.  To this end the interest in marine natural 
products can trace its origin to the 1970’s with the 1980’s being the decade showing the 
largest growth and highest activity.1 This important time led to the discovery of an array 
of diverse compounds with unique structures that differ greatly from those isolated from 
terrestrial sources.  A new array of steroidal compounds was isolated providing lead 





1.1.1 History of Bis-Steroidal Pyrazines 
In 1972, as part of SCUBA expeditions for marine natural products, Professor 
George Pettit and his team, from the University of Arizona began harvesting marine 
species at depths of greater than 20 meters off the coast of Africa and isolating natural 
compounds from extracts exhibiting high activity.  During this expedition to the deep 
shark infested waters, the hemichordate tube worm Cephalodiscus gilcristi was first 
obtained.2 After two years and extensive fractional separations, methanol and water 
extracts were screened against the NCI’s PS system (murine P-338 lymphocytic 
leukemia) proving to be highly active with an average GI50 of 1.2 nM and further showed 
a 32-41 % increase in the life span of mice.2-34  In 1988, after fifteen years of research, 
Pettit and coworkers were able to communicate with confidence the structures of 
cephalostatins 1 (1.1) and 7 (1.2) (Figure 1.1).3  Cephalostatin 1 (1.1) is one of the most 
active natural products ever screened against NCI’s 60 cell line panel showing 
subnanomolar to picomolar activity.  In subsequent communications through 1994, Pettit 
and coworkers communicated the structures of 19 cephalostatins (1-19).2-3,5 After several 
expeditions, 450 kg of the marine tube worm were harvested and 0.1 g of cephalostatin 1 
(1.1) and 60 mg of cephalostatin 7 were obtained.  Clearly, with the extremely low yield, 
harvesting will do more damage to the marine ecosystem than can be gained from the 





Figure 1.1 Cephalostatins 
While Pettit’s program was harvesting and isolating the cephalostatins, a separate 
group led by Fusetani began similar marine expeditions off the coast of Japan where the 
tunicate Ritterella tokioka was isolated and extractions revealed an active class of bis-
steroidal compounds called ritterazines (Figure 1.2).6 Fusetani and coworkers have since 
isolated 26 ritterazines (A-Z) bringing the total of this unique family of natural products 




Figure 1.2 Ritterazines examples                                        
1.1.2 Bis-Steroidal Pyrazine Structure and Nomenclature 
 The cephalostatin and ritterazine class of 45 trisdecacyclic compounds are 
characterized by symmetrical or unsymmetrical bis-C27-steroidal units connected in a 
serpentine manner through a pyrazine ring.  The cephalostatins two steroidal hemispheres 
are referred to as “North” and “South” (Figure 1.3), while the ritterazines are referred to 
as “East” and “West” (Figure 1.2).  Each steroid hemisphere is numbered (carbons 1-27) 
and ring designations A-F according to IUPAC standard for steroid nomenclature.  For 
the “South” and “West” units of cephalostatins and ritterazines, respectively, the “prime” 
designator is used for both carbon and ring position, (e.g. C12′ oxo = 12′-ketone of the 
South hemisphere of cephalostatin 1 (1.1)).  Steroidal subunit nomenclature follows 
published practice, e.g. “North 1” indicates the North unit of cephalostatin 1 (1.1) which 
is abbreviated as “1N” while “BW” indicates the West unit of ritterazine B 1.4.  
Stereochemistry is often designated as α (down) and β (up) with respect to the properly 
orientated steroidal structure and known stereochemistry is as drawn while solid circles 




Figure 1.3 Numbering and nomenclature 
1.2 Biological Background  
This rare class of natural products has been investigated by several groups and the 
NCI-60 COMPARE analysis has shown the activity profile of the cephalostatins to be 
among the most potent compounds ever tested and divergent from other known 
anticancer agents.8 The ritterazines, although harvested from different phyla, exhibit a 
similar activity profile against the NCI-60 panel as the cephalostatins with overall lower 
average GI50 values and sometimes variability in different cancer cell lines.
9 Of the 
ritterazines the most active of the family is ritterazine B with an average GI50 of 3.2 nm.
10 
Also exhibiting a similar activity profile was the terrestrial saponin truncate OSW-1 1.7 
and its four natural analogs (Figure 1.5) isolated from Ornithogalum saundersiae by 
Sashida11 and coworkers at Tokyo University.  OSW-1 exhibits a 10 fold increase in 
potency against the P338 cell line with a GI50 of 0.1 nM, and an NCI-60 correlation 




Figure 1.4  Family of potent steroidal antineoplastics 
The cephalostatins were first suggested to be members of the topoisomerase II 
class of inhibitors as these compounds were most similar to the cephalostatin activity 
profile in the NCI-COMPARE analysis.  Pettit excluded cephalostatins as topoisomerase 
inhibitors or antimicrotuble agents like taxol.12 It was also later determined that this class 
of compounds were not inhibitors of protein kinase C, nor tyrosine phosphatase cdc25, 
important molecular chemotherapeutic targets for effective reduction in tumor cell 
division.13 In studies conducted with cephalostatin 7 (1.2), Fuchs and coworkers had 
observed inhibition of the isoprenoid biosynthesis pathway, however, it was later 
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determined that this inhibition was not a result of deactivation of the key enzyme FTPase, 
which is responsible for post translational isoprenylation of ras proteins required for 
attachment to the cell membrane in order to initiate signal transduction from membrane 
receptors.14 Irrespective of the lack of inhibition of the FTPase, and lack of growth 
inhibition exhibited by simple symmetrical bis-steroidal pyrazine derivatives (Figure 1.5) 
in NCI’s 2 day 60 cell panel assays, these compounds continued to show strong 
differential cytotoxity of normal and ras transformed epithelial cells.15 The cephalostatin 
GI50 values were markedly enhanced, 10 fM, in Purdue University’s 6 day 8-10 cell mini-
panel compared to that of NCI’s 2 day 60 cell line assays.16 The strong time dependence 
was hypothesized and later confirmed by flow cytometery to result from apoptotic 
induction by these anti-neoplastic agents.16 The exact cellular target of these compounds 
and the link to the apoptotic response has been sparsely investigated, and progress has 
slow as a result of limited compound supply. 
 
 
Figure 1.5  Simple symmetric bis-steroidal pyrazines 
8 
 
 There are two known pathways involved in apoptosis, the first being extrinsic 
pathway mediated by the ligation of death receptors while the intrinsic pathway is 
mediated through the cells normal apoptosome formation, executioner complex, induced 
by cytochrome c release mediated by increased mitochondrial permiability.17  A recent 
publication by Wu and coworkers has shown the extrinsic pathway to be involved in the 
apoptotic behavior of OSW-1 in mammalian cells.18  The cytochrome c independent 
apoptosis exhibited by OSW-1 in Chinese hamster ovarian cells, was shown to result 
from activation of caspase-8 dependent cleavage of Bcl-2, a known protein involved in 
the suppression of apoptosis in healthy cells.  The cleavage of Bcl-2 has also been 
speculated to regulate cross talk between the death receptor pathway and the intrinsic 
mitochondrial pathway leading to the release of cytochrome c and successive apoptosome 
formation.  Interestingly however, the apoptotic activity of OSW-1 was substantially 
reduced in leukemia Jurkat T cells over expressing the Bcl-2 protein, a situation often 
occurring in most chemo and apoptotic resistant tumor cells.19 
In the case of cephalostatin 1 however, the extrinsic activation of caspase proteins 
triggered by endoplasmic reticulum (ER) stress has been cited by Vollmar and 
coworkers.16a,20  Although the specific role ER stress plays concerning tumor 
development and therapy is under debate, ER stress caused by chemotherapeutics has 
been clearly presented as an important factor in the regulation of tumor cell death.21  A 
few key proteins have been shown to be important for cephalostatin 1 apoptosome 
independent induced apoptosis.  In humans, these include the caspases-4 and 9 as well as 
the ASK1/JNK cascade.  The authors have found that although caspase-916a is required 
for apoptosis in leukemia Jurkat T cells, it is the upstream activation of caspase-4 that is 
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necessary for apoptotic induction.  They determined that cells deficient of caspase-9 pre-
treated with a known caspase-4 inhibitor did not show reduced DNA fragmentation 
induced by cephalostatin 1.  Further support of the upstream regulation of caspase-4 was 
determined from cells showing down regulation of the caspase-4 by RNA interference, 
which exhibited highly reduced levels of DNA fragmentation upon treatment with 
cephalostatin 1.20  In a separate study, they have linked the caspase cascade to increased 
mitochondrial permeability followed by release of SMAC/Diablo responsible as well for 
the amplification of the apoptotic signal.  Contrary to Wu’s data concerning the treatment 
Jurkat T-cells over-expressing the Bcl-2 with OSW-1 showing a reduction in apoptotic 
behavior versus normal Jurkat T cells, cephalostatin 1 continued to strongly induce 
apoptosis but showed a delayed release of the SMAC/Diablo.16a    
Shair and coworkers have recently claimed to have found the cellular targets of 
the cephalostatins, proteins OSBP (oxysterol binding protein) and ORP4L (OSBP related 
protein 4L).  They have gone as far as to coin the cephalostatin and related compounds as 
ORPphilins for the unique mechanism of action and the high binding affinity for OSBP 
compared to 25-OHC.22  OSBP and ORP4L have been shown to be involved in the 
cancer cell survival and linked between cancer cell proliferation and lipid processing, 
consistent with the isoprenoid biosynthesis pathway inhibition observed by Fuchs23  
From the work of Shair, it is important to note that there appears to be more than a 
transport phenomenon suggested by cells designed with their two mutant OSBP proteins 
that did not show reduced binding affinity for either cephalostatin or OSW-1, but the 
cells were desensitized to both cephalostatin 1 and OSW-1.22  OSBP has been reported to 
function as sterol-sensing scaffolding protein capable of making multiprotein complexes 
10 
 
in a ligand binding–dependent fashion.  The possible explanation for the desensitization 
of cells over expressing for OSBP mutants is that the mutations affect protein-protein 
interactions, and these interactions of OSBP with other proteins is involved in initiating 
antiproliferative activity of the ORPphilins.  The exact roles OSBP and ORP4L have on 
cancer cell survival is yet to be determined.  One suggestion is that translocation and 
sequestering of the oxysterol binding proteins could disrupt cell proliferation by down 
regulation of the lipid manufacturing machinery.24 By taking the OSBP proteins out of 
play, the cells may be unable to transport cholesterol and therefore could cause inability 
for cells to manufacture stable cell membranes or could shut down the membrane 
synthesis all together.      
1.2.1   Structure Activity Relationships of Steroidal Antineoplastic Agents 
The majority of cephalostatin and ritterazines natural products have mix-matched 
North and South subunits, and the 45 bis-steroidal pyrazines and OSW-1 provide a large 
group of natural analogs in which to study structure activity relationships.  For instance 
ritterazine G 1.5, one of the most active ritterazines, shares the Southern hemisphere of 
cephalostatin 7, while 23 other ritterazines also have at least one hemisphere in common 
with the cephalostatins.  Interestingly though, the same compound has not been isolated 
from the different phyla, and the degree of potency is not identical for the trisdecacyclic 
pyrazine natural products varying considerably by structural characteristics differences.  
The most potent compounds of the class are those bearing a molecular dipole consisting 
of covalently linked lipophilic “nonpolar” and hydroxylated “polar” domains, with a 
spatial separated by ~30Å.  Pro-oxocarbenium spiroketals with high ground state energies 
11 
 
have been correlated to increased apoptotic activity.10,25  The cephalostatins  also show 
activity dependence on the presence of the C14,15 olefin as well as free C12 and C17 
hydroxyl groups in the Northern hemisphere.26  The North hemisphere has been 
designated as the key to biological activity, while the Southern is less critical.27  For 
instance, the surprisingly potent interphylal spliced hybrid ritterostatin  GN1N  1.8 (Figure 
1.5), made from the replacement of the South steroid of cephalostatin 1 with the less 
complex North subunit of ritterazine G, continued to show subnanomolar activity in 
many cell lines, while having an average GI50 value was only ten-fold lower than that of 
cephalostatin 1.  The ability to replace the complex South unit (difficult to synthesize) 
(vide infra), with the less complex North G (easily synthesized in 9 operations) without 
considerable loss of activity increases the viability of the ritterostatins as biologically 








It has also been clearly indicated that at least one spiroketal in a higher energetic 
conformation is necessary for high antineoplastic activity.  It has often been speculated 
that the spiroketal plays a passive role in binding to the active site; however the 
spiroketals may play a central role in the level of cytotoxicity.  Through relating semi-
empirical calculations of the endothermicity of oxocarbenium ion formation to the  
relative cytotoxicity of tested compounds, the Fuchs28 group was able to predict the 
potency of untested compounds, this is exemplified by the fact that outliers in the original 
calculations were determined to have structural miss-assignments through synthesis.29  
These calculations have predicted 23’-deoxy-25-epi cephalostatin 1 1.10 as well as 25-
epi-ritterostatin GN1N 1.11 to be 10 to 100 times more active than cephalostatin 1 in the 
range of 0.1 to 0.01 nM, and have led to syntheses directed toward these highly desirable 
compounds (Figure 1.5).  Synthesized 25-epi-Ritterostatin GN1N was found to be 10 
times more active than cephalostatin 1 (submitted results).  The strong antiproliferative 
activity of 25-nat and its epimer 25-epi cephalostatin 1 indicates the C26 hydroxyl group 
can be orientated on either face without loss of activity.  Based on this observation 26,27-
dihydroxy-cephalostatin 1 (1.12) and 26,27-dihydroxy-ritterostatin GN1N 1.13 have 
emerged as a high value targets for their increased oxygenation of the North hemisphere, 
further enhancing the polarity difference between the hemispheres, along with the 
removal of the C25 stereocenter, a stereocenter proven to be challenging to install with 
high stereoselectivity.  However, the 1,2,3-trioxo arrangement brings about a new set of 
synthetic challenges and  efforts directed toward the synthesis of the high value 26,27-
dihydroxy North 1 subunit will be covered in chapter 3.  
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1.3 Cephalostatin Synthesis 
 
The original classic synthesis of cephalostatin 1 competed in 1999 was a 
tremendous feat by the Fuchs and group.30  However, the synthetic complexity and lack 
of atom economy of the original synthesis, did not provide a viable process for the 
production of the large quantities needed for clinical trials.27  The South 1.18 and North 














































































Figure 1.7 Fuchs first generation synthesis of cephalostatin 1 
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with an overall yield of ~1 % and 3% respectively, from the accessible plant steroid 
hecogenin acetate 1.14 (Figure 1.7).  The supply of both subunits was further limited by 
the long linear sequences employed in the synthesis and also relied upon the excision of 
six carbon atoms of the hecogenin acetate F-ring by the Marker degradation to give enone 
1.15.31  This was followed by differential reintroduction of the same six carbon atoms 
containing 5-6 stereocenters onto the unsaturated ketone 1.15 to give both the North and 
South units 1.19 and 1.18, respectively.  Finally, utilization of the procedure developed 
by Guo and Fuchs for unsymmetrical pyrazine coupling and global deprotection led to 
cephalostatin 1 (1.1).32 Cephalostatin 1 and the analogs 1.8-1.11 mentioned previously 
are by far the best candidates for clinical trials based on their calculated cytotoxicity.  
Coupled with the complexity of the classic synthesis and the inability to harvest 
substantial amounts of cephalostatin 1, a second generation synthesis was desperately 
needed.  
Substantial progress toward the synthesis of cephalostatins, ritterazines and OSW-
1 has been achieved, with the work of Fuchs and coworkers truly leading the way.  The 
overall focus of this thesis will be on those synthetic aspects related to present synthetic 
efforts of cephalostatin North 1 analogs.  Detailing fully the tremendous synthetic 
progress made up to this point is beyond the scope of this thesis and the reader is strongly 
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CHAPTER 2: ‘RED-OX’ STRATEGY 
2.1 Introduction 
 
Cephalostatin 1 is the highest valued member of the 45 trisdecacyclic pyrazine 
natural product family characterized by either symmetrical or unsymmetrical bis-C27-
steroidal subunits joined in a serpentine manner through a pyrazine ring.  The two 
cephalostatin steroidal halves are referred to as the North and South hemispheres (Figure 
2.1).  The original classic total synthesis of cephalostatin 1 completed in 1998 was a 
tremendous feat by the Fuchs1 group, and more recently by Shair2 and Tian.3 From the 
readily accessible plant steroid hecogenin acetate, the South and North subunits of 
cephalostatin 1 were synthesized by the Fuchs group in 36 and 32 operations, 
respectively with very modest overall yields. 
  
 










































The Fuchs synthesis relied upon the excision of the 6 carbon atoms of hecogenin acetate 
F-ring 1.14, followed by differential reintroduction of the same six carbon atoms 
containing the requisite stereochemistry to achieve both the North and South subunits 
(Figure 2.1).  Furthermore, the total syntheses of cephalostatin 1 by Shair and Tian also 
relied on the use of either F-ring excision or other simple steroids as precursors.  
Regardless of the removal of the six carbons of the F-ring, the syntheses remain complex, 
linear and lacked atom economy.  Of the three syntheses to date, the synthesis by Shair is 
the most convergent it still lacked atom economy in the southern hemisphere.  From these 
realizations, new strategic plans were undertaken to facilitate more efficient syntheses of 
cephalostatin analogs.  The ‘Red-Ox’ strategy was designed to increase the atom 
economy of the synthesis by maintaining the original 27 carbons of hecogenin acetate 
1.14, where the desired products differ only in their oxidation level and atom 
connectivity.  Through the development of new methodologies it was envisioned that the 
simple idea of reduction and oxidation could bring about an efficient (albeit linear) 
synthesis.  Regardless of this simple realization, no synthesis of the cephalostatin North 1 
hemisphere has been achieved to date through utilization of the ‘Red-Ox’ principle. 
 
2.2 ‘Red-Ox’ Strategy: the Beginning 
 
The strategy for the concise synthesis of each cephalostatin hemisphere through 
maintaining the original 27 carbons of hecogenin acetate can be traced as far back as 
1994.4  Since this time, several trisdecacyclic pyrazine natural products as well as OSW-1 




the ‘Red-Ox’ strategy is easily mapped by the site of oxidation, reduction or 
rearrangement (Figure 2.1).  Conversion of hecogenin acetate 1.14 into the North 1 
subunit requires reduction at C12 along with oxidations at carbons 14, 15,17, 23, and 25. 
Transformation of the 5/6 E/F- ring spiroketal of hecogenin through rearrangement to the 
kinetic 5/5 spiroketal is also required.  Endeavors into this strategy have generated 
several new synthetic methods and have led to some very interesting findings.  Organized 
by the ‘Red-Ox’ site, the early efforts of the ‘Red-Ox’ strategy are partially presented 
below focusing mainly on the North subunit of cephalostatin 1. 
2.2.1 Preceding C23 Oxidation Results 
The earliest application of the ‘Red-Ox’ strategy led to the synthesis of 17-deoxy- 
14,15-dihydro-derivative of cephalostatin North 1 2.3 by Jeong and Fuchs (Scheme 2.1).4 
The straightforward synthesis of the protected North 1 derivative was completed in 13 
steps and set the stage for this strategy.  Prior to C25 oxidation, Jeong and Fuchs 
achieved C23 functionalization through selective allylic oxidation of diene 2.1 via TFAA 
(trifluoroacetic anhydride) activated phenyl methyl sulfoxide providing a 1:2.2 mixture of 
C23 alcohols 2.2 in favor of the undesired β-isomer.  Stereochemical inversion of the 
undesired carbinol 2.2β was accomplished through a Mitsunobu reaction providing 79 % 
overall yield of the desired C23-(R)-alcohol in three steps.  The unavoidable C23 stereo 






Scheme 2.1 C23 allylic oxidation 
The introduction of the C23 oxo-functionality was also achieved through C-H 
oxidation prior to reductive F-ring opening of sapogenin C22 spiroketals (Scheme 2.2).  
Direct C23 C-H oxidation of sapogenins 2.4 can be traced back to 1970, where Barton 
first utilized nitrous acid or sodium nitrite (NaNO2) and BF3•OEt2 with the latter giving 
68 % yield of the desired C23-oxo compounds 2.5.5 The nitronium ion mediated C-H 
oxidation continues to be the method of choice by many groups.6 Stereoselective 
reduction of C23 ketone to the desired (R)-alcohol has proven to be difficult.  The Suarez 
group reported the use of sodium borohydride and L-Selectride which provided mixtures 
of alcohols 2.6α:2.6β in 95:5 and 37:63 ratios, respectively.7 These results clearly lacked 
the stereospecificity necessary for an efficient synthesis and the use of CBS reduction 






Scheme 2.2 Preceding oximinylation results for the production of C23 alcohols 
2.2.2 Preceding C25 Oxidation Results 
The number of methods available to achieve C25 oxidation is as limited as those 
for the C23 oxidation described above.  C25 oxidation has been most commonly achieved 
through Sharpless asymmetric dihydroxylation of the 1,1-disubstituted olefin 2.7 (Table 
2.1).  The degree of stereoselectivity achievable during dihydroxylation of the sapogenin 
side chains is highly substrate specific.  The substrate dependence can be attributed to 
general difficulties associated with the oxidation of 1,1-disubstituted olefins, which 
display overall lower stereoselectivities compared to internal and terminal olefins 
combined with the steric effects brought about by the bulkiness of the pendant steroid 
backbone.8 From the Sharpless dihydroxylation data in Table 2.1, no strong correlation 
between the bulk of C23 homoallylic substituents and the dr of 2.8(S):2.8(R) can be 
extrapolated.  Comparing entries 2 (R2 = OBz) and 7 (R2 = H) with the ligand free 
reaction of entry 3 (R2 = OTBS), dihydroxylation in these instances can be considered to 
be uncatalyzed.  What is truly interesting is the effect the remote C14 and C20 olefins 
have on the Sharpless dihydroxylation.  Stereoselectivities were greatly increased with 




both reaction rate and stereoselectivity was observed for C20 olefinic compounds (Entry 
2).  On the other hand, the deleterious effects of the C20 olefin were overcome by 
employing Corey’s (S,S)-diamine ligand (Entry 1).9 
 
Table 2.1 Summary of C25 oxidation through asymmetric dihydroxylation 
 
What is also noteworthy is the difference in stereoselectivities between entries 5 
and 6, which mainly differ in the presence of the C14 olefin.  Although AD-mix-α was 
used in both cases, complete reversal of stereoselectivity was observed with the C14 
unsaturated substrate providing the highest stereoselectivities for the natural isomer.  
From the collective data, the presence of the C14 olefin generally provides for more 
selective asymmetric dihydroxylation, while the saturated C14,15-dihydro compounds 
suffer from lower stereoselectivities with maximum diastereomeric ratios of 1:5.1 for 
C25-epimers (Entry 5) and 3:1 (Entry 4) for natural isomer.10  Overall, Sharpless 
 
 
Entry R R2 C20,22 / C14,15 Ligand (mol %) Yield (%) C25S : C25R 
1 β-OAc α-OTBDPS Δ20,22 / 14 α-H Corey9 (S,S) 98 7.7:14 
2 β-OBz α-OBz, Δ20,22 / Δ14 ADmix-α (10) 58 1.8:1
10 
3 H, H α-OTBS 22 α-H / 14 α-H ---- 99 2:17 
4 β-OAc α-OBz 22 α-H / 14 α-H ADmix-β (2) > 95 3:111 
5 β-OAc α-OBz 22 α-H / 14 α-H ADmix-α (2) > 95 1:5.111 
6 β-OBz α-OBz 22 α-H / Δ14 ADmix-α (1.4) 92 13:110 





asymmetric dihydroxylation has not been a consistent method for effective C25 oxidation 
of sapogenin substrates, and considerable development was needed in this area. 
2.2.3 Preceding C17 Oxidation Results 
The introduction of the C17 hydroxyl group is by far the most challenging of the 
required ‘Red-Ox’ transformations reflected in the limited number of syntheses reporting 
the introduction of this important functionality.  The strategy by Jeong and Fuchs 
mentioned earlier, although concise with only 13 operations, did not allow for 
introduction of the essential C17 hydroxy group to North 1.  The overall strategy of 
‘North 1’ analogs must provide access for the C17 hydroxy compound, as this 
functionality has been indicated for high antineoplastic activity.11 Significant effort was 
made by J. S. Lee to incorporate the C17-OH; through TFAT (trifluoroacetyl trifluoro-
methylsulfonate) mediated E-ring opening of D-ring allylic ether 2.9 provided 14,16-
dienyl-22β-triflate 2.10 in 92 % yield (Scheme 2.3).12 Hydrolysis of triflate 2.10 followed 
by Swern oxidation, provided 22-ketone 2.11, which was subsequently protected as 
dioxolane 2.12.  Irradiation of D-ring diene 2.12 in the presence of tetraphenylporphine 
(TPP) under an O2 atmosphere gave the 14,17-bridged peroxo-compound 2.13 in 98 % 
yield as a single diastereomer.  The peroxo moiety was later reduced with Zn/AcOH to 
provide diol 2.14 in 86 % yield.  Upon DDQ mediated dioxolane cleavage, the 17- 
hydroxyl compound 2.15 was obtained, which J. S. Lee and Fuchs further transformed to 





Scheme 2.3 C17 oxidation through singlet oxygen [4+2] cycloaddition  
Around the same time, S. M. Lee and Fuchs had developed a method for the 
introduction of the C17 hydroxyl group for the 14,15-dihydro series (Scheme 2.4).10 
From the highly functionalized 14,15-dihydro compound 2.17, S. M. Lee developed a 
chromium trioxide protocol for the oxidative cleavage of the E-ring to provide the 16,22-
diketone 2.18.13 Treatment of diketone 2.18 with preformed TMSI and HMDS gave 
intermediate silyl enol ether 2.19 which subsequently underwent epoxidation with in situ 
generated TFDO to provide the C17-dihydroxy compound 2.20 in 45 % yield over two 
steps. To date these are the only two methods to introduce the C17-hydroxyl group 
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a) TFAT, DTBMP, CH2Cl2, -30 °C; b) Na2CO3, THF/MeOH/H2O 92 %; over 2 steps; c) DMSO, TFAA, DIPEA, CH2Cl2,
-78 °C; d) Sc(OTf)3, 1,2-diol, (MeO)3CH, CH3CN, 91 %; e) TPP, O2, sunlamp, -78 °C, 98 %, C20 - adduct only; f) Zn,
















Scheme 2.4 C17 oxidation through α-hydroxylation 
2.2.4 Spiroketal Rearrangement: Ring Opening 
The necessity for the dihydroxylation of C25 olefin 2.7 was essential as stated 
above (Table 2.1), and required controlled F-ring opening of C22 spiroketals to provide 
the C26 alcohol needed for further functionalization.  The requisite F-ring opening has 
been achieved through several methods (Scheme 2.5).  Under vigorous acid conditions, 
the 26-acetoxy-20,22-dehydro-compound 2.23 is obtained from 2.22 in moderate to good 
yields.  The C26 iodo compound 2.24, counterpart to the acetate above, was achieved 
through concurrent F-ring opening/iodination developed by LaCour and Fuchs to give the 
iodo compounds with small amounts of chloride.14 J. S. Lee and Fuchs later developed 
the effective Lewis acidic TFAT for F-ring spiroketal opening as well as E-ring 




compounds 2.25 in high yields.  Unlike the former two ring-opening procedures, the 
TFAT cleavage can accommodate functionality at the C23 position.   
 
 
Scheme 2.5 Effective F-ring spiroketal ring opening procedures 
Use of excess TFAT on C14,15 olefinic compounds first brings about F-ring 
opening followed by eliminative E-ring opening to give D-ring dienes 2.26.  Orthogonal 
to the F-ring eliminative procedures, two reductive F-ring opening methods have been 
developed.  Suarez adapted the titanium chloride/diphenyl silane mediated reductive ring 
















a) (i) octanoic acid, Ac2O, reflux; (ii) KOH, MeOH; b) PPh3•I2, DTMP, BF3 OEt2, 83 °C, up to 85 % and 18:1 2.24I
/ 2.24Cl; or PPh3•I2, base (2,6-lutidine or imidazole), 42- 140 °C, 73-92 % and up to 17:1 2.24I / 2.24Cl; c) TFAT,
1.5 - 3.2 eq., CH2Cl2, -30 - -40 °C; d) TFAT > 3 eq., CH2Cl2 -78 °C, 20 mixture; e) TiCl4, Ph2SiH2, CH2Cl2,
















X = O; H,H; or - OR
Y = H; or - OR
where R = H, Ac, or Bz
R1 = H or 14
X = H,H; or - OR
Y = H; or - OR
where R = Ac, or Bz
R1 = H or 14X = H,H; or - OR















hydroxy-rockogenin 2.22 providing the 23,26-diol 2.27 (Y = OH) in 67 % yield as a 
single diastereomer.7 Several years later on the way to reassigning the structure of 
ritterazine M, S. M. Lee and Fuchs reported a similar reductive F-ring opening protocol 
utilizing BF3•OEt2 and triethylsilane to provide 2.27 (Y = H) in 94 % yield.
17 Of the 
procedures reported, the BF3•OEt2/triethylsilane method has proven to be the highest 
yielding (up to 99 %), controllable and tolerant of functional groups with the exception of 
silyl protecting groups. 
2.2.5 Spiroketal Rearrangement: Ring Closing 
As described in Chapter 1, SAR studies and modeling calculations accomplished 
by LaCour and Fuchs correlated the biological activity of the bis-steroidal pyrazines to 
spiroketal stability and rate of oxocarbenium ion formation.11,18 The correlation between 
oxocarbenium ion stability and inhibitory activity is just one factor affecting the overall 
anticancer activity of these natural products.  The most active pyrazine natural products 
described earlier, all posses either a 5/5 or 5/6 spiroketal in the non-thermodynamic 
configuration.  To this end, construction of kinetic 5/5 spiroketals of cephalostatin North 
1 analogs has been a challenging and critical endeavor.  Successful strategies for 
construction of kinetic spiroketals have included acid catalyzed cyclizations, electrophilic 
halogen mediated cyclizations and intramolecular hydrogen abstraction (IHA) protocols.  
Universally, these strategies have shown to be influenced by both the level of 
oxygenation of the side chain as well as the nature of the C14,15 bond.  To date a 
universally effective method for the controlled construction of kinetic spiroketals has yet 





Figure 2.2 Successful acid catalyzed spiroketalizations 
Acid catalyzed spiroketalizations have been mostly widely employed for 
cyclization of 16,22-diketones 2.31 and 22-hemiketals 2.29 predominantly providing the 
thermodynamic spiroketals 2.28 characterized by double anomeric stabilization (Figure 
2.2).19 Conversely, CSA mediated cyclization of the 23-benzoyl-22-methylketal 2.32 
generated the desired kinetic spiroketal 2.33 almost exclusively, confirmed by X-ray 
crystallography (unpublished results). Considering the observed hemi-ketal side product 
2.34, it is believed the inversion of product distribution under thermodynamic conditions 
is effected by C23 neighboring group participation.  Attack of the C23 benzoate on the 




The production of the kinetic spiroketal is in stark contrast to that of acid catalyzed 
cyclization of the C23-benzoyl-diketo compound 2.31 (Z = OBz).10 The observed switch 
back to the thermodynamic control for the similarly C23 substituted diketo compounds 
can be attributed to the order of ring formations.  To take advantage of the C23 
neighboring group participation, the E-ring must be formed prior to F-ring cyclization.  
Given the cascade of events for acid catalyzed diketone cyclization, the E-ring cannot be 
formed first (Figure 2.2).   
Acid catalyzed 5/5-spiroketalizations were not successfully employed for the 
C22-20 olefinic compounds 2.35 or 2.36 during the construction of the northern 
hemisphere toward the first total synthesis of cephalostatin 1 (Figure 2.3).20 Acid 
catalyzed cyclization of 17-deoxy-23-hydroxy- compounds 2.35 led to the desired kinetic 
spiroketals, however, the C20β-Me epimers 2.41 were obtained exclusively.21 The C20 
epimer problem was overcome by utilizing a 2 step protocol involving electrophilic 
bromonium directed oxy-cyclization with subsequent chromium(II) mediated radical 
debromination to obtain the natural C20α-methyl products.  NBS mediated cyclization of 
23-hydroxyl-20,22-ene compounds 2.35 and 2.36 resulted in the formation of the C20α-
bromo compounds 2.37 and 2.38 containing the desired kinetic C22-(S)-spiroketals.  
Chromium(II) chloride mediated radical debromination of 2.38 resulted in a 9:1 mixture 
of C20α:C20β-Me compounds 2.40α and 2.40β favoring the C20α-Me product 2.40α.  
On the other hand, quantitative radical debromination of 14,15-dihydro-compound 2.37 
led to compound 2.39β maintaining the C20β-Me. C20 stereoselectivity of 14,15-






Figure 2.3 NBS/CrCl2 mediated kinetic spiroketalization 
and C18 methyl groups.  The interaction is exacerbated by the conformational change 
induced by the C14,15 double bond of 2.38 compared to the 14,15-dihydro compound 
2.37.  The successful sequence was adapted from a triphenyltin hydride mediated radical 
debromination protocol developed during the ‘Red-Ox’ synthesis of 17-deoxy-14,15-
dihydro-North 14 when the original debromination conditions were unsuccessfully 
applied to the C17-hydroxylated series resulting in complex mixtures without signs of 
debromination.21a The desired natural C20α compound 2.40α was furnished in only 80 % 























2.36 Y = OTMS R = Ac
Z = OTBDPS, or C14,15 = H
2.41 C14,15 = H
a) PPTS, CH2Cl2, 0 °C, 5h, 8:1 2.41:2.42; b) PPTS, DCE, 80°C, 2 h,
97:3 2.41:2.42; c) NBS, THF, -78 to 0 °C; d) CrCl2, DMSO, BuSH.
2.37 Y, R = H; Z = OH,

























2.38 Y = OTMS R= Ac
Z = OTBDPS, 91%
2.39 C20- Y, R = H; Z = OH;
C14,15 = H quant





debromination protocol for the exclusive formation of the C22 kinetic spiroketals was 
unequalled for more than 2 decades. 
 The electrophilic halogenation of C20,22 ene compounds resulted in the kinetic 
spiroketal regardless of the protecting group on the C23 alcohol, free OH for 2.35 or 
TBDPS for 2.36 (Figure 2.3).  The driving factor is the approach of the electrophilic 
bromine from the sterically less hindered α-face of the alkene.  Acid mediated 
cyclizations however, lack a bridged intermediate and the addition of H+ has little bearing 
on the stereochemical outcome of the spiroketalization.  Regardless, acid mediated 
cyclization of 2.35 provided the C22-(S) 5/5 spiroketal 2.41 exclusively as the C20β-Me 
isomer along with the 5/6 spiroketal 2.42 which could be converted to 2.41 nearly 
quantitatively through acid catalyzed equilibration.  Two possible factors contribute to 
the high stereoselectivity observed for the acid catalyzed cyclizations; 1) the steric 
interaction of the C23 hydroxy with the C20β-methyl may decrease the stability of the 
unnatural spiroketal resulting in the natural spiroketal to become the thermodynamic 
product, or 2) the free C23 hydroxyl group may play an active role in the stereochemical 
outcome through formation of a transient 3-membered oxonium ion.  The two hypothesis 
are both supported by the ability to isomerize the 5/6 spiroketal 2.42 to the natural 5/5 
spiroketal 2.41 under acidic conditions, and insufficient data is available with regard to 
the C20β-methyl compounds to discern between the two hypotheses.  
On the other hand, the natural C20α-methyl compounds have shown preference 
for kinetic spiroketals with nucleophilic neighboring groups at the C23 position.  The 
benzoate has been postulated to stabilize the carbenium ion and directly affect the 




naturally occurring C23-hydroxy substituted kinetic spiroketals?  Shair and coworkers 
nicely showed C23-deoxy compounds prefer to form the unnatural spiroketal under 
thermodynamic conditions, and any kinetic isomers can be quickly equilibrated in the 
presence of mild Lewis acids like aqueous MgSO4.
19 Based on their findings, they 
avoided thermodynamic cyclizations conditions during their synthesis of cephalostatin 
North 1.2  Tian’s observations during their synthesis of North 1, corroborates the C23 
neighboring group effect.22 Acid catalyzed cyclization of 23-acetoxy-22-methyl ketal 
exclusively provided the natural spiroketal on a 5 g scale along with partial hydrolysis of 
the C23-acetate.  Deprotection of the C23-acetate is a result of Prevost-Woodward 
hydrolysis of the bridged oxonium ion 2.44 arising from the attack of the acetate on the 
C22 oxonium ion 2.43 (Figure 2.4).  A similar C23-benzoate deprotection was also 
observed during cyclization (chapter 3).  These observations combined with the 
characterized side product 2.34 (Figure 2.2) described above definitively indicated the 
neighboring group participation of C23 esters.   
There are limited reports detailing acid catalyzed spiroketalizations of 23-hydroxy 
compounds, however the stability of naturally occurring cephalostatins and ritterazine  
with kinetic spiroketals containing C23 hydroxyl groups suggests a similar neighboring 
group effect.4  Therefore, it can be rationalized that kinetic spiroketalization is favored 
when a nucleophilic C23 substituent can stabilize the oxonium ion through transient 
attack from the α-face of the oxonium ion 2.43 (R = Ph, Me) or 2.47 providing the lower 
energy 3 and 5-membered intermediates 2.44 and 2.48 (Figure 2.4).  The cyclic 
resonance structures obtain the lowest energy upon attack from the α-face providing 




C23 on the same side as the C16 oxygen.  With these facts in mind, effective 
stereochemical control of 5/5 spiroketalization of sapogenins relies on two contributing 
factors, 1) preformation of the E-ring with the correct oxidation at C22 and 2) the 
presence of nucleophilic C23-(R) substituents.  On the other hand, thermodynamic 




Figure 2.4 Proposed C23 benzyloxy and hydroxyl oxonium stabilization 
In 2002 Suarez first utilized their previously reported IHA23 protocol to effect the 
formation of various spiroketals from C25 alcohol derivatives (Table 2.2).7 The IHA 
mediated cyclization is effective for the formation of spiroketals from E-ring ethers 2.50, 
however, as can be seen in Table 2.2 the unnatural spiroketals 2.51b are predominantly 
formed.  Employing the IHA protocol on the C23 TBS protected compounds 2.50, Suarez 




natural compounds while obtaining a 33:67 ratio for the C25-epi-compounds (Entries 1 
and 2).  These results are in line with those obtained by Fuchs17,24 and Shair.19 Not unlike 
the acid catalyzed spiroketalization protocols described above, the IHA mediated 
spiroketalization (Entries 4-5 and Entries 6-7) is heavily affected by both the level of 
oxygenation and nature of the C23 substituents.  J. S. Lee and Fuchs24 obtained the 
desired kinetic spiroketal 2.51a nearly exclusively for the 23-deoxy compound (Entry 3), 
while Shair (Entries 6 and 7)19 and S. M. Lee (Entries 8 and 9)17 later observed ratios 
ranging from 1:2.7 to 0:100 during their ritterazine studies. 
 
Table 2.2 IHA mediated spiroketalization 
 
J. S. Lee observed a strong negative effect with C23 silyl protected alcohols 
resulting in exclusive formation of the undesired spiroketal 2.51b (Entry 4).  The C23 
Entry X Y Z R1 .R2 C25 2.51a:2.51b Yield (%) 
1 H H OTBS 14 α-H Ac nat 1:2.5 83 
2 H H OTBS 14 α-H Ac epi 1:2 83 
3 OAc H H Δ14 Ac nat 20:1 87 
4 OAc H OTBS Δ14 Ac nat 1:20 81 
5 OBz H OBz Δ14 Bz nat 1:1.7 75 
6 OAc H H Δ14 Me nat 1:2.7 100 
7 OAc H H 14 α-H Me nat 1:3 100 
8 H H H Δ14 Bz nat 0:100 90 
9 OBz H H 14 α-H TBDPS nat 0:100 51a
10 Bz H H 14 α-H Bz nat 28:72 83 
11 Bz H OH Δ14 Bz nat 100:0 - 





























benzoate compounds surprisingly gave a ratio of 1:1.7 in favor of the unnatural spiroketal 
2.51b (Entry 5), displaying significantly lower selectivity than observed with acid 
mediated cyclization suggesting a loss of the strong positive effect of C23-benzoate.  On 
the other hand the desired spiroketals 2.51a were obtained as nearly single diastereomers 
when C23 = OH and C23 = H (Entries 11 and 3).  Although a 20:1 mixture was obtained 
for the 23-deoxy compound, the lack of C23 substitution does not correlate directly to 
positive stereocontrol (Entries 6-9).   
Based on the data provided the following mechanism was proposed (Figure 2.5); 
during the course of the reaction the transient O-I bond of 2.53 undergoes homolytic 
cleavage to give the oxygen centered radical 2.54, which initiates a 1,5 intramolecular 
hydrogen abstraction of the α-H to give the C22 centered radical 2.55.  The C22 centered 
radical 2.55 recombines with either an iodinine radical or molecule of iodine to generate 
the unstable 22-iodo species 2.56, which readily generates oxonium ion 2.57 giving way 
to a mixture of C22 spiroketals 2.58 and 2.59 through attack of the β and α-faces, 





Figure 2.5 Oxygen centered radical mediated intramolecular hydrogen abstraction 
Although oxonium intermediate 2.57 is proposed in both the IHA and acid 
catalyzed spiroketalizations (Figure 2.5), the positive control of spiroketalization 
observed for 23-hydroxy compounds along with a lack of positive effect for 23-benzoyl 
compounds denotes a pronounced change compared to the positive effects observed for 
both C23 substituents during hemi-ketal acid catalyzed cyclizations.  Potentially the 
reduced positive effect of the 23-benzoyl compounds is a result of transition state pre-




radical 2.54, increasing the rate of α-attack on the oxonium ion.  A lower C22-23 barrier 
of rotation for the C23-hydroxy compounds combined with hydrogen bonding between 
the C23 and C25 alcohols potential maintains the positive spiroketalization effect 
compared to the larger 23-benzoyl compounds exhibiting a larger rotational barrier.  
Therefore, the potential for stereocontrol during IHA mediated spiroketalization is 
plausible only with small C23 substituents with the largest effect being observed for 23-
hydroxy compounds.  However, data suggests acid catalyzed equilibration of the products 
would provide the desired spiroketals for C23 acetoxy, benzyloxy and alcohols which to 
has yet to be reported.   
Overall the preceding efforts toward ‘Red-Ox’ functionalization of hecogenin 
acetate provided a stellar foundation for further development of this strategy.  Although 
noteworthy, the methods developed for oxidation of the C23 and C25 positions were only 
moderately stereoselective requiring further development and is the subject of the 
following sections.  On the other hand, by looking at the reported data as a whole a 
highly effective strategy for the production of kinetic C22 5/5 spiroketals has been 
revealed to overcome this difficult transformation.   
2.3 Toward the Synthesis of 25-epi-14,15-dihydro-North 1 Analogs 
2.3.1 Diketone Strategy: Retrosynthesis  
As stated more extensively earlier, the synthesis of the 25-epi-14,15-dihydro-
North compounds from hecogenin acetate 1.14 required C12 reduction and oxidations at 
carbons 17, 23 and 25 prior to formation of the kinetic 5/5 spiroketal.  Preceding work 




oxidative methods13,25 while illuminating the difficulty in achieving both high C25 
diastereoselectivity and formation of kinetic spiroketals (Figure 2.6).10   The synthesis 
showcased the use of two new oxidative methods developed by S. M.  Lee and Fuchs:  
the oximinylation25 through in situ nitrosonium ion formation for the introduction of the 
C23-oxo functionality of 2.65, and the use chromyl trioxide13  for efficient oxidative E-
ring opening providing 16,22-diketone 2.61 that set the stage for C17 oxidation and 
thermodynamic spiroketalization. These transformations were re-examined for process 
driven optimization as well as the introduction of new strategies for the efficient 
synthesis of 25-epi-14,15-dihydro-North 1 analogs.   
 
 
Figure 2.6 Diketone strategy retrosynthesis 
2.3.1.1 Diketone Strategy: C23 Alcohol Formation: Oximinylation   
Readily available 12β-rockogenin acetate 2.4 through the established 
stereoselective C12 keto-reduction of hecogenin acetate providing the starting point for 









































earlier, C23 oxygenation required an improved oxidative method that could take 
advantage of the spiroketal/enol equilibrium generated under acidic F-ring open 
conditions.  In 2005 S. M. Lee and Fuchs published an efficient method to afford the 
C23-oxo functionality through direct C-H α-oximinylation of 5,6 spiroketals.25 The 
controlled addition of catalytic BF3•OEt2 to a solution of t-butyl nitrite and spiroketal, 
provided the C23 oxime 2.66 of rockogenin in up to 92 % yield.  Hydrolysis of oxime 
2.66 under harsh acidic conditions resulted in the desired C23 ketone 2.67 in 77 % yield 
along with partial hydrolysis of the C3 acetate which was reintroduced with acetic 
anhydride / DMAP to give an overall yield of 69 % for the two steps.  
 
 

































2.66 X = NOH
2.67 X=O
92 %
a) cat. pTSA, .1 M HCl, EtOAc, reflux; ii) Ac2O, DMAP, TEA, CH2Cl2,77 %, 2 steps; (69 % from 2.4);
b) HCOOH, EtOAc, 60 °C 90 % from rockogenin acetate 2.4
b
2.68 45 %














Taking a closer look at the oximinylation reaction, the originally reported oxime 
2.66 was indeed generated, however, inspection of 13C NMRs indicated the presence of 
the ketone signal at 202 ppm in the crude reaction mixture along with the oxime at 154 
ppm (Scheme 2.6).25  The ketone signal indicated the reaction conditions themselves 
were capable of hydrolyzing oxime 2.66 to the C23 ketone 2.67 which contradicted the 
original report that the ketone was formed solely upon hydrolysis with strong acid.  The 
oximinylation reaction utilized acetic acid as a solvent which has a pKa = 4.5, which was 
inefficient at driving the hydrolysis to completion.  On the other hand, p-TSA in aqueous 
HCl/ EtOAc (pKa < 1) was too harsh, resulting hydrolysis of the oxime and hydrolysis of 
the C3 acetate.10  By controlling the pH, it was envisioned hydrolysis of oxime 2.66 could 
be achieved chemoselectively.  The first choice was to evaluated acids with a moderately 
greater acidity between 1 and 4.5.  Subjecting the crude product to aqueous formic acid 
(pKa = 3.8)/ ethanol system at 60 °C provided complete conversion of the oxime 2.66 to 
ketone 2.67 in 6 hours without loss of the C3 acetate.  As a result of this seemingly minor 
change, the C23 ketone 2.67 was obtained in 90 % overall yield in a single operation 
compared to 69 % yield obtained from the original harsh hydrolysis conditions requiring 
acetate re-protection.  
Review of the literature, resulted of several reports accounting the formation of 
the C23 ketones 2.67 directly through in situ NO+ C-H oxidation.  Iglesias-Arteaga and 
co-workers in 1999, reported the direct synthesis of the C23 ketone through 
oximinylation of rockogenin acetate 2.4 under Bartons’s conditions NaNO2/BF3•OEt2 in 
68 % overall yield (Equation B).6a,26 The ketone 2.67 was also obtained with 
commercially available NO+BF4




observed lack of oxime 2.66 intermediate was viewed as the result of oxidative cleavage 
of the incipient oxime with excess nitrosonium ion.  This was certainly supported by 
Wolfram et al. whereby addition of sodium nitrite in acidic cleaves the C=N bond of 
oximes 2.69 to regenerate the carbonyl 2.70 in good yields (equation D).27  Iglesias-
Arteaga and coworkers dug deeper into the nitrosation reaction, and were able to isolate 
and characterize the nitroimine 2.72 providing confirmation of its formation from 2.66 
(Scheme 2.7).6c,28 The use of excess commercial and in situ generated NOBF4 provided 
sufficient amounts of NO+ to convert the oxime 2.66 to the short lived nitroimine 2.72 
which undergoes rapid hydrolysis during work-up to provide ketone 2.67.6c  
In contrast to the reports described above, catalytic BF3•OEt2 was used in the 
Purdue group’s  BF3•OEt2/t-BuONO system, and acetic acid was too weak to rapidly 
generate sufficient amounts of  NO+ to fully oxidize oxime 2.66 to nitroimine 2.72 in the 
short reaction times (Scheme 2.7).  Extending the reaction times of the catalytic system 
provided increase yields of ketone 2.67, however, F-ring cleavage of the intermediary 
oxime 2.66 through second order Beckmann rearrangement gave increased amounts of 
lactone 2.68 (Scheme 2.6, Equation C).6c,29  The competitive nature of these two reaction 
pathways is made apparent from the formation of the lactone in all reported 






Scheme 2.7 Fate of the oxime intermediate 
Catalytic BF3•OEt2 / t-BuONO mediated oximinylation provided higher yields 
than the previously reported methods; however, it came with its own set of challenges.  
The reaction was observed to be extremely sensitive to reagent quality and subtle 
temperature changes.  Addition of boron trifluoride to a mixture of starting material and 
t-butyl nitrite too quickly caused subtle increases in the reaction temperature which in 
turn caused increased formation of the lactone side product 2.68 in up to 25 % yield 
(Scheme 2.7).  The effect of the temperature increase from exothermic mixing of boron 
trifluoride and acetic acid was exacerbated by the solvent viscosity which leads to 
increased lifetimes of the boron trifluoride / oxime solvation pair with sufficient energy 
to rapidly induce the second order Beckmann rearrangement providing increased yields 
of lactone 2.68.  The lactone byproduct 2.68 can be avoided completely through a slow 
rate of addition and high quality reagents with the BF3•OEt2 quality being the most 




and decreased ratios of ketone 2.67:lactone 2.68 regardless of the rate of addition (vide 
infra).  
 
2.3.1.2 Diketone Strategy: Synthesis of the C23-(R)-Alcohol 
With increased efficiency and control of the nitrosonium C-H oxidation, as 
described in section 2.3.1.1, the C23 ketone was poised to provide access to the required 
C23-(R)-alcohol through stereoselective reduction.  S. M. Lee had found that reduction of 
12β-acetoxy-23-ketone 2.67 via Corey-Bakshi-Shibata (CBS) reduction with the (S)-2-
Me-CBS catalyst and BH3•SMe2 as the terminal reductant provided the desired (R)-
alcohol in a 6:1 ratio and 90 % combined yield (Table 2.3, Entry 1).  CBS reduction of 
the 12β-benzoyl-23-ketone 2.73 under the above conditions resulted in only a 2.5:1 
mixture of alcohols which proved difficult to separate by column chromatography (Entry 
2). 
 
Table 2.3 Production of C23-(R) alcohol 
Entry R Reductant Solvent d.r. (R):(S) Yield (%) 
1 Ac BH3•SMe2 THF 6:1 90 
2 Bz BH3•SMe2 THF 2.5:1 89 
3 Bz BH3•THF THF 2.5:1 37 
4 Bz BH3•SMe2 DCM 2.5:1 66 
5 Bz BH3•SMe2 PhMe 2:1 73 
6 Bz Catechol THF N.D 30 
7 Ac CeCl3/ NaBH4 MeOH:THF 5:95 95 




Desiring higher stereoselectivity to counter act the difficult separation, attempts  
were made to increase the overall diastereoselectivity of the C12-OBz compound 2.75.  
Given the success of the CBS reduction, compared to Luche conditions and L-Selectride 
which produce the (S)-alcohol as the major product in 95:5 and 72:28 respectively (Table 
2.3, Entries 7 and 8), a closer look was taken at this transformation.30 The low selectivity 
(Entry 2) was considered a result of uncatalyzed reduction through approach of the 
borane complex from the less sterically hindered top face across the C26 oxygen to 
provide the equatorial alcohol.  Believing that a lower chelating solvent could increase 
the rate of catalytic reduction, dichloromethane and toluene were screened (Entries 4 and 
5).  Lowering the solvent polarity reduced the reaction times, but had little effect on the 
diastereoselectivity and resulted in lower yields.  Changing the rate of addition to 1 hr 
from 20 minutes caused an even further reduction in yield resulting in the formation of 
C3 deacylated products.  This same phenomena was also observed when BH3•THF was 
used as the terminal reductant (Entry 3).  On the other hand, changing to the bulkier 
catechol borane resulted in only 30 % conversion (Entry 6).  At this point, further 
optimization was halted, however future directions should focus on the investigation of 
chiral transfer hydrogenation and hydrosilylation as larger transition metal catalysts could 
provide enhanced chiral environments and/or selective non-chelation controlled delivery 





2.3.1.3 Diketone Strategy: Kinetic Resolution of α-hydroxy Spiroketals 
With moderate stereoselective access to the C23-(R)-alcohol as described in the 
previous section, the synthesis of 23,26-diol 2.77 was realized through the earlier 
described stereoselective reductive F-ring opening.  Through use of  BF3•OEt2 / 
triethylsilane, diol 2.77 was obtained in 99 % from the purified alcohols 2.76  (Table 2.4, 
Entry 1 R = ax-OH).17  During investigation of reductive ring opening of a mixture of 12-
benzoate-23-alcohols 2.73 containing 10 % of the undesired equatorial alcohol, complete 
consumption of the axial alcohol was observed prior to the consumption of the equatorial 
alcohol by TLC prior.  Taking a deeper look at this observation, each pure 12-acetoxy-
23-alcohols was subjected to BF3•OEt2/ triethylsilane reductive ring opening and the 
reactions were complete in 8 and 48 hours for the axial and equatorial alcohols, 
respectively (Table 2.4, Entries 1 and 3).   
 
Table 2.4 Substitution effect on reductive ring opening 
 
Entry R1 R2 
BF3•OEt2 
(equiv) 
Et3SiH (equiv) Time (h) Yield (%) 
1 Ac ax.-OH 3 3 8 99 
2 Bz ax.-OH 3+ 3+ 8 89 
3 Ac eq. -OH 3 3 48 37 
4 Ac H 3 3 12 66 
5 Ac ax. -OAc 9 9 36 73 






Considering the apparent difference in reaction rate and the previous observation 
for the 12-OBz compounds, it was clear that kinetic resolution of the two diastereotopic 
alcohols could be potentially realized.  Treating a 2:1 mixture of C23-(R):(S) alcohols 
2.78 with BF3•OEt2 / triethylsilane equivalents adjusted to the to coincide with the 
percent of axial alcohol in the mixture, kinetic resolution was achieved to provide 
23(R),26-diol 2.79(R) with > 12:1 diastereoselectivity as determined by 1H NMR 
(Scheme 2.8).  A 4:1 mixture of 12-acetoxy-23-alcohols 2.80 were treated under the same 
conditions to provide 23(R),26-diol 2.81(R) in > 19:1 diastereoselectivity.  The resulting 
drastic difference in polarity allowed for 23(R),26-diol 2.81(R) to be easily obtained in 75 
% yield through simple silica gel plug filtration.  Cyclic eq-alcohol 2.80(S) was then 
recycled through Swern oxidation followed by a second iteration of CBS reduction and 
kinetic reductive ring opening to provide access to an additional 14 % of diol C23-(R),26 
diol 2.81(R), bringing the total yield to 89 %.   
 




To consider why this kinetic resolution is possible, a deeper examination of the 
C23 substitutions effect on the rate of reductive ring opening was accomplished (Table 
2.4).  Clearly seen, the highest rate of reductive ring opening belonged to the unprotected 
axial alcohols (Entries 1 and 2).  Protection of the axial alcohols as either acetate or 
benzoate required increased equivalents of BF3•OEt2 / triethylsilane for complete 
spiroketal reduction in 36 hours (Table 2.4, Entries 5 and 6).  On the other hand, the 
unsubstituted C23 spiroketal completes in only slightly longer reaction times of 12 hours 
(Table 2.4, Entry 4). 
The rate of reductive ring opening is affected by the equilibrium position between 
spiroketal 2.80 and the oxonium ion 2.81 (Figure 2.7).  The more the equilibrium lays 
toward the oxonium ion, the more accelerated the reaction, suggesting the axial alcohol 
must help stabilize the oxonium ion, despite the inductive nature of the Lewis acid / 
alcohol complex which is expected destabilize the oxonium ion.  Considering the higher 
Lewis basicity of alcohols compared to the spiroketal oxygens, the increased rate with the 
presence of the axial alcohol is even more surprising.  The decreased reaction time for the 
C23 axial alcohols was believed to result from two possible factors; 1) the stabilization of 
the oxonium ion 2.81 through the intermediacy of the epoxide 2.82, or 2) a neighboring 
group proximal directing effect, delivering the Lewis acid to the C26 oxygen of the 
spiroketal.  The possibility for scenario one was decreased by the retarded rate of the C23 
acetate and benzoate which have also been shown to stabilize the oxonium ion as 






Figure 2.7 C23 alcohol stabilization of oxonium 
Furthermore, molecular modeling showed the equatorial alcohol lays anti-
periplanar to the 22,26 spiroketal C-O bond and would be expected to stabilize the 
oxonium more effectively through formation of 5/3 spiroketal 2.82(S) pointing toward 
the idea that the strained spiroketal intermediates were not significant contributors to 
oxonium stabilization.  Strain relief was determined to a non-factor for the observed 
reactivity, as axial C23 acetate and benzoates would again show enhanced reaction rates 
which failed to do so (Table 2.4 Entries 5-6).  Therefore, the close proximity of the axial 
alcohol to the C26 oxygen must result in the enhanced equilibrium shift toward the 
oxonium ion through a directing effect.  Comparatively, the equatorial alcohols are not in 
the proper orientation to facilitate the directing effect and as mentioned earlier the 
electron withdrawing effect of the Lewis acid alcohol complex serves only to destabilize 





2.3.1.4 Diketone Strategy: C25 Olefination  
Having gained efficient access to the 23(R),26-diol 2.81(R), the incorporation of 
hydroxy functional group at the C25 position was crucial.  Access to the desired 25,26-
diol relied on the production of C25 olefin 2.88 (Scheme 2.9).  The standard reaction 
sequence to incorporate the olefin 2.88, utilized selective tosylation of 23(R),26-diol 2.81, 
followed by C23 benzoyl protection providing 2.84 in 65 % yield over 2 steps.10  
Interestingly, if recrystallized p-TSCl was not used, production of the SN2 cyclization 
product 2.97 was obtained in up to 30 % yield.  Treatment of C26 tosylate 2.84 with NaI 
in DMF provided 26-iodo compound 2.87.  DBU mediated iodo elimination of 2.87 in 
acetonitrile provided olefin 2.88 with inconsistent yields ranging from 53-92 %.  The 
reaction was highly sensitive to both moisture and purity of the substrate, and attempts to 
increase the yield of the elimination step showed promise when C23 deoxy compound 
2.89 was treated with DBU in DME at 80 ºC for 8 hrs generating olefin 2.90 in 94 %.  
Application of the altered conditions to that of 23-acetoxy-26-iodo compound 2.91 
resulted in only slightly increased consistency in yields of 59 % for the two steps.  
Overall the 4 step sequence provides olefin 2.88 in 30 % yield from diol 2.81(R) resulting 






Scheme 2.9 Increasing the efficiency of C25 olefination 
The low yielding and fickle reaction sequence required revamping to produce a 
more reliable route to the desired product.  Selenoxide syn-elimination to achieve the 
desired olefination was examined.  23(R),26-diol-2.81 was treated with TBSOTf to 
provide crude 23,26-bis(t-butylsilyl) compound which upon treatment with AcOH in 
methanol / THF provided selective deprotection of the primary alcohol to give 23-silixoy-
26-hydroxy compound 2.93 in 93 % yield (Scheme 2.9).  Treatment of the 26-alcohol 
2.93 with Grieco’s31 reported conditions (2-pyrididylseleno cyanate/PBu3) provided the 
26-selenide which was subsequently oxidized to the selenoxide (H2O2 and NaHCO3) 




over 3 steps from the 23,26-diol 2.81.  Despite the increased overall yield of olefin 2.95, 
a one step procedure was desired and conversion of the diol to the homoallylic alcohol 
via the Grieco procedure was next considered.  A one-pot procedure posed two potential 
issues; 1) the reaction would not be selective and result in a mixture of selenides, 2) 
competitive intramolecular nucleophilic displacement of the phosphonium to provide 
furan 2.97, obtained previously under less reactive conditions.  Delightfully, treatment of 
23(R),26-diol 2.81 with 2-NO2PhSeCN/PBu3 provided the C26 selenide exclusively 
which afforded homoallylic alcohol 2.96 in 94 % yield following oxidative syn-
elimination of the selenide. The new one-pot procedure to access the homoallylic alcohol 
2.96 directly from diol 2.81 in high yield was realized, turned out to a key intermediate 
(vide infra).  At this point, the overall synthetic strategy had seen a boost in efficiency 
headed by kinetic resolution of C23 α-hydroxy-spiroketals, elimination of 3 steps during 
C25 olefination, with the need for only a single column chromatography at that stage of 
the synthesis.  In 2002 Suarez applied a similar Grieco olefination procedure to provide 
the C25 olefin 2.96 from doil 2.81 through in 4 steps and only 71 % yield containing an 
undesired two step protection / deprotection sequence.7,32   
 
2.3.1.5 Diketone Strategy: C17 Hydroxylation 
With more efficient access to C25 olefin 2.96, the low diastereoselectivity 
obtained during Sharpless asymmetric dihydroxylation had considerable less impact on 
the amount of material available increasing the efficiency access to the key diketone 2.18 




diketone strategy, one more step required attention.  As mentioned earlier in section 
2.2.3, C17-hydroxylation of 2.18 was accomplished in 45 % yield over 2 steps via a 
trimethylsilyl enol ether.10   Barton’s benzene seleninic anhydride (BSA) mediated 
tandem, dehydrogenation-angular hydroxylation of diketone 2.18 to provide 2.98 was 
proposed as a solution to the low through put during C17-hydroxylation (Figure 2.8).33  
Preliminary experiments in this area carried out by S. M. Lee found that the conversion 
of 2.99 to 2.100 could be achieved in 38 % yield with 2.5 equivalents of BSA in 
chlorobenzene at 110 °C.34   
 
 
Figure 2.8 Barton tandem hydroxylation/ dehydrogenation 
  To increase the yields of C17-hydroxylation, a more electrophilic seleninic 
anhydride was envisioned to provide increased yields potentially at lower temperatures.  
To this end, 3,5-bis(trifluoromethyl)phenyl seleninic anhydride 2.103 was synthesized in 




Addition of 3,5-bis(trifluoromethyl)phenyl seleninic anhydride 2.103 to diketone 2.104 
under S. M.  Lee’s original conditions provided incomplete conversions and complex 
mixtures with only a negligible amount of 2.105 was observed by 1H NMR.  Attempts to 
improve the yield by adjusting the solvent or temperature proved ineffective.  Yamakawa 
and coworkers illustrated pre-addition of either NaH or AlCl3 afforded either angular 
hydroxylation or dehydrogenation, respectively.35 Attempts to accomplish the conversion 
of 2.104 to 2.105 in a stepwise fashion utilizing the conditions of Yamakawa and 
seleninic anhydride 2.103 continued to produce complex mixtures.  The complex 
mixtures obtained with the more electrophilic seleninic anhydride were most likely a 
result of poor regioselectivity and the limited success of C17-hydroxylation required the 
design of new strategies.      
2.3.2 Furan Strategy: Retrosynthesis 
The ability to control the diastereoselectivity at the C25 position has been a 
tremendous challenge as outlined earlier in Table 2.1.  Previous efforts towards the 
synthesis of the North 1 hemisphere relied heavily on dihydroxylation to afford the 
requisite stereochemistry at C25.  Sharpless asymmetric dihydroxylation has resulted in 
poor to moderate stereoselectivities depending on the substrate.1,30,36  To summarize, in 
the case of C25-epi North 1, dihydroxylation gave > 5:1 in favor of the desired 
compound, while compounds with  the C25 natural configuration were obtained with 
stereoselectivities up to 13:1.37 The challenging diastereoselective control during C25 
oxidation has pushed the search for methods beyond asymmetric dihydroxylation 




mediated C16 C-H oxidation to produce the C16 hemiketal 2.110 in the presence of the 
C25 olefin in 84 % yield allowed new ‘Red-Ox” strategies to be envisioned to affect C25 
oxidation (Figure 2.9).38 The retrosynthesis of the furan strategy depicted in Figure 2.9 
centers around  the key C25 oxidation envisioned through intramolecular oxidative 
alkoxylation of 16-hemiketal-25-ene 2.110. The furan strategy was further designed to 
provide the desired kinetic spiroketal 2.106 through Suarez IHA cyclization between the 
C16 alcohol and C22 anomeric C-H of the pre-formed F-ring furan 2.107.7,17,23,32  The 
required trans-diol would be prepared first by α-hydroxylation of ketone 2.108 to provide 
the required C17 hydroxyl, similarly employed for the diketone strategy, which would be 
exploited for chelation directed reduction of C16 ketone.  The required C26 hydroxyl was 
envisioned to derive from the oxidative displacement of chalcogen X 2.111 which would 
be generated by the chalcogen mediated etherification upon concurrent ring opening of 
the hemiketal 2.110/ ring closing.  The hemiketal 2.110 would continue to be provided 
through regioselective chromium mediated C16-C-H oxidation of E-ring ether 2.109.38 
The strategy harnessed the desired principles of the “Red-Ox” strategy and contained the 
aforementioned key features further presenting intriguing synthetic challenges and unmet 
scientific questions; most notably being if the more rigid preformed F-ring furan, could 
undergo radical mediated Suarez IHA to provide the desired kinetic spiroketal 
exclusively, or would it ultimately succumb to equilibration leading to the undesired 






Figure 2.9 Furan strategy retrosynthesis 
2.3.2.1 Furan Strategy: C25 Oxidation through Iodoetherification 
The main goal of the furan strategy was effective stereocontrol during the C25 
oxidation.  Near the end of his tenure in the Fuchs lab, S. M. Lee utilized 
iodoetherification to provide early stage F-ring furan formation.  Starting with 23-deoxy-
16-hemiketal model compound 2.112, generated through the aforementioned chromyl 
trioxide C-H oxidation protocol38, the addition of iodine in acetonitrile at 0 °C provided 
the 26-iodo-16-oxo furan product 2.113 with 3:1 diastereoselectivity and 92 % overall 
yield.  The model cyclization conditions were next employed on the 23-acetoxy 
compound 2.115, which unfortunately did not undergo cyclization returning only starting 
material.  Suspecting sterics as a potential cause for the lack of reactivity, the compound 
was globally deprotected to provide the triol 2.118.  Treatment of globally deprotected 
compound 2.118 under the original conditions provided the 22-furanyl-23-hydroxy-16-




the desired cyclized compounds, the functional group interconversion of iodide 2.120 the 
desired 26-alkoxy functionalized compounds 2.117 were examined.  Oxidative iodoso 
displacement successful employed in earlier syntheses39 through use of m-CPBA, 
DMDO, or potassium superoxide, all failed to provide the desired alcohols from the 
respective 26-iodo compounds.  Radical oxidation with triethylborane and oxygen also 
failed to convert the neopentyl iodide to the alcohol.40  With little success with oxidative 
protocols, nucleophilic displacement with hydroxides or carboxylates in the presence of 
either silver nitrate or HMPA also failed to provide the desired conversion.  Although 
iodonium mediated cyclization provided a new route to C25 oxidation in moderate to 
high stereoselectivity, the unfortunate need for global deprotection and inability to 
convert the iodide to the desired alcohol drove the search for other methods to provide 
the desired furanyl intermediates.  
 
 




2.3.2.2 Furan Strategy: C25 Oxidation through Oxysulfenylation / Oxyselenylation 
The potential for executing the critical stereoselective C25 oxidation through 
concurrent hemiketal ring opening/electrophilic cyclization was made apparent by the 
success of the iodoetherification results described above.  Wanting to continue to exploit 
the “onium” pathway to provide the necessary C25 oxidation, attention was turned to 
electrophilic sulfenyl reagents, imagining the conversion of the sulfide product to the 
oxygen functionality would be less problematic than exhibited by the C26 iodo 
compounds.  We envisioned episulfonium intermediates generated through olefin attack 
of the electrophilic sulfenyl by olefins 2.121, would capture the C22 hydroxyl group 
upon hemiketal ring opening to provide keto-furanyl sulfide 2.122 (Figure 2.11). 
Oxidation to sulfoxide 2.124, followed by Pummerer rearrangement would provide 
acetoxy sulfide 2.123 which upon reduction would furnish the C26 acetate 2.125.   
 
 
Figure 2.11 Oxy-sulfenylation forward 
With previous difficulties posed by the C23 acetate during the iodonium 
promoted cyclization combined with greater diastereoselectivities observed for 
unprotected compounds, the globally deprotected substrate 2.126 was the ideal candidate 




into episulfonium mediated oxidative cyclization began with in situ generated 
phenylsulfenyl chloride (PhSCl) from NCS/benzenethiol.41 Addition of in situ generated 
PhSCl to globally deprotected compound 2.126 returned only starting material and 
diphenyl disulfide upon work-up.  The numerous free hydroxyl groups were believed to 
compete successfully for the sulfenyl generating transient O-sulfenyl esters.42 Treatment 
of the globally deprotected compound 2.126 with excess reagent, however, could not 
overcome the problem.  On the other hand, treatment of the protected C23 deoxy model 
compound 2.129 with PhSCl under these conditions led to 1,2 chlorosulfide addition 
product 2.131 indicated by lack of geminal coupling of the C26 methylene protons 
diagnostic of the cyclized product.  Higher reaction temperatures or prolonged reaction 
times continued to produce the 1,2 chlorosulfide product.  With the potential equilibrium 
between 1,2-chlorosulfide and the episulfonium salt, the 1,2 adduct 2.131 was treated 






Scheme 2.10 Chlorosulfenylation 
In light of the effectiveness of iodonium mediated oxy-cyclizations, the lack of 
cyclization appeared at first quite confusing considering that PhSCl oxy-sulfenylations 
have been reported.43 Deeper investigation determined these results were not atypical for 
RSCl olefin addition reactions, including unsubstituted terminal olefins. Mechanistically, 
the addition of RSCl reagents to alkenes has been shown to be quite complex, and the 
intermediacy of episulfonium salts were under debate.43-44 Although there are some 
reports of sulfenyl chloride mediated sulfenyl cyclizations, earlier reports mainly 
demonstrated 1,2 chloro sulfenyl additions even in polar organic solvents (MeOH, 
CH3COOH, CH3CN) without the presence of competitive solvolysis or skeletal 
rearrangement products.43  
Electrophilic addition of sulfenyl chlorides to olefins has been universally 




depending on the stereochemical outcomes of the reactions.  Episulfonium ions generated 
from addition of RSCl to olefins were considered as weak electrophilic intermediates that 
do not undergo skeletal rearrangements.  They have also been considered as non polar 
strongly Type I bridged species with large S-Cl covalent character, incapable of reacting 
with external nucleophiles or undergoing rearrangement (Figure 2.12).44 
 
 
Figure 2.12 Episulfonium ion pairs 
 The extensive work of Smit and coworkers dispelled these myths, demonstrating 
that episulfonium salts are in fact ion pairs of varying polarity depending on the nature of 
the reaction media and the counter ion involved.43 Based on their observations, they 
proposed RSCl episulfonium salts as bridges tight ion pairs of the Type II capable of 
being shifted to weak ion pairs (Type III) or even dissociated ion species (Type IV) by 
increasingly polar solvents or through the “doping effect” with perchlorate salts.  With 
higher polarity solvents and the addition of “doping” agents, the episulfonium salts 
generated with RSCl can be forced to undergo solvolysis as well as skeletal 
rearrangements.  Interestingly, Smit and coworkers believed the doping effect was the 
result of the strong electrolytic nature of the solvent and stabilization of the carbocation.  




loosely associated ion pair.  In the last decade there have been reports of intramolecular 
cyclizations involving PhSCl in weakly polar solvents such as dichloromethane, although 
the published systems predominately involved rigid cyclic structures with reduced 
degrees of freedom.45 On the other hand, with acetonitrile as the solvent, linear systems 
underwent intramolecular episulfonium mediated etherification or lactonization rather 
efficiently.46 Regardless of these successes, there have been only a few reports 
highlighting effective oxysulfenylation of 1,1-disbstituted olefins leading to 
tetrasubstituted cyclic ethers.45a,47  
In this system, oxysulfenylation via RSCl will only occur if the hemiacetal is 
labile enough to be a competitive nucleophile with the chloride ion.  Given the tight ion 
pair nature of the chloro episulfonium salt and the small concentration of the open form 
of the hemiacetal at temperatures where episulfonium ions are stable (between -50 and -
20 °C), it is not surprising that the 1,2 adducts were the sole product.  The effectiveness 
of oxysulfenylation for formation of cyclic ethers could only be achieved by decreasing 
the episulfonium ion pair strength by utilizing larger counterions as noted above or 
through increasing stabilization of the onium bridge species by means of increasing the 
electron donating capability of the aryl sulfenyl.  It was believed these adjustments would 
generate episulfonium intermediates with sufficient lifetimes to permit the slow ring 
opening of the hemiketal eventually leading to cyclization.  
Continued evaluation of the effect of more polar episulfonium salts on the 
potential oxy-cyclization, other sulfenyl halides were investigated.  The first logical 
choice was the larger bromide ion of benzenesulfenyl bromide which could provide more 




addition of Br2 to diphenyl disulfide as previously described.
48 Focusing again on C23 
deoxy model compound 2.132, addition of PhSBr provided the desired keto-furans 2.133 
in variable yields ranging from 50 – 75 % as an inseparable 1:1 mixture (Scheme 2.11).  
A third set of C26 geminal coupling signals were also detected which was originally 
believed to be due to bromonium mediated cyclization.  The possibility of the bromonium 
mediated cyclization however, was ruled out by mass spectroscopy.  In the 13C NMR a 
third ketone signal was also detected and when combined with the downfield C26 signals, 




Scheme 2.11 Phenylsulfenyl bromide oxysulfenylation 
Having achieved moderate success with PhSBr mediated oxysulfenylation, the 
ability to provide the desired C26 acetate 2.138 was investigated (Scheme 2.12).  As 
described earlier, conversion of the sulfide to the desired protected alcohol was conceived 
to proceed through Pummerer rearrangement sulfoxide of 2.135 which was generated 
through mCPBA oxidation in 82 % crude yield.  The unpurified sulfoxide 2.135 was 
subjected to standard Pummerer conditions, acetic anhydride/sodium acetate 
(Ac2O/NaOAc), to provide the mixed acetoxy sulfide 2.137 in 75 % yield as a mixture of 




produce the desired C26 acetate 2.138.  Realizing the Pummerer rearrangement could 
furnish aldehyde 2.136 directly, the more reactive trifluoroacetic anhydride 
(TFAA/lutidine) protocol was investigated.  Treatment of the sulfoxide 2.135 with 
TFAA/lutidine generated the desired the aldehyde 2.136 in 51 % crude yield by NMR.  
The small scale preliminary results quickly established Pummerer rearrangement as an 
effective method for the desire functional group interconversion, and further investigation 
was halted until the oxy-cyclization process could be optimized.  
 
 
Scheme 2.12 Pummerer Results 
With preliminary success of the Pummerer rearrangement, attention was turned 
from oxysulfenylation to oxyselenylation on the premise that the more stable and isolable 




a) Ph2S2 1.1 eq., Br2 1.05 eq. NaHCO3 5 eq., ACN rt 1 hr 50 - 75%; b) MCPBA 1.1 eq., CH2Cl2,-20°C 2 hrs, 82 %; c) i)
TFAA 1.1 eq., 2,6-lutidine 1.5 eq., CH2Cl2, -10°C 51 % (crude yield); ii) aq. NaHCO3, rt, 2 h; d) NaOAc 6 eq., Ac2O 6





























The longer C-Se bond length of the bridge selenonium ion was considered ideal to 
increase the carbonium ion character of the tertiary C25 atom, potentially providing 
better regioselectivity and more efficient cyclization.  Continuing with the evaluation of 
the C23-deoxy model, hemiketal 2.132 was treated with phenylselenyl bromide (PhSeBr) 
furnishing the desired keto-selenide 2.139 as 3:1 mixture of diastereomers in 64 % yield 
(Scheme 2.13).  Unlike oxysulfenylation no other products were detected, prompting 
further evaluation of the selenonium ion mediated cyclization on the desired C23 
substituted homoallylic substrates.  Attempts to employ the model conditions to promote 
the oxyselenylation of either the C23 OTBS 2.142 or acetate 2.140 protected substrates, 
led only to 1,2 addition products.  Despite the increased reactivity of the selenonium ion, 
the bulkiness of the C23 substituent retarded the hemiketal- keto alcohol equilibrium 
reducing the ability of the alcohol to compete with the bromide.  Furthermore, treatment 
of globally deprotected 2.144 with phenylselenium bromide and triethylamine or 








The consistent inability to promote the cyclization of C23 protected substrates led 
to further reevaluation of the selenylation strategy.  Turning again toward a combination 
of higher polarity bridged selenonium intermediates and lower nucleophilic counterions, 
in situ generated phenylselenyl triflate obtained from phenylselenium bromide and silver 
triflate were investigated (Table 2.5).  Initial screening of conditions to promote 
cyclization of protected C23 substrate 2.140, was performed in the absence of base at -78 
⁰C and with insoluble K2CO3 at 0 ⁰C, providing the desired cyclized keto-furans 2.141 in 
29 and 60 % yields, respectively (Entry 1 and 2).  The base free reaction at -78 ⁰C 
resulted in a 3:1 ratio of diastereomers, while the reaction at 0 ⁰C was not stereoselective.  
Treatment of the 2.140 with phenylselenyl triflate at -78 ⁰C in the presence of NaHCO3 
gave a 2.5:1 ratio of diastereomers (Entry 5).  Other solvents and temperatures were 
screened and the best results were obtained at lower temperatures with lower polarity 
solvents consistent with the idea that stabilization of the carbocation could lead to 
reduction in stereoselectivity (Entries 2 - 5).  
 
Table 2.5 Oxyselenylation 
 
 
Entry Base Solvent Temp (°C) Yield %a d.r.b
1 None CH2Cl2 -78 29 3:1 
2 K2CO3 THF 0 60 55:45 
3 K2CO3 ACN 0 nd 1:1
4 K2CO3 ACN -40 nd 2:1 
5 NaHCO3 CH2Cl2 -78 nd 2.5:1 




Needing to resurrect the stereoselectivity and increase the overall yields, 
evaluation of more substituted selenonium salts were performed particularly the 2,4,6-
tri(isopropyl)phenylselenium bromide (TIPPSe-Br) previously reported by the Lipshutz 
group (Scheme 2.14).49   Lipshutz and coworkers reported that in situ generated TIPPSe-
OTf resulted in the formation of tetrahydrofuran compounds via 5-endo-cyclization of a 
variety of substituted homoallylic alcohols with up to 50:1 diastereoselectivity depending 
on the olefin geometry of the starting homoallylic alcohol.  TIPPSe-Br was synthesized 
following the reported procedure with 78 % yield (Scheme 2.14).49 Employing the 
conditions reported by Lipshutz which utilized propene oxide as a halide scavenger, 
furnished the desired keto-furan 2.146 in 90 % crude yield from the C23 acetate protected 
substrate 2.140.  Unfortunately complete loss of stereoselectivity was observed, and all 
attempts to increase the stereoselectivity failed. 
 
 
Scheme 2.14 Lipshutz-selenylation 
The oxy-sulfenylation/oxy-selenylation strategy was moderately successful when 
applied to the model substrates for both the cyclization as well as the Pummerer 
rearrangement.  However, the modest yields obtained for selenyl triflate mediated 




and unproductive.  The best scenario for the success of the strategy was implementation 
of a new protection scheme that would allow for the selective deprotection of the C23 
alcohol.  Orthogonal protection would not be trivial, as the limited protecting groups that 
were compatible with chromyl trioxide mediated C16 C-H hydroxylation.  The revelation 
created a need for a new synthetic pathway to provide the unprotected homoallylic 
alcohol before the strategy could be further pursued.  The ability to generate the 
unprotected homoallylic alcohol 2.96 described earlier eventually opened new pathways 
toward C25 oxidation and was oxy-selenylation was therefore never revisited. 
 
2.3.2.3 Furan Strategy: Iodocarbonatation 
Several hurdles were overcome for the furan strategy, however oxy-sulfenylation 
and oxy-selenylation had failed to achieve the ultimate goal of stereoselective C25 
oxidation.  The development of the high yielding two pot Grieco procedure for the direct 
conversion of 23,26-diol 2.86 to the unprotected homoallylic alcohol 2.96 opened up the 
possibility of  new strategies centered around homoallylic alcohol (Figure 2.13).  The 
value of the breakthrough in the production of the homoallylic alcohol cannot be 
overstated, as it is the key that opened the door to the incredible possibilities.  
Homoallylic alcohol 2.96 presented two possible options for stereoselective C25 
oxidation; 1) the C23 protecting group could be exploited for substrate controlled 
stereoselective C25 oxidation Route A, or 2) C23 alcohol directed catalyzed asymmetric 






Figure 2.13 Proposed routes to stereoselective C25 oxidation through homoallylic alcohol 
Keeping with the overall furan strategy, possible strategies involving the 
homoallylic alcohol focused alternatively on C25 oxidation prior to the formation of the 
C16 hemiketal on route to the desired F-ring furan.  Catalyzed asymmetric epoxidations 
of allylic alcohols have been shown to be highly stereoselective, while on the other hand; 
methods for asymmetric epoxidation of homoallylic alcohols have shown only 
moderately stereoselective.  Catalyzed asymmetric epoxidation of 1,1 disubstituted 
homoallylic alcohols have suffered from low to moderate stereoselectivities ranging from 
55 % for Sharpless’ titanium tetra-isopropoxide protocol to 86 % ee for the zirconium 
tetra-tert-butoxide version developed by Onaka.50  It wasn’t until Yamamoto’s 
development of bis-hydroxamic acid ligands that high stereoselective epoxidations of 
homoallylic alcohols were achieved.51  Apart from the intramolecular alcohol directed 
asymmetric epoxidation methods, intermolecular catalysts such as Shi’s chiral ketones 




disubstituted olefins.52  Without access to a suitable asymmetric catalyst, substrate 
directed methods for the C25 oxidation were examined.   
Focus on substrate directed oxidation methods led to the discovery of Bartlett’s 
iodine mediated carbonation reaction later exploited by Johnson during their synthesis of 
the calcitrol lactone vitamin-D derivative.53 The iodocarbonatation provided 
diastereoselectivities of 50:1 in favor of the C25(S)-epi-iodo carbonate. Given Johnson’s 
success of high stereoselective induction on a similar substrate, iodocyclization was 
viewed as a great alternative to metal catalyzed asymmetric epoxidation of homoallylic 
alcohols.  The similarities between the steroidal side chains and Johnson’s C-D ring 
vitamin D derivative, provided confidence a similar level of stereocontrol could be 
realized (Figure 2.14).   
From 23,26-diol 2.86, the homoallylic alcohol 2.96 was constructed efficiently as 
described earlier (Figure 2.14).  Protection of the homoallylic alcohol as the t-butyl 
carbonate 2.148 set the stage for the iodo cyclization to provide cyclic carbonate 2.149.  
The cyclic carbonate 2.149 was shown previously produce epoxide 2.150 upon 
hydrolysis of the cyclic carbonate which the presence of the two acetate protecting 
groups posing potential challenges.53b  After C-H oxidation at C16 to give the hemi-ketal 
2.150, the keto-furan 2.151 was believed to be accessible through concurrent E-ring 
opening and nucleophilic attack of the acid activated epoxide. Provided the desired C25-
epi-stereochemistry could be achieved it was envisioned that the primary C26 alcohol 
could promote relay IHA spiroketalization to give 2.152.  Prior to spiroketal formation, 




generated from 2.151.  Finally C17 directed reduction of C16 would provide trans-diol 
and set the stage for spiroketalization. 
 
 
Figure 2.14 Iodocarbonatation strategy 
The research into the iodocarbonatation strategy began with the production of the 
homoallylic alcohol 2.96.  Protection of the crude alcohol 2.96 as the t-butyl carbonate 
2.148 proceeded smoothly in 92 % yield with di-t-butylcarbonate and catalytic DMAP.  
Using conditions previously described by Johnson, the C23-Boc protected homoallylic 
alcohol 2.148 reacted with I2 in propyl nitrile at -40 °C  to provide cyclic carbonate 2.149 
through the iodonium mediated carbonation in nearly quantitative yield and 94 % de 
(Scheme 2.15).53a  Similarly, treatment of the BOC-homoallylic alcohol with ICl in 
CH2Cl2 at -78 °C resulted in comparable yield and diastereoselectivity.  The absolute 




showing enhancements between the C27 methyl and C23 hydrogen expected from the 
pseudo 1,3-diaxyl relationship of the two groups.  There was also an absence of an NOE 
interaction between the C26-iodomethyl with the C23-H.  The preference for the (S)-
isomer is consistent with either kinetic or thermodynamic control during cyclization.  
Bartlett original reported 6.5: 1 selectivities for the iodine mediate BOC cyclization of 
terminal alkenes under thermodynamic control (0 °C in CH3CN, 8 hr).  Johnson later 
reported much higher selectivities of 50:1 under kinetic control (-40 °C, CH3CH2CN, 30 
min) for the 1,1 disubstituted alkenes of vitamin D side chain in favor of the (S)-isomer.  
Under thermodynamic conditions provided by longer reaction times and raised 
temperature (5 hr, 0 °C), Johnson reported erosion of stereoselectivity down to 5:1.  In a 
similar manner, prolonged reaction times of 2.148 with iodine also led to erosion of 
stereoselectivity leading to 8:1 in favor of the (S)-isomer confirming higher 
stereoselectivities obtained during kinetically controlled cyclization.   
 
 
Scheme 2.15 Iodocarbonatation results with NOE enhancements 
Although the rate determining step is considered to be a SN1 type cleavage of the 
t-butyl group of the transition states 2.149, the lower temperatures slow the equilibration 




2.149-(S) brought on by attack of the carbonate on the Re face of the alkene (Figure 
2.15).  Crude MM2 comparisons of 2.149-(S) and 2.149-(R) showed a 0.4 kcal energy 
difference which is indicative of a thermodynamically controlled product like transition 
state.  On the other hand, with a more reactant like transition state, allylic strain should be 
the main determining factor for the high selectivities under kinetic control.  Crude MM2 
dynamic dihedral calculations showed the expected hydrogen eclipsed conformation Re-
2.153  to have lower energy by 1.6 kcal compared to the 1,3–methyl eclipsed 
conformation Si-2.153. The larger conformational energy difference combined with even 
higher barriers of rotation about the allylic system corroborates the observation of  kinetic 
control being more selective than thermodynamic control resulting in the high 
selectivities obtained in favor of the dominant (S)-cyclized product 2.149-(S).   
 
 




Hydrolysis of the crude cyclic carbonate 2.149-(S) to provided epoxide 2.154 did 
not proceed as smoothly, as a result of competitive deacylation, (Table 2.6).  Treatment 
of 2.149 with K2CO3 in 2:1 MeOH: H2O at 0 °C initially provide the desired epoxide 
2.154 along with deacylated products 2.155 and 2.156 in an overall 2:1:1 ratio.  Addition 
of THF creating a more homogeneous mixture, 7:3:1 MeOH:THF:H2O, led to a further 
decrease in epoxide 2.154 (Entry 2).  The diacetate protected C25 epoxide was guarded 
from further hydrolysis by using nearly stoichiometric amounts of K2CO3 resulting in 
complete elimination of bis-deacylated product 2.156 (Entry 3).  Finally with portionwise 
addition of 1.05 equivalents of powdered K2CO3 in a MeOH:THF:H2O 9:1:1 solution of 
2.149, gave a 95:5 mixture of 2.154 to 2.155  which was easily converted to a single 
product 2.154 through re-acylation of the 3 position under standard conditions (Entry 4). 











2.154 R1 = Ac, R2 = CO2Me
2.155 R1 = H, R2 = CO2Me
2.156 R1 = R2 = H
Ac2O,
DMAP
Entry K2CO3 (eq.) Solvent 2.154 : 2.155 : 2.156 
1 1.5 MeOH:H2O 2:1 2: 1: 1 
2 1.5 MeOH:THF:H2O 7:3:1 1:3:1 
3 1 MeOH:THF:H2O 7:3:1 2:1:0 






The ability to obtain controlled chemoselective hydrolysis of the carbonate in the 
presence of two acetates with a single equivalent of base was key to the economical value 
of the synthetic route and surprising considering the increased hydrolytic stability of 
carbonates compared to acetates.  Epoxide 2.154 was further observed to be extremely 
sensitive to column chromatography giving only 73 % isolated yield. However, as with 
many steps in the synthetic route, the crude product could be pushed forward to deliver a 
higher overall yield for the synthetic route. 
Having optimized the exclusive production of epoxide 2.154, the synthesis of the 
C16 hemiketal 2.150 through C-H oxidation was needed.  The previously utilized CrO3/ 
Bu4NIO4 oxidation method discussed earlier was originally screened, and led to a non-
isolable mixture of products.38  From crude 1H NMR, products from a concurrent C-H 
oxidation/rearrangement to 2.157 and 2.158 could be detected by the two AB patterns at 
3.5 and 4.2 ppm for the diastereotopic C26 protons, respectively.  The formation of 2.157 







Scheme 2.16 Tandem C-H oxidation/cyclization 
Desiring a softer, more controllable C-H oxidation under neutral conditions to 
efficiently provide the hemiketal, in situ prepared trifluoromethyl-methyl dioxirane 
(TFDO) was investigated (Scheme 2.17).  Treatment of epoxide 2.154 with 1,1,1-
trifluoro-2-propanone and oxone® led to a crude yield of 96 % for the desired hemiketal 
2.150.  The reaction conditions were very sensitive to potential impurities which caused 
competitive decomposition of the oxone, however, if the reaction failed to reach 
completion, the crude product could be quickly accessed through extraction, and 
resubjected to the reaction conditions.  The product 2.150 was also very labile to column 





Scheme 2.17 Synthesis of keto-furan 
Several conditions were screened for the rearrangement of the epoxy hemiketal 
2.150 to keto-furan 2.151, of which catalytic Lewis acids BF3OEt2, Sc(OTf)3; and 
Bronsted acids CSA, formic acid, and PPTS were screened (Scheme 2.17).  Of all the 
conditions screened the weaker Bronsted acid PPTS was found to be the most effective at 
providing the desired 5-exo-product while stronger Lewis and Bronsted acids led to 
complex mixtures.  These complex mixture may have resulted from neighboring group 
participation by the methyl carbonate allowing for multiple rearrangement pathways.54 
The dependence on milder acid conditions for the formation of 2.151 potentially results 
from the hemiketal / keto-alcohol equilibrium again lying heavily away from the open 




released and attack the C25 position without attack of  the methyl carbonate attack of the 
epoxide.  Interestingly, the formation of the epoxide rearranged product which would be 
expected as a competing byproduct if the methyl carbonate was indeed participating was 
not observed under these mild PPTS conditions.  Treatment of hemiketal 2.150 with 40 
mol % PPTS while monitoring by NMR provided the crude keto-furan 2.151 as single 
diastereomer (Scheme 2.17).  Finally the C26 alcohol was protected with TBS-Cl and 
imidazole in dichloromethane to provide tert-butyldimethylsilyl protected alcohol 2.159 
in 39 % yield from 2.148, for an average yield of 83 % over the five steps.  In a samilar 
manner on the 1 g scale, the C26 benzoate 2.160 was formed in 55 % yield from 2.148, 
averaging 89 % yield over 5 steps.     
 The absolute stereochemistry was tentatively determined by difference NOE to be 
the natural C25-(S)-furan resulting from inability to obtain corroborating enhancement 
during the NOE experiments.  This assignment suggested that the cyclization went 
through a double inversion resulting in retention of stereochemistry.  This was of course 
not impossible if the methyl carbonate, which does not readily reform the cyclic 
carbonate, acted as a neighboring participant in the reaction.  Given that the absolute 
stereochemistry had to be (S)- the double inversion needed to be confirmed and upon 
revisiting the issue at a later date with 2D- NOESY NMR, the stereochemistry of the C25 
was in fact determined to be the C25-epi-(R)-configuration.  Overall, the strategy resulted 
in the formation of the desired 25-epi-keto-furans 2.159 and 2.160.  Although not 
prepared, the natural C25 diastereomer can be easily obtained through hydrolytic 
inversion of epoxide 2.154 with 1N H2SO4/THF, conditions reported earlier by Johnson 




With the keto-furan 2.159 in hand, the synthesis 25-epi-14,15-dihydro 
cephalostatin-North 1 2.21 and 25-epi-North 1 could be envisioned (Figure 2.16).  The 
synthesis of 25-epi-14,15-dihydro-North 1 was designed to conclude in two possible 
pathways, the first being the shortest and most direct, but also the most challenging.  The 
original design was to introduce the C17-hydroxyl through oxidation of the silyl enol 
ether of 2.159, followed by directed reduction of 17-hydroxy-16-ketone 2.161 to give the 
16,17-trans-diol 2.162.  Diol 2.162 could also be formed through reduction of ketone 
2.159 followed by POCl3 mediated elimination to give the alkene 2.163.  
Dihydroxylation of the alkene would generate 2.164 which followed by oxidation and 
directed reduction could then provide the trans-diol 2.162.  The challenge of the synthetic 
design was to generate the spiroketal through an unprecedented C16-initiated Suarez IHA 
of diol 2.162 or through the aforementioned C26 relay IHA reacation.  The introduction 






Figure 2.16 25-epi-14,15-Dihydro-North 1 synthesis end game 
Attempts to generate the silyl enol ether 2.166a with either TMSI56 or TMSOTf 
led to the complete recovery of starting material.  On the other hand an attempt to form 
the more stable triethylsilyl enol ether using TESOTf57 and Et3N, generated a mixture of 
four compounds, two O-silylated products, 2.166a and 2.166b, and two C-silylated 
products, 2.165a and 2.165b in 85 % overall yield.  From 1H NMR the major products 
were determined to be the desired enol ether 2.166a and C15-silylated compound 2.165a 
isolated as mixtures with the minor isomers obtained in 42 % and 43 %, respectively 






Scheme 2.18 Attempts to introduce the C17-hydroxyl 
Although rare, there have been reports of C-silylation of hindered ketones.58  The 
inability to form the trimethylsilyl enol ether due to its proposed poor stability, along 
with the C15-silylation as a major side product suggests considerable steric demand for 
the formation of the enol ethers.  The hypothesis was corroborated by MM2 modeling 
calculations revealing a large increase in energy for the C-16 silyl enol ethers.59 
Unfortunately, the limited formation of the C17-silylated product precluded attempts to 
exploit the C-silylation through a Tamao-Fleming oxidation of C17-allyldimethylsilane.60 
Considering the difficulties  of preparing the C16-enol ethers, direct enolate oxidation 
with either KHMDS/P(OEt)3/O2
61 or the KHMDS/Davis oxaziridine62 manifolds were 
attempted with little success (Scheme 2.19).  Furthermore, benzeneseleninic anhydride 
mediated α-hydroxylation led to a complex mixture of products including complete 





Scheme 2.19 Attempts at direct C17 oxidation  
With the limited success of the TESOTf / TEA mediated formation of the desired 
C17-enol ether 2.166a, the oxidation to provide the C17 hydroxyl compound 2.161 was 
investigated.  Based on earlier success of in situ generated TFDO to provide the desired 
C17-stereochemistry (vide supra), TFDO mediated oxidation of 2.166a was first 
investigated.  Reaction of 2.166a with 1,1,1-trifluoroacetone and oxone® in 3:2 mixture 
of CH3CN: borate buffer provided α-triethylsiloxy-ketone 2.167 which was confirmed by 
mass in 42 % yield as a single diastereomer.  The two step protocol provided α-siloxy-
ketone 2.167 from 2.159 in very modest yield of 18 % over two steps.  
 
 




The remaining piece of the puzzle to investigate was spiroketalization through 
C16-alcohol directed C-H oxidation of the C22-furan.  Prior to the successful α-oxidation 
of the ketone, the C17 non-functionalized alcohol 2.168 was used to examine the 
potential for the C-H oxidation of the C22 carbon.  Alcohol 2.168 was synthesized from 
keto-furan 2.159 through Luche reduction in 73 % yield (Scheme 2.21).  Suarez’s IHA 
protocol was first investigated leading to the formation of a complex mixture, which 
showed complete disappearance of the C22 proton by crude NMR.  Attempts to isolate 
and characterize the 2.169 had yet to be successful; however the potentially successful 
C22-oxidation warrants further investigation.   
 
 
Scheme 2.21 Preliminary Suarez IHA to install the C22 spiroketal 
In another vein, the C-H oxidation through either in situ formation of a C16 
dioxirane or known non-directed C-H oxidation protocols were investigated on 
compound 2.159.  The addition of oxone to ketone 2.159 at 0 °C in a 3:2 mixture of 
CH3CN: borate buffer, failed to promote the C22 oxidation providing complete recovery 
of starting material after 24 hrs (Scheme 2.22).  Chromyl acetate64 and either in situ 
generated DMDO or TFDO failed to promote C-H oxidation to provide hemiketal 2.170.  




methyl carbonate substantially reduces the reactivity to non-radical modes of C-H 
oxidation.65   
 
 
Scheme 2.22 Failed attempts at direct C-H oxidation of C22 furan 
Although not executed prior, the spiroketal synthesis is believed to be achievable 
through Suarez IHA, not through formation of the originally proposed C16 alkoxy 
radical, but through activation of the primary C26 alcohol of 2.172 which resides on the 
same face of the furan as the C22 proton.  Therefore, upon abstraction of the C22 proton 
by the C26 alkoxy radical, the desired spiroketal is envisioned to be afforded given that 






Figure 2.17 Proposed C26 alkoxy radical directed Suarez IHA 
In summary, great advancements towards the effective synthesis of the 14,15-
dihydro-25-epi-North 1 were achieved (Scheme 2.22).  These achievements include 
optimized production of C23-ketone 2.68, along with the kinetic resolution of the C23 
alcohols.  The use of the Grieco reaction to produce homoallylic alcohol 2.96 opened up 
a new synthetic pathway providing diastereoselective introduction of the C25 oxygen 
through a process friendly synthesis with limited need for extensive column 
chromatography.  The production of keto-furan 2.159 in 2 operations and 6 overall steps 
from homoallylic alcohol 2.96 paves the way for the completion of the process orientated 
‘Red-Ox’ synthesis of 25-epi-14,15-dihydro-North 1.  Overall the synthetic sequence is 2 
– 4 steps from completion and currently stands at 4 operations and 12 steps providing 
keto-furan 2.159 in 20 % overall yield.  Further investigation was required to improve the 
C17-oxidation and final spiroketalization, and efforts toward the 14,15-dihydro-analogs 
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CHAPTER 3: LACTONE STRATEGIES TOWARD THE EXPEDITED SYNTHESIS 
OF CEPHALOSTATIN UNITS  
3.1 Introduction 
 
The olefin is a ubiquitous functionality for access to a variety of functional groups 
through oxidation, reduction, cleavage or rearrangement.  To this end the development of 
olefination methodology has been crucial to the progress of organic synthesis.  The 
Wittig reaction is very effective for the stereoselective synthesis of alkenes from 
aldehydes and ketones.  However, unlike the Wittig reaction, the highly reactive non-
basic metal based olefinations Tebbe, Petasis, Takai and Takeda mediated titanium 
olefinations are capable of olefination of aldehydes and ketones, but also carboxylic and 
carbonic acid derivatives including esters, thioesters, carbonates, and amides as well as 
their cyclic counterparts.  There have also even been a few instances of titanium mediated 
alkylidenation of acid halides.1  
The influence of titanium mediated alkylidenations on natural product synthesis 
continues to flourish.1a The spiroketal moiety is prevalent in many natural products, 
surprisingly there are only few reports involving the use of titanium alkylidenation for the 
synthesis of spiroketals.2 There are several reported methods for the construction of 
spiroketals utilizing olefination as the linchpin for non-ketal based cyclizations.3 
Alkylidenation of lactones provides quick access to enol ethers which are excellent 
linchpins for both the construction of spiroketals and for introduction of functionality to 
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the α-position.  There are a number of reports on oxidative spiroketalization of 
endocyclic enol ethers for the construction of either 5,6 or 6,6 α-hydroxy-spiroketals.4 
There had yet to be reports on the oxidative spiroketalization of exocyclic enol ethers.  
Most importantly, the synthesis of α-hydroxy spiroketals through oxidative 
spiroketalization of enol ethers generated from lactone alkylidenation had yet to be 
reported.2a The 45 members of the bis steroidal pyrazine family of natural products all 
contain two spiroketal moieties; and the means to divergently access either the α-hydroxy 
or non functionalized spiroketals would be critical for the streamlined synthesis of many 
of the sought after compounds and their analogs.  Therefore, the introduction of the side 
chain to the bisnorcholanic lactones though titanium mediated alkylidenations is an 
attractive methodology to access a variety of spiroketals and spiroaminals (Figure 3.1).  
From examples shown in Figure 3.1, the impact of the methodology is clear with the 
ability to synthesize either 5,5 or 5,6 spiroketals through acid or electrophilic oxygen 
initiated cyclizations defined by the compound being targeted.  Although, the method is 






Figure 3.1 Unifying 'plug and play' alkylidenation strategy 
The overall design for synthesis of the 26,27-dihydroxy-25-epi-cephalostatin 
North 1 target was based on increasing the synthetic convergence while providing 
functionality featuring the desired oxidation state at C22 and C23 to stereoselectively 
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install the C23-hydroxy group and spiroketal late in the synthesis.  Meanwhile, a general 
convergent method for the formation of spiroketals was desired.  Late stage installation of 
the C23-alcohol reduces the need for selective protection schemes of the polyhydroxyl 
steroids, and the unprotected C23-alcohols have been shown to influence the 
stereochemical outcome during spiroketalization (Chapter 2).  Retrosynthetically, the 
spiroketal 3.1 was envisioned to be generated from the cyclization of either the C25 or 
C26 alcohol onto the α-hydroxy hemiketal formed by diastereoselective epoxidation or 
dihydroxylation of the Z-enol ether 3.2 (Figure 3.2).  As described above, the enol ether 
would arrive from the titanium mediated alkylidenation of the bisnorcholanic lactones 
with pre-functionalized side chains 3.3.  The bisnorcholanic lactones 3.4 as described 
earlier in chapter 2 arrive from F-ring oxidative cleavage of hecogenin acetate 1.14.   
 
 






























3.2  Synthesis of Bisnorcholanic Lactones 
3.2.1 Nitrosonium Oxidative Cleavage Strategy 
The reaction of spiroketals with the presence of nitrosonium ion precursors in the 
presence of BF3•OEt2 and acetic acid have been widely used for the introduction of the 
C23-oxo functionality through C-H oxidation of 5,6 spiroketals (Chapter 2).5 Isolated 
along with the desired 23-oxo compounds was the undesired bisnorcholanic lactone 3.9, 
which in the earlier development of the ‘Red-Ox’ strategy was a plaguing nuisance.  
However, the current strategy embraces bisnorcholanic lactone 3.10 as a key 
intermediate.  It has been well established that oxime 3.6 is formed through electrophilic 
addition of the nitrosonium ion (NO+) to the transient enol ether 3.5 (Figure 3.3).5 Once 
formed, oxime 3.6 quickly reacts through to two competing pathways to give either the 
C23 ketone 3.11 or the C22-lactone 3.9.  If the oxime 3.6 comes react with another 
molecule of BF3•OEt2, 3.7 undergoes a second order Beckmann rearrangement providing 
lactone 3.9.  On the other hand, if oxime 3.6 reacts with a second equivalent of NO+, 
oxidation occurs forming nitroimine 3.10, which upon work-up partially hydrolyzes to 





Figure 3.3 Competitive reaction pathways of the C23-oxime nitrosation product  
From experience with the optimization of the oximinylation reaction for 
production of ketone 3.11; it is worth noting that the rate of oxime oxidation is far greater 
than either the nitrosation or Beckmann rearrangement, which has been reported to take 
24 hours with pure oxime under the conditions above (Figure 3.3).5c The need for 5 
equivalents of nitrosonium ion to obtain complete conversion while simultaneously 
reducing the 2nd order Beckmann rearrangement provides evidence for the slower rate of 
nitrosation.  The slower rate of nitrosation is not unexpected given the low concentrations 
of enol ether 3.5.  13CNMR of the crude product mixture further supports the slower rate 
of nitrosation by the observed lack of the C=N oxime signal at 158 ppm.  Instead, 
chemical shifts of 205 ppm and 170.5 for ketone 3.11 and nitroimine 3.10 respectively 












































carbonyl carbon due to its similar chemical shift of 170.67.  Iglesias-Arteaga and 
coworkers dug deeper into the nitrosation reaction, and were able to isolate and 
characterize the nitroimine 3.10 providing confirmation of its formation from 3.6.5d,6 
They also tested whether or not the nitroimine itself undergoes 2nd order Beckmann 
fragmentation, and found the nitroimine to be unaffected by the reaction conditions.  
Therefore, the rapid oxidation of the oxime to the nitroimine with excess nitrosonium ion 
protects against the 2nd order Beckmann rearrangement thereby increasing the yields of 
the C23 ketone 3.11.   
In order to reengineer the nitrosation reaction selectivity towards production of 
lactone 3.9, the rate of nitroimine formation needed to be reduced while simultaneously 
accelerating the rate of Beckmann fragmentation.  The optimization of the Beckmann 
fragmentation posed quite a challenge considering the relatively fast rate of oxime 
oxidation.  Earlier reports showed non-polar solvents with stoichiometric amounts of 
Lewis acids increased formation of lactone 3.9, which appeared to be a good starting 
point for reverse optimization of the spiroketal nitrosation reaction.5 Acetonitrile solvent 
afforded the highest production of lactone 3.9 at 45 % yield with dichloromethane and 
toluene providing slightly lower yields.5a Switching to lower polarity solvents was 
expected to increase the rate of Beckmann fragmentation while potentially slowing the 
rate of oxime oxidation through destabilization of the nitrosonium ion.  Extensive 
experiments were conducted to further optimize the formation of the lactone 3.9, which 
were met with limited success; the most productive results are summarized in Table 3.1.  
With CH2Cl2 as the solvent, a slight increase in lactone formation from 31 to 38 % was 
observed when the rate of t-BuONO addition to a solution of substrate 1.14 and 2 
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equivalents of BF3•OEt2 was extended to two hours from 15 minutes (Table 3.1 Entry 1).  
A four-fold increase in the Lewis acid along with 3 equivalents of nitrosonium ion 
precursor was insufficient to provide complete conversion, but giving only 40 % yieldof 
lactone 3.9.  Further increasing both the BF3•OEt2 and t-butyl nitrite equivalents provided 
better conversions, however, the ratio of ketone 3.11 increased as the equivalents of 
nitrosonium ion precursors increased.  This trend was also observed when both CH3CN 
and PhMe were screened under similar conditions.  Replacement of the Lewis acid with 
strong protic acids such as 2N HCl or sulfuric acid resulted in no lactone formation 
accompanied by decomposition and incomplete conversion to ketone 3.11.  The protic 
acids promote the conversion of sodium nitrite and t-butyl nitrite into the nitrosonium 
ion, which accelerates the rate of oxime oxidation to provide nitroimine 3.10 and its 
hydrolyzed ketone product 3.11.  
The best conditions of those screened were those that included the addition of a 
second Lewis acid, FeCl3, also known to promote the Beckman rearrangements (Table 
3.1).7 The late addition of solid FeCl3 to a mixture of the sodium nitrite and BF3•OEt2 in 
acetic acid accelerated the formation of the lactone 3.9 (Entries 2-5).  Addition of 5 
equivalents of FeCl3 to a mixture of 5 equivalents each of sodium nitrite and BF3•OEt2 
portionwise over five minutes gave complete conversion and 58 % yield of the lactone 
3.9 (Entry 2).  The rate and timing of FeCl3 addition was critical (Table 3.1).  Fast 
addition rates provide the best results, when added in one shot or portionwise over 5 
minutes upon the complete addition of the nitrite (Entries 2 and 3).  However the addition 
of FeCl3 was highly exothermic, and attempts to reduce the exothermicity by slowing the 
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rate of addition of FeCl3 or adding it prior to nitrite addition, resulted in reduced 
production of the lactone 3.9.   
 
Table 3.1 Optimization of the bisnorcholanic lactone 
 




Yield of 3.9c 
(%) 
1 t-BuONOd (3) BF3•OEt2 (2) CH2Cl2 40 3.12 38 
2 NaNOd (5) BF3•OEt2 : FeCl3
e (5:5) AcOH 100 1:2 58  
3f t-BuONOd (5) BF3•OEt2: FeCl3
f(5:5) AcOH 100 nd 62 
4 NaNOd (5) BF3•OEt2 : FeCl3
g (5:5) HCOOHh 56 1:1.5 nd 
5i NaNOd (5) BF3•OEt2 : FeCl3 (5:5) AcOH 100 3:2 41  
a) General reaction conditions: Nitrite was added to 1.14 and Lewis acid in 0.1M solution in the appropriate 
solvent at room temperature, b) conversion and product distribution determined by 1HNMR comparison of the 
C16 chemical shifts at 4.37, 4.53, 4.53 and 4.87 ppm for 1.14, 3.10, 3.11 and 3.9.  The ratio of 3.10 to 3.11 could 
be determined by the C26 signal for 3.11 at 3.74 ppm, c) isolated yields, d) added dropwise over 2 hours, e) 
added in three portions over 5 min, f) reaction run on C12 acetate, g) FeCl3 added portionwise over 30 min, h) 
1M, i) reaction run at 60 °C on the 2 g scale and the FeCl3 was added over 15 min.  
 
 
Due to the hazardous exotherm, scaling up the reaction required slower rates of 
FeCl3 addition.  To counterbalance the effect of the slower addition, the reaction was run 
at higher temperatures (60 °C), which resulted in only 41 % yield of the lactone 3.9 and 
increased formation of the ketone 3.11 (Entry 5).  Switching to formic acid resulted in 
lower conversion and slightly reduced ratio of the lactone 3.9 (Entry 4).  Use of FeCl3 as 
the sole Lewis acid did not provide significant quantities of the lactone in acetic acid or in 
non-polar solvents.  
With either sodium nitrite or t-BuONO and BF3•OEt2:FeCl3, approximately 60 % 
of the C22-bisnorcholanic lactones could be obtained (Entries 2 and 3).  In light of the 
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potentially hazardous exotherm exhibited upon addition of FeCl3 and the need for the fast 
addition rates, further investigation was required to find more controllable conditions that 
allowed for reaction scales greater than 2 grams.  With faster rates of the nitroimine 
formation, the ability to obtain 60 % of the lactone in under 30 min is noteworthy 
considering the length of time required (24 h) for the conversion of pure oximes with 
stoichiometric quantities of BF3•OEt2 in acetic acid.
5d Iglesias-Arteaga and coworkers 
demonstrated the ability to utilize the nitrosation reaction to produce lactone 3.9, 
however, the three step sequence provided only 66 % overall yield.  What is noteworthy 
was their ability to obtain nearly quantitative conversion of oxime 3.6 to the lactone 3.9 
under the former BF3•OEt2/AcOH conditions.
5c The three step process however is not 
directly applicable to C12-oxo substrates due to the need to reform the C23-oxime 3.6 
from 23-oxo-hecogenin 3.11 in the second step generating an issue of chemoselectivity.  
3.2.2 Baeyer-Villiger Strategy 
Although the unoptimized direct conversion of hecogenin acetate 1.14 to the 12-
oxo-bisnorcholanic lactones 3.9 with BF3/FeCl3/nitrite was only moderately yielding, it 
was only one of two known methods for the direct oxidative cleavage of 12-oxo steroidal 
spiroketals to the bisnorcholanic compounds.  The other method for the conversion of 
hecogenin acetate 1.14 to the desired 12-oxo bisnorcholanic lactone 3.9 was reported by 
Tian and coworkers.8 The method exploited a chemoselective Baeyer-Villiger type 
cleavage of the spiroketal with persulfonic acid to produce the keto-lactone in 71 % 
overall yield (Scheme 3.1).  Attempts to reproduce the selective Baeyer-Villiger 
oxidative F-ring cleavage were unsuccessful.  The use of peracetic acid or m-CPBA for 
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mediated Baeyer-Villiger spiroketal cleavage resulted in a double Baeyer-Villiger 
oxidation forming 12,22-bislactone 3.12 in 85 % yield, consistent with the results 
obtained by Tian and coworkers.8   
 
 
Scheme 3.1 Baeyer-Villiger results 
Anticipating the potential to slow the competitive reactivity of the C12 carbonyl 
toward nucleophilic oxidants through exploiting the greater steric environment around 
C12 ketone, dioxolane 3.15 was prepared quantitatively with ethylene glycol and 
catalytic pTSA in refluxing benzene (Scheme 3.2).  The C12-dioxolane 3.15 was quickly 
examined as a possible precursor to C22 lactones through selective Baeyer-Villiger 
oxidation.  The non catalyzed m-CPBA mediated spiroketal cleavage was reinvestigated 
with C12 dioxolane 3.13; with  2.2 equivalents of m-CPBA  in DCE at 60 °C, complete 
consumption of the starting material was observed.  However only 9 % of the desired 
lactone 3.16 was detected by crude 1HNMR while 13CNMR showed the dioxolane 
remained mostly intact.  Addition of iodine to further promote the spiroketal cleavage 
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resulted in complete conversion of the dioxolane 3.15 providing a complex mixture, 
however, the formation of the lactone was not observed in this case.    
 
 
Scheme 3.2 Baeyer-Villiger and dioxane 
Looking to take advantage of both the smaller ring size of the C12 ketal along 
with the increased sterics, addition of the less reactive TBHP with catalytic amounts of 
BF3•OEt2, was explored (Scheme 3.2).  The combination of the strong Lewis acid with 
the weakly nucleophilic peroxide did not produce the desired regioselectivity even at low 
temperatures in non polar solvents.  Finally, treatment of the C12 protected spiroketal 
3.15 with 5 equivalents of oxone and wet alumina, known to promote Baeyer-Villiger 
oxidations of cyclic ketones, in CH3CN at 60 °C provided very little conversion.
9  The 
lack of reactivity was surprising at first, however, the conditions were later shown to be 
effective for the oxidation of acetals to hydroxy esters while at the same time being rather 
inert towards ketals.10 With these less than stellar preliminary results, regioselective 
Baeyer-Villiger oxidation of C12- dioxolane-spiroketal 3.15 was not investigated further. 
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3.2.3 Non Baeyer-Villiger Oxidative Cleavage Reactions 
With the lack of chemoselectivity of the Baeyer-Villiger type cleavage and the 
limited success of the nitrosation strategy, a non-nucleophilic oxidative cleavage method 
was desired to provide the 12-oxo-bisnorcholanic lactones 3.9.  The originally observed 
chemoselectivity observed during the α-C-H oxidation with in situ generated nitrosonium 
ion illustrates the potential for chemoselective spiroketal cleavage of hecogenin acetate 
1.14 to the desired C12-oxo-bisnorcholanic lactone 3.9 through exploiting the low 
concentrations of the enol ether 3.5 (Scheme 3.3).  The ketal-enol equilibrium of 5/6 
steroidal spiroketals has been exploited to introduce a number of functional groups to the 
C23 position.  In addition to nitrosonium ion C-H oxidations, bromination with Br2 in 
acetic acid and iodination with ICl have been known since 1966 favoring the equatorial 
halides 3.17 in good yields.11 A chemoselective aldol reaction has also been 
accomplished through BF3•OEt2 assisted addition of benzaldehyde to enol ether 3.5 of 
hecogenin acetate and other steroidal spiroketals in selectively yielding giving the E-
benzylidines 3.18.12 Another interesting reaction is the direct stereoselective C23-
acetoxylation of hecogenin acetate 1.14 to exclusively form the 23(R)-acetate 3.19 with 
diacetoxy iodobenzene (DIB) and BF3•OEt2 in acetic acid.  In all of these cases there was 
no competitive reactivity at the C11 position, resulting from ring strain destabilization of 
the enol.  From these select examples, it was envisioned that the right oxidant/ Lewis acid 
combination could effectively capture the exocyclic enol leading to direct cleavage to the 




Scheme 3.3 Chemoselective electrophilic additions to 12-oxo spiroketals 
To commence the investigation into direct enol ether oxidation, the reaction of 
hecogenin acetate 1.14 with ozone and BF3•OEt2 in ethyl acetate at -78 °C led to little 
reactivity under saturated ozone conditions (Scheme 3.4).  Upon warming to -30 °C, 
hecogenin acetate 1.14 was completely consumed; however, several compounds were 
formed and the desired lactone was not detected by 1HNMR upon reduction of potential 
ozonides.  Treatment of hecogenin acetate 1.14 with KMnO4 and I2 under acidic 
conditions, AcOH with 16 % H2SO4, again showed complete consumption of the 
spiroketal forming several products, with no detectable levels of the desired lactone 3.9.  
The conditions appeared to be too harsh and milder sodium periodate was substituted for 
potassium permanganate.  With 0.1 equivalents of I2 and 5 equivalents of NaIO4 in 60: 1 
108 
 
acetic acid / H2SO4 at room temperature, 50 % conversion of hecogenin acetate 1.14 was 
observed giving two distinct products.   
 
 
Scheme 3.4 Attempts at direct oxidation of the exocyclic enol ether 
A minor product isolated in 6 % yield, was determined to be a 19:1 axial:eq  
mixture of C23-iodides 3.21 whose spectral data was consistent with reported literature 
(Scheme 3.4).11a  1H NMR of the major product did not show the diagnostic 
bisnorcholanic lactone 4.84 ppm downfield shift of the C16 proton; however, the C16 
proton signal appeared much further downfield at 5.84 ppm.  From the 1H and 13C NMR 
observations, it was concluded that the unknown product was consistent with the 10 
membered bislactone 3.20 isolated in 26 % yield.   
The proposed steroidal structure was unprecedented in the literature, however a 
few instances of 10 membered bis-lactones are known.  Along with the downfield shift of 
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the C16 proton, the C26 methylene protons remained present with one proton shifted 
downfield to 4.59 ppm (ddd, J = 11.0, 3.8, 1.4 Hz, 1H) and the other appearing at 3.34 
ppm (t, J = 10.9 Hz, 1H) (Figure 3.4).  The distinct chemical shifts and coupling of the 
two C26 protons with the C25 proton is consistent with a locked ring conformation.  The 
large chemical shift differences observed for the two C26 methylene protons of 
compound 3.20 matched those of the analogous structure 3.22 with chemical shift of 4.97 
and 3.85 ppm for the methylene protons.13  Furthermore, the downfield C26 methylene 
proton is a ddd which can only arise from w-coupling with the C24 methylene proton 
confirming its identity and locked ring conformation.  The downfield shift of the C20 
proton to 3.18 ppm from below 2 ppm is also consistent with the higher oxidation state at 
C22 (vida infra).  13C NMR showed the presence of four carbonyl peaks along with 
absence of a spiro or hemiketal carbon.  The four carbonyl peaks were consistent with the 
C12-ketone at 214.3 ppm, C3-acetate at 170.7 ppm, and two lactones at 171.0 and 174.8 
ppm.  Only one acetate methyl was present in the 1HNMR confirming the two other 
carbonyls were lactones formed through oxidative cleavage of the spiroketal.  
 
 






























The characterized structure 3.20 suggests two interesting facts about the 
mechanism; first the C16 oxygen at some point migrated from the C22 to the C23 
position, and second the cleavage took place between carbons 22 and 23.  Sodium 
periodate on its own has not been shown to be a great oxidant for the cleavage of double 
bonds, suggesting the intermediate bis hemiketal 3.43 was potentially cleaved in the final 
step to produce the bislactone (Scheme 3.5).  With these key factors, the following 
mechanisms were proposed.  The first step was the electrophilic α–iodination of enol 
ether 3.5 to produce the C23-iodide 3.23.11,14 Although direct electrophilic addition of I2 
to spiroketals was not originally known, the reaction is supported by the isolation of 6 % 
of the axial 23-iodo-spiroketal 3.21.  Moreover, in the presence of oxidants, accelerated 
electrophilic iodination of alkenes has been well established.15 Only catalytic amounts of 
iodine are necessary due to IO4-mediated reoxidation of expelled 2I
- to iodine (Figure 
3.5).  The 23-iodo spiroketal 3.23 can undergo a second electrophilic iodination 
producing 23-diiodide 3.34 (Pathway A) or the monoiodide undergoes solvolysis forming 
the acetoxy hemiketal 3.32 followed by neighboring group assisted displacement of the 
iodide to give C23-acetate 3.29 (Pathway B).  Following Pathway A, the 23-diiodo 
spiroketal 3.34 can react further by two different pathways resulting in the same product.  
The first pathway is brought about by acetic acid solvolysis of oxonium ion 3.34.  The 
acetoxy hemiketal 3.33 provides the 23-acetoxy-23-iodo spiroketals 3.36 and 3.37 which 
undergoes neighboring group assisted iodide displacement via cyclic onium intermediate 
3.32.  The 23-acetoxy-23-iodo spiroketals 3.37 and 3.67 are also potentially formed 





Figure 3.5 Oxidative regeneration of iodine 
The 23-iodo-23-acetoxy spiroketals 3.36 or 3.67 as well as the 23-diiodo 
spiroketals 3.33 are all potential precursors to the 22,23-bis-hemiketals 3.43 through 
migratory displacement of either iodide or acetate by the C16 oxygen to give the fused 
6,6 hemiketals 3.44 through hydrolysis of oxonium ion intermediates 3.40 or 3.41, where 
X = I, or Ac.  The fused 6,6 22,23-bis-hemiketals 3.34 are generated through the 
hydrolytic displacement of either the 23-iodo or 23-acetate of 3.44 to provide an 





Scheme 3.5 Proposed mechanism for the synthesis of 3.20 
The fused 6,6 bis-hemiketals 3.43 can also be generated from the bridged 
oxonium ions 3.32 through a Prevost-Woodward reaction by hydrolysis of the 1,3-
dioxolon-2-ylium ion followed by subsequent iodide displacement forming C23 ketone 
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spiroketal 3.38 can undergo E-ring expansion through acid promoted migration of the 
C16 oxygen to the C23 position to give the fused-6,6 oxonium intermediate 3.42 (X = 
OH) which provides the required bis-hemiketal 3.43 upon hydrolysis.  Lewis acid 
promoted 5/6 – 6/6 rearrangements of 23-oxo-spiroketals have been independently 
reported by both Suarez (TiCl4) and Morzycki (BF3•OEt2), suggesting strong protic 
acidic promoted rearrangements are plausible.16  
The lack of isolated bis-furans 3.28 calls into question the existence of bridged 
oxonium ion intermediates 3.27 and 3.32 which can suffer 5-exo intramolecular 
cyclizations by attack of the C26 alcohol.  However, the acetate rearrangement is 
potentially faster than the intramolecular 5-exo-cyclization and the presence of water may 
result in rapid hydrolysis of 3.32 to give the 23-oxo spiroketal 3.38. The hydrolysis 1,3-
dioxolon-2-ylium ions 3.32 to provide the 23-oxo-spiroketal is supported by the work 
Sudalai and coworkers on the Prevost-Woodward reaction with LiBr and NaIO4 (Figure 
3.6).17 They found that catalytic bromide (as well as iodide) in the presence of catalytic –
IO4 and AcOH was effective for syn-dihydroxylation of alkenes through hydrolysis of the 
1,3-dioxolon-2-ylium ions 3.47 formed from the anchimeric assistive bromide 





Figure 3.6 Syn-dihydroxylation through hydrolysis of 1,3-dioxolon-2-ylium:  Prevost 
Woodward reaction 
The final step of the mechanism results in periodate mediated oxidative cleavage 
of the cis-6,6-fused 22,23-bis-hemiketal 3.43 to provide the 10 membered bis-lactone 
3.20.  Although there are no reports that support the formation of a 10 membered 
bislactones through the oxidative cleavage directly, 10 membered keto lactones have 
been formed from through Pb(OAc)4 promoted oxidative cleavage of fused 6,6 enol 
ethers.18 Periodate has also been reported to cleave non-fused α-hydroxy hemiketals 
effectively furnishing a lactone and an aldehyde.19 
While a search for a more effective procedure for the direct synthesis of the 12-
oxo-bisnorcholanic lactones 3.9 from hecogenin acetate 1.14 through direct spiroketal 
cleavage were unfruitful, the procedure developed by Tian and coworkers was utilized 
for the production the key intermediate.20 The procedure developed by Tian and 
coworkers utilizes a CH3CO2OH/cat. I2 /AcOH/H2SO4 system for the effective spiroketal 
cleavage of C12-hydroxy or non-functionalized steroidal sapogenins.  Starting from 
hecogenin acetate 1.14, reduction of the C12-ketone was accomplished quantitatively 
with NaBH4 in MeOH/THF as solvent providing a mixture of C12-diastereomeric 
rockogenins 3.13 in 3:1 ratio the favoring C12-β alcohol (Scheme 3.6).  Rockogenin-3-
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acetate 3.13 was treated with CH3CO2OH/cat. I2/AcOH/H2SO4 followed by 
saponification with 13 N NaOH to afford the 3,12-dihydroxy-bisnorcholanic lactone 3.14 
in 85 % yield.  Regioselective protection of the 3-hydroxy was easily accomplished with 
TBSCl and imidazole in CH2Cl2 to provide the 3-tert-butyldimethylsilyl-12-hydroxy-
bisnorcholanic lactone 3.50 nearly quantitatively, due the fixed equatorial nature of the 
C3 alcohol and the steric hindrance of the C12-alcohol.  
 
 
Scheme 3.6 Synthesis of 12-oxo-bisnorcholanic lactone 3.51 
The crude mixture of 12-hydroxy bisnorcholanic lactones 3.50 were subjected to 
Swern oxidation to give 3-tert-butyldimethylsilyl-12-oxo-bisnorcholanic lactone 3.51 in 
82 % yield from the diol on the 100 mg scale (Scheme 3.6).  On the gram scale, the 
substrate to reagents ratio of 1:3:6:9 oxalyl chloride/DMSO/NEt3 in CH2Cl2 required 
additional DMSO (added until homogeneous) to accommodate the low solubility of 12-
hydroxy lactones at -78 °C; and the reaction failed to go to completion providing only 65 
% of the desired 12-oxo lactone.  On a separate 7 g batch, 82 % yield was obtained when 
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the crude 12-hydroxy compound 3.50 was partially purified by passing through a silica 
plug prior to Swern oxidation. 
While the Swern oxidation produces the desired 12-oxo lactone in good yields, 
large scale batches required at least a silica plug purification of the 3-TBS-12-hydroxy 
lactone 3.51.  Desiring a cheaper and cleaner procedure for the oxidation of crude 12-
hydroxy compounds 3.50, catalytic oxidant systems compatible with the secondary TBS 
protecting group were sought.  A quick look into the literature showed TPAP as a mild 
and effective catalytic oxidant for the conversion of sterically hindered secondary 
alcohols to ketones.21 Employing the conditions reported by Gonsalvi and coworkers 
utilizing NaOCl as the terminal oxidant with 3 mol % TPAP in a MTBE/Phosphate buffer 
(pH = 9.5) biphasic solvent system, provided a clean reaction.  However, only moderate 
conversions were obtained due to the low solubility of the alcohols 3.50 in MTBE.  With 
the addition of small amounts of CH2Cl2 to solubilize the substrate, TPAP loading could 
be reduced to 1 mol % and provided the desired ketone 3.51 in 94 % yield from the diol 
3.50 requiring only a silica gel plug filtration.   
3.2.4 TBSOTf Mediated Prins Cyclization 
With the 3-TBS-12-oxo-bisnorcholanic lactone 3.51 in hand, the introduction of 
the 14,15 D-ring olefin was required.  The work by Bladon and then by Winterfeldt, 
demonstrated hecogenin acetate 1.14 undergoes C-ring Norrish-Type 1 photolytic 
cleavage to produce lumihecogenin 3.52, and oxetane byproduct 3.53 (Figure 3.7).  
Lumihecogenin 3.52 and oxetane 3.53 are converted to homoallylic alcohol 3.54 through 
a BF3•OEt2 mediated ene reaction, producing the α-isomer in 80 % yield.
22 Treatment of 
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the photolysis mixture with protic acids on the other hand, results in the formation of the 
14-hydroxy compounds 3.55α and 3.55β in a 7:1 mixture through Prins cyclization.   
 
Figure 3.7 Blandon/ Winterfeldt introduction of Δ14-15 D-ring olefin 
Although the desired C12β stereochemistry is not favored in the above 
transformations, it was envisioned that a similar sequence could be used to access the 12-
β-hydroxy-14,15-ene-bisnorcholanic lactone (Scheme 3.7). 3-acetoxy-12-oxo-bis-
norcholaninc lactone 3.56 underwent photolysis at 300 nm in CH2Cl2 to provide aldehyde 
3.58 along with small amounts of the oxetane 3.62 upon prolonged photolysis.  BF3•OEt2 
mediated ene reaction of the crude mixture provided exclusively the Δ14-15 unsaturated 
12-α-alcohol 3.60.  Diastereoselectivity favoring the α-alcohol is consistent with the 
earlier results observed for lumihecogenin 3.52 with either BF3•OEt2 or ZnBr2.
23 
Treatment of the 3-TBS-12-oxo-lactone under the same conditions provided the 
deprotected 3,12-dihydroxy-14,15-ene-lactones exclusively, not surprising as the 
presence of aldehydes accelerates TBS deprotection at low temperatures (Table 3.2 Entry 
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1).  Similarly, SnCl4 also produced the ene products with complete loss of the silyl 
protecting group (Entry 2).  While Cu(OTf)2, MgBr2•OEt2, and Sc(OTF)3 tolerated the 
silyl protecting group, they all showed reduced reactivity at 0 °C compared to BF3•OEt2 
and ZnBr2, with the best results obtained from MgBr2•OEt2 providing 81 % conversion 
and 2:1 α:β (Entries 3-4).  From preliminary results and previous reports on the ene 
reaction of lumihecogenin, it was clear small Lewis acid catalysts favor the formation of 
the α-alcohols and a system compatible with the silyl protecting group was necessary to 
provide the C12 β-alcohol 3.59.  Chiral Lewis acid catalysts, Ag/BINAP, CBS, and 
BINOL/TiCl2 were also screened; all failing to provide more than 10 % of the desired 
ene products.   
 





Table 3.2 Ene/ Prins cyclization of lumi-bisnorcholanic lactone 3.57 
 
As mentioned in chapter 2, Lee and Fuchs developed a TFAT promoted E and F 
ring opening protocol.  The highly active acyl triflate was envisioned as an effective 
Lewis acid for potential promotion of the desired ene reaction.  Treatment of aldehyde 
3.57 with TFAT in presence of DTBMP provided an inseparable 1:1 mixture of Δ14-15 
3.70 and Δ8-14 3.76 12-β-trifluoroacetates 3.70 and 3.76 in 65 % yield (Table 3.2 Entry 5).  
 
 
Entry Lewis Acid Eq. Temp. (°C) Solvent 
Conversion 
(%)a 
α:β:Δ8-14 a Yield (%)b 
1 BF3•OEt2 0.10 -78 CH2Cl2 73 2.6:1:ND - 
2 SnCl4 0.10 -78 CH2Cl2 99 α only - 
3 MgBr2 0.10 -78 CH2Cl2 81 2.5:1 - 
4 Sc(OTf)3 0.10 -78 CH2Cl2 100 α only < 30 
5 TFAT 1.5c -78 CH2Cl2 73 0:1:1 65 
6 TMSOTf 1.5 c -78 CH2Cl2 100 1:1:0.11 - 
7 TBSOTf 1.5 c -78 CH2Cl2 80 1:2 :0.23 75 
8 Me2ThexSiOTf 2.0
d 25 CH2Cl2 85 1:3:0.33 63 
9 TIPSOTf 2.0 c -30 CH2Cl2 40 - 51 1:3 - 1:5:0 38 %
a 
10 TBSOTf 1.5 c -78 THF 97 1:1.5:ND - 
11 TBSOTf 1.5 c 25 ACN - 1:1: ND 41 
12 TBSOTf 1.5d -20 CH2Cl2 95 1:2:ND - 
13 TBSOTf 1.5 d -78 CH2Cl2 97 1:3:0.14 87/65
e 
14 TBSOTf 3.0d 0 CH2Cl2 100 1:3:0.32 94 / 60
e 
a) Determined by 1HNMR, b) combined isolated yields, c) DTBMP used as base, d) 3.5 equiv. 2,6- 
lutidine used as base,  e) isolated yield for protected β- alcohol 
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While TFAT provided the 12β-trifluoroacetates exclusively, the lack of olefin 
regiocontrol was undesirable, so less reactive silyl triflates were screened to combat the 
loss of regioselectivity.  Reaction of aldehyde 3.57 with TMSOTf/DTBMP increased the 
olefin regioselectivity to 9:1 in favor of Δ14-15 3.71, however, the stereoselectivity was 
lost providing a 1:1 mixture of C12-trimethylsilyl ethers 3.65:3.71 in 98 % yield (Entry 
6).  Switching to TBSOTf/ DTBMP provided a 2:1 mixture in favor of the 12-β-silyloxy 
3.72 at -78 °C (Entry 7).  The olefin regioselectivity in the cases of TBSOTf was 
intriguing as the isolated β-isomer 3.72 contained 10 % of the Δ8-14 olefin, while the α-
silyloxy 3.66 contained only the desired Δ14-15 olefin.  Thexyldimethylsilyl triflate 
provided yields and diastereoselectivities consistent with that of TBSOTf, 63 % and 3:1 
dr (Entry 8).  Finally, the bulky TIPSOTf  was found to promote the formation of the 
desired products 3.73:3.67 in ratios ranging from 3:1 to 5:1, however, conversions were 
consistently low with the highest being 51 %.  All attempts to improve the conversion 
were unsuccessful.  Aside from the desired products and formation of the Δ8-14 olefin side 
product; signals consistent with the silyl enol ether were observed in the crude 1HNMR 
accounting for the low yields.    
With the optimum silyl triflate obtained, further optimization through solvent and 
temperature screening were evaluated.  As temperatures increased, the 
diastereoselectivity increased with the best results obtained at 0 °C giving 3:1 β:α (Entry 
14).  More polar solvents surprisingly also led to decreased stereoselectivities with THF 
and CH3CN providing ratios of 1.5:1 (Entries 10-11).  The last drawback of the reaction 
to be optimized was the need for stoichiometric excess of the expensive bulky base 
DTBMP.  Although DTBMP could be recovered and recrystallized, a cheaper alternative 
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was sought to justify the practicality of the reaction given the less than stellar yields and 
diastereoselectivities achieved.  Switching the base to either 2,6 lutidine or collidine had 
no affect on the yield or stereoselectivity, providing a suitable replacement (Entries 12-
14).  Ultimately, the optimized diastereoselectivities were obtained at 0 °C with 2,6-
lutidine and CH2Cl2 as solvent giving 3:1 ratio and 60 % overall yield of the β-silyl ethers 
as an inseparable 9:1 mixture of regioisomers (Entry 14). 
 
 
Figure 3.8 Blandon / Winterfeldt ene and Prins cyclizations 
Mechanistically, the formation of two olefin products from Lewis acid mediated 
cyclization of unsaturated C-ring aldehydes was previously unprecedented and suggested 
competitive mechanisms were involved.  Unsaturated C-ring aldehyde 3.52 was known to 
undergo ene reactions in the presence of heat or Lewis acids under anhydrous conditions, 
while in the presence of acids, Prins-cyclization dominates and the 14-hydroxy products 
3.55 are formed (Figure 3.8).22b With small Lewis acids, a concerted ene reaction can 
dominate as the necessary transition state confirmation 3.82 can be achieved to form the 
α-product (Figure 3.9).  On the other hand, to obtain the β-products through a concerted 
ene mechanism, a proton must be abstracted from across the β-face of the C-ring which is 
blocked by the C13 methyl group and the silyloxy is pointed outward from the ring 
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resulting in a switch to a non-concerted Prins reaction mechanism through an carbonium 
ion 3.83 or triflate 3.84 intermediates.   
 
 
Figure 3.9 Duality of ene and Prins cyclization 
  With the 3,12-di-t-butyldimethylsiloxy-Δ14-15-bisnorcholanic lactone 3.57 in hand, 
the focus turned to the introduction of the C17-hydroxyl functionality.  The best route to 
stereoselectively install the C12 hydroxy was through [4+2] cycloaddition of singlet 
oxygen across the D-ring diene.  J. S. Lee and Fuchs showed that D-ring allylic ethers are 
readily susceptible to eliminative E-ring opening with highly active acyl triflates, such as 
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TFAT, furnishing the desired diene and acyl protected alcohol 2.10 from allylic ether 2.9 
as previously described in chapter 2 (Scheme 2.3).24 S. M. Lee further showed the degree 
of susceptibility toward E-ring opening of allylic ethers with their recent publication 
(Figure 3.10).25  When allylic ether 2.9 was reacted with catalytic iodine and a weak base 
in refluxing benzene, the iodonium ion C25 bishomoallyic olefin became activated 
driving the E-ring opening producing the diene-22-furanyl compound 3.86 in 95 % 
yield.25 What is even more surprising is the in situ reduction of the C26-iodo intermediate 
3.87 under these conditions, which did not occur at lower temperatures with 
stoichiometric amounts of iodine in acetonitrile.  Instead, at low temperatures iodonium 
mediated E-ring opening gave the iodo furan 3.87 in 82 % yield.26 The authors did not 
speculate on the mechanism for the apparent in situ reduction of 3.87 to give 3.86.  Even 
more interesting, C7-hydroxy D-ring allylic ether 3.88 did not undergo iodonium 
mediated E-ring opening, giving only olefin isomerization product 3.89. 
   
 
Figure 3.10 E-ring opening methods 
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Considering the better leaving capability of the of the E-ring lactone, it was 
expected that the diene could be readily prepared in a similar manner through TFAT 
mediated E-ring lactone opening.  Treating the D-ring unsaturated bisnorcholanic lactone 
3.72 with TFAT and DTBMP furnished the diene acid 3.90 upon cold work-up in 90 % 
yield (Scheme 3.8).  It is noteworthy, that if the reaction was not quenched cold, some 
desilylation of the C3-TBS protecting group was observed giving only 50 % of the 
desired product along with epimerization of the C20 methyl.    
 
 
Scheme 3.8 TFAT E-ring opening results 
With successful lactone opening, a one pot lactone opening / acid activation 
reaction was envisioned for direct installment of the side chain through nucleophilic 
addition to the activated acid (Figure 3.11).  To this end, a Yamaguchi activation protocol 
was an attractive choice, and it was envisioned that treatment of the allylic lactone 3.72 
with 2,4,5-trichlorobenzoyl triflate 3.92 could provide the desired activated asymmetric  
anhydride 3.93.  The foreseeable drawbacks to the reaction were the need for more than 2 
equivalents of nucleophile due to the presence of triflate byproducts and the unknown 
stability of the activated acid 3.93.  To potentially overcome the first issue, the metalated 
alkyne 3.94 was envisioned as the coupling partner for its ability to be quickly recycle the 




Figure 3.11 Tandem E-ring opening acid activation strategy 
To test the possibility of the one pot reaction, the effective lactone opening with 
2,4,5-trichlorobenzoyl triflate 3.92 was evaluated.  When the allylic lactone 3.72 was 
treated with 1.5 equivalents of the benzoyl triflate 3.92 and DTBMP at 0 °C, 49 % 
conversion was observed while the isolated yield of acid 3.90 was a mere 31 % (Scheme 
3.9).  With two equivalents of in situ generated benzoyl triflate the conversion was still 
low.  Complete conversion was not obtained until 6 equivalents of the benzoyl triflate 
were employed and the 2,4,6-trichlorobenzoic acid was isolated along with the desired 
product from column chromatography.  Insoluble bases K2CO3 and NaHCO3 were also 
screened at 0 °C, and both conditions resulted in the formation of C3-alcohol 3.96.  With 
the potential ability to generate the activated diene acid 3.93, the addition of a bulky 
weak nucleophile was tested.  Upon complete conversion of the allylic lactone, excess 
tert-butanol was added to obtain the tert-butyl ester 3.97 in only 24 % yield by 1HNMR.  
From the results, lactone opening was not as readily achievable as hypothesized, which 
may have been due to the better nucleophilicity of the carbonyl resulting in reformation 




Scheme 3.9 E-ring opening results with trichlorobenzoyl triflate 
The need for excess amounts of the expensive reagent quickly reduced the 
potential for the one pot opening/ activation protocol originally designed and other 
methods to open the lactone.  The prior proven TBS compatible Lewis acids were 
screened which included zinc triflate, magnesium dibromide and ytterbium triflate.  All 
of these Lewis acids failed to provide complete conversion of the lactone with either 
weak or strong Bronsted bases (Scheme 3.10).  Taking a page out of Tsuji’s play book, 
the opening of the lactone with either Pd(0) or the highly active combination of catalytic 
Pd(OAc)2/PBu3 in the presence of Hunig’s base at 100 °C also failed to provide the 
desired diene.  TMSOTf and triflic anhydride were both screened at -78 °C, with 
TMSOTf resulting in no reaction at -78 °C.  Triflic anhydride quickly promoted lactone 
elimination to the diene, but also resulted in complete epimerization of C20 methyl most 





Scheme 3.10 Other attempts at effective E-ring opening 
Further investigation in to effective ring lactone opening was not needed once a 
serendipitous discovery was made during the scale up production of 14,15-dihydro 
bisnorcholanic lactone 3.72.  Aldehyde 3.57 was treated with TBSOTf/2,6-Lutidine in 
CH2Cl2 as done previously to form a diastereomeric mixture of the fully protected 3,12-
dihydroxy-bisnorcholanic lactones 3.66, 3.72, and 3.78 (Scheme 3.11).  However, the 
reaction was inadvertently allowed to run 6 hours longer at which time the reaction had 
warmed to room temperature and a new UV active product was formed.  In the event, 
TBSOTf had not only mediated the Prins cyclization, but had also promoted the 
eliminative E-ring lactone opening to provide the diene silyl ester 3.101 and the diene 
acid 3.90 along with the normal ene/Prins products 3.66 and 3.78.  What is even more 
noteworthy is that the two C12 Δ14-15 diastereomers were kinetically resolved, as only the 
12-β-TBS-lactone reacted further to produce the diene silyl ester.  Furthermore, the 
inseparable Δ8-14 olefin regioisomer also did not react providing both a regiospecific and 
diastereospecific route to the diene silyl ester 3.101.  The ester 3.101 was hydrolyzed 
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with addition of cold AcOH to the reaction mixture and purified to provide the acid 3.90 
as a single isomer.  
 
 
Scheme 3.11 TBSOTf mediated tandem Prins cyclization E-ring opening 
It was later determined that the acid 3.90 could be easily purified by passing the 
crude mixture through a 2 % TEA silica plug.  The optimized sequence provides the 
3β,12β-di(tert-butyldimethylsiloxy)-14,16-dienyl-bisnorcholanic acid 3.90 in one 
operation as a single diastereomer in 58 % overall yield starting from the bisnorcholanic 
lactone 3.51 (Scheme 3.11).  The conversion of the saturated lactone to the diene acid 
3.90 encompasses a regio- and diastereoselective one pot 5 step reaction (photolysis, 
cyclization, alcohol protection, E-ring opening and silyl ester deprotection).  The original 
methodology to obtain the desired 3β-12β-di-silyloxy-diene acid product 3.90 would 




































alcohols 3.59 (Scheme 3.12).  Regioselective C3-alcohol silylation followed by C12 
reoxidation, C12 reduction and silyl protection would provide the 12-β-TBS protected 
bisnorcholanic lactone 3.72.  The desired acid product 3.90 would finally be accessible 
through TFAT mediated E-ring lactone opening to give an overall 7 step synthesis from 
the saturated bisnorcholanic lactone 3.51.  If yield of the BF3•OEt2 mediated ene reaction 
did provide 73 % yield of the diastereomeric alcohols 3.59, and complete diastereomeric 
control during the reduction of the C12-ketone 3.102 to provide the C12-β-alcohol 3.69 
could be realized, then the optimized original sequence would theoretically provide 54 % 
of the desired 3β,12β-di(tert-butyldimethylsiloxy)-14,16-dienyl-bisnorcholanic acid 3.90.  
Given these facts, the synthetic impact of this new one pot methodology is hard to ignore.   
 
 

















a) TBSCl, imidazole, CH2Cl2, 94%; b) TBSOTf, 2,6-lutidine, CH2Cl2, 99%
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3.2.5 Synthesis of the 17-Hydroxy Bisnorcholanic Lactones 
With the diene 3.101in hand, the introduction of the C17-hydroxyl was the next 
target to address.  The original synthesis was designed around the [4+2] cycloaddition of 
singlet oxygen to diene 3.101 to form the bridged peroxide 3.103 which had been 
previously reported with high diastereocontrol (Scheme 3.13).27 When the diene silyl 
ester 3.101 was reacted with O2 in the presence of catalytic tetraphenyl porphyrin (TPP) 
as a photosensitizer, the cycloaddition took place smoothly giving complete conversion 
with nearly complete stereocontrol.  The chemical shifts of 3.103 were consistent with 
reported 1HNMR assignments for the similar α-endoperoxide adduct previously 
confirmed by X-ray crystallography.28 The peroxoadduct 3.103, however could not be 
isolated as it was extremely unstable.  
  
 
Scheme 3.13 [4+2] cycloaddition of O2
1 to diene 
131 
 
Speculating the lability of the TBS ester as a factor in the instability of the 
products, the cycloaddition was also performed on the methyl ester 3.105 (Scheme 3.12).  
The methyl ester 3.105 was generated through quantitative addition of 
trimethylsilyldiazomethane to the parent acid 3.90.  Cycloaddition of the methyl ester 
3.105 provided complete conversion; however, a 1:1 mixture of diastereomers was 
obtained.  The peroxo-adducts of the methyl ester also proved to be very labile resulting 
in decomposition even when passed through a short neutral alumina plug.  All attempts to 
isolate the peroxide-adducts resulted in substantial decomposition.  The D-ring bridged 
peroxides and allylic epoxides have been shown to readily undergo both dyotropic 
rearrangements29 and Grob fragmentations.27d The high stereoselectivity for α-
endoperoxide of the TBS ester is noteworthy and the requirement of bulky substituents at 
C22 position to achieve the high levels of stereoselectivity during [4+2] cycloadditions 
has been previously shown.27b,29 The lack of bulky C22 substitution in substrates 
explored by Tian, could have contributed to the low yields they observed, although no 
mention was made of the β-adduct being formed.    
The TBS and methyl ester adducts 3.103 and 3.106 had the potential to be good 
substrates for the tandem peroxide reduction/ SN1’ cyclization to produce the 17-
hydroxy-bisnorcholanic lactone 3.104 (Scheme 3.13).  Addition of zinc in AcOH to the 
crude TBS ester 3.103 resulted in the formation of 17-hydroxy-bisnorcholanic lactone 
3.104 in an unoptimized yield of < 20 % by 1HNMR.  As mentioned earlier, the TBS 
ester is readily hydrolyzed under the above conditions and was more than likely 
converted to the acid prior to cyclization.  Tian had previously demonstrated the 
formation of the 17-hydroxy-bisnorcholanic lactone 3.111 in a similar fashion from either 
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the diene acid 3.108  or the methyl ester in 30 % for the 2 steps (Figure 3.12).28 The low 
yield obtained is consistent with the observed lability of the bridged peroxo adduct 3.109.  
Low yields at the critical stage of the synthesis made the [4+2] cycloaddition route to the 
desired 17-hydroxy-bisnorcholanic lactone less viable for large scale syntheses.  The 
[4+2] cycloaddition of singlet oxygen was determined to be better suited for late stage 




Figure 3.12 Tian [4+2] cycloaddition of O2
1 to diene 
 
Figure 3.13  Selective epoxidation strategy to 17-hydroxy-bisnorcholanic lactones 
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While investigation into the [4+2] cycloaddition route was ongoing, regioselective 
diene epoxidations were being explored.  It was envisioned that allylic epoxide 3.113 
could be obtained through regioselective C16,17 diene epoxidation of diene acid 3.90 to 
provide the 17-hydroxy-bisnorcholanic lactone 3.104 through either direct attack by the 
carboxyl on the epoxide, or through a stepwise acid catalyzed hydrolytic opening of the 
epoxide followed by acid mediated lactone formation (Figure 3.13).  The potential for 
regioselective epoxidation was established by earlier work in the Fuchs group with 
selective epoxidation of the Southern hemisphere D-ring diene 3.114 (Figure 3.14).  Wei 
Li and Fuchs nicely showed small oxidants like DMDO were moderately selective 
providing mono epoxides 3.115 and 3.116 along with bisepoxide 3.117 as a 3.9:1:1.7 
mixture.27a m-CPBA in the absence of buffer led to a similar product distribution to 
DMDO giving a 3.7:1.2:1, while with phosphate buffer a 10:3:1 mixture of the desired 
C16,17 epoxide 3.115 and the over oxidation bisepoxide 3.117 was obtained in 53 % 
yield.  The desired product however was isolated as a 10:1 mixture of the desired C16,17 
epoxide 3.115 and the over oxidation bisepoxide 3.117.  Shi’s fructose30 and Denmark’s 
cyclic bis ammonium ketone31 derived enantiopure dioxirane catalysts were too large, 
failing to react with the diene.  Investigation into medium sized epoxidation catalysts to 
overcome these poor selectivities led Wei Li to try the tetrafluoroacetophenones 3.118.32 
These bulkier versions of TFDO, provided increased reactivity and selectivity for the 
desired C16,17 oxirane in 6-7:1 of 3.115 :(3.116 + 3.117) in 79 % yield (based on 





Figure 3.14 Li and Fuchs selective epoxidation of southern D-ring diene 
 
In a similar manner, several catalysts for in situ regioselective diene epoxidation 
of dienoic acid 3.90 were screened including Jacobsen, Shi’s D-fructose 3.123, and Wei 
Li’s ketone 3.118 catalysts described above, along with stoichiometric oxidants Davis’ 
phenyl sulfonyl oxaziridine, m-CPBA, DMDO, and TFDO, (Table 3.3).  Compared to the 
southern D-ring diene 3.114 the D-ring dienoic acid 3.90 is far less rigid making selective 
epoxidation more challenging and the screened reaction conditions presented a range of 
conversion spanning <10 % to 100 % with the oxaziridine 3.122 reaction being the least 
productive (Entry 4).  DMDO, TFDO and m-CPBA all resulted in complete conversion 
with an observed lack of selectivity indicated by the multiple products formed (Entries 1, 
2 and 4).  Aside from Shi’s fructose catalyst 3.123 (run 6), all other conditions including 
ketone 3.118 failed to provide the desired allylic epoxides expected to present as slightly 




Table 3.3 Selective epoxidation of D-ring dienoic acid 
 
Unfortunately, the allylic epoxide or epoxides formed during Shi epoxidation 
could not be purified due to instability toward column chromatography.  From the crude 
1HNMR the structure 3.120 was tentatively assigned through comparison to literature 
data.27a,32 Although ketone 3.118 also failed to provide the desired epoxides, the reaction 
showed the most potential based on previously mentioned success along with cleaner 
reaction profiles and high conversion rates which prompted further investigated. 
As mentioned above, the originally optimized catalytic epoxidation utilizing 
tetrafluoroacetophenone 3.118 (20 mol % ketone 3.118, Oxone, NaHCO3, in 
Run Oxidant / Conditions Conv.a Results 
1 Acetone, Oxone, NaHCO3  CH3CN:1 x 10
-4 EDTA (1.5:1), 0 °C 100 % 
No epoxides 
2 1,1,1-Trifluoroacetone, Oxone, NaHCO3, CH3CN, 0 °C 100 % 
No epoxides 
detected 
3 m-CPBA, NaHCO3, CH2Cl2 80 % 
No epoxides 
detected 




Shi catalyst 20 mol % 0.05 M Na2B4O7 10H2O (in 4x10
-4 EDTA 








Ketone 3.118 0.05 M Na2B4O7 10H2O (in 4x10
-4 EDTA pH = 








-4 EDTA pH = 9.14/CH3CN 1/1.5) did not provide the allylic 
epoxides.  Further examination determined that the 17-hydroxy-bisnorcholanic lactone 
3.104 was formed in 14 % yield (Table 3.4 Entry 1).  Having found a potential catalyst 
for the direct synthesis of the C17-hydroxylactone 3.104 the optimization of both 
selectivity and yield began.  Increasing the amount of oxone to 0.8 equivalents (1.6 
equivalents of active oxidant) furnished 33 % of hydroxy lactone (Entry 2). Changing the 
solvent from acetonitrile to a 1:1 DMM:CH3CN cosolvent mixture, utilized during Shi’s 
selective diene epoxidations, converted the biphasic mixture to a nearly homogeneous 
reaction when combined with the sodium borate buffer in an overall organic: aqueous 
ratio of 1.5:1.33 Under these conditions 50 % yield of the desired 17-hydroxylactone 
3.104 was produced along with a new less polar product which eventually was 
determined (vide infra) to be diene 3.124 (Entry 3).  Replacing DMM with DME resulted 
in increase heterogeneity (solid : liquid) which had little effect on product distribution, 
but increased the reaction time to greater than 24 h with reduced conversions regardless 
of the base employed (Entries 4-5).  The reduced conversions are likely due to oxone 
decomposition during the longer reaction times.  Addition of CH2Cl2 to help solubilize 
the starting material or DME alone created a biphasic mixture which nearly retarded the 




Table 3.4 Optimization of D-ring dienoic acid selective epoxidation 
 
Looking into the literature for the effect of pH on dioxirane epoxidations, 
variability with regard to optimal pH was uncovered.  Denmark demonstrated strict 
control of pH between 7.8 and 8.0 with use of his quaternary ammonium cyclic dioxirane 
catalysts; observing that below pH 7.8 increased degradation of the ketone catalyst 
 
Entry Solvent a 
Oxone® 
(equiv) 






1 CH3CN 0.6 NaHCO3 (2.5) ≈ 8.5 10 1:1.5:ND: 14 
2 CH3CN 0.8 NaHCO3 (2.5) ≈ 8.5













1 K2CO3 (5) ≈ 9.1 20 0:4:1 55 









1 NaHCO3 (5) 8




1 K2CO3 (5) 10








0.6 K2CO3 (5) 10 0 0:12.5:1 61 
All reactions were run with 20 mol % of tetrafluoroacetophenone 3.118 in a 1.5:1 mixture of organic solvent and 0.05 
M Na2B4O7 10H2O buffer in 4x10
-4 EDTA at 0 °C; 0.18 M Oxone in 4x10-4 EDTA solution and base in an equal 
volume of 4x10-4 EDTA were added over 2.5 h by syringe pump unless otherwise stated.  cReaction run without 0.05 
M Na2B4O7 10H2O buffer in 4x10
-4 EDTA providing less homogeneous mixture. d Reaction progressed roughly 20 % 
after 24 h as the reaction was fairly homogeneous and oxidant still remained as indicated by KI-starch paper. e 













through Baeyer-Villager oxidation was seen.  On the other hand the rate of oxone 
decomposition was too high above pH 8.0.31 Contrarily, Shi determined optimal pH for 
the D-fructose catalysts to be between 10-12.34 The variation in the pH recommendations 
is a direct reflection on the homogeneity of the reactions and the subsequent effect on 
reaction rates.  Shi’s catalyst with sufficiently higher activity under nearly homogeneous 
conditions reduced reaction times to a couple of hours making the oxone decomposition 
at the higher pH negligible.  Denmark’s biphasic conditions, calls for longer reaction 
times of 24 h creating a more critical need for pH control to maintain oxidant activity by 
reducing the rate of oxone decomposition.   
In light of these observations and the reduced susceptibility of 
tetrafluoroacetophenone 3.118 to Baeyer-Villiger oxidation,27a,32 the governing factor for 
controlling the pH in addition to product distribution and catalyst activity is the rate of 
oxone decomposition.  The pH was screened over a small pH range of 8 and 10 (Table 
3.4 Entries 8-11).  At lower pH = 8, oxone was present after 24 h while very little 
conversion was seen.  The conversion under these conditions was increased to 20 % in 48 
hours with the addition of another 20 mol % catalyst, generating only the undesired 
decarboxylation product 3.124 (Entry 8).  At pH 10, the reaction was complete within 5 
hours and gave a 4:1 of 3.104 to 3.124 with a modest 20 % isolated yield of 17-
hydroxylactone 3.104 when run at room temperature (Entry 9).  Reducing the 
temperature to 0 °C did not enhance either the selectivity or yield (Entry 10).  The yield 
was restored to 61 % when the reaction was run with 0.6 equivalents of oxone signaling 
over-oxidation as the cause of reduced yields (Entry 11).  The selectivity was also found 
to be directly affected by the phase transfer catalyst, showing a decrease in selectivity 
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with increased amounts of nBu4NHSO4.  The inverse effect was believed to be caused by 
ion pair association between the carboxylic acid and the ammonium salt leading to 
blocking of the C16,17 alkene.  The decarboxylation side product 3.124 could be nearly 
excluded through elimination of the phase transfer catalyst, resulting in a 12.5:1 
selectivity in favor of 3.68 (Entry 11). 
To our knowledge, this is only the second method developed for the direct 
synthesis of Δ14,15-17-hydroxy lactones from the diene acid 3.90.  Tain’s synthesis 
described earlier provided 30 % overall yield from the diene acid 3.108 through a [4+2] 
singlet oxygen cycloaddition followed by reduction of the peroxo adduct with zinc to the 
diol which subsequently underwent acid catalyzed SN1’ substitution of the C14 allylic 
alcohol to produce the 17-hydroxy lactone 3.111 (Figure 3.12).28 Under the acidic 
conditions the mechanism for the cyclization is easily discerned, however, under basic 




Scheme 3.14 Comparison of D-ring epoxide cyclization results 
The cyclization of the C16,17-epoxy substrates have been reported both with and 
without the presence on the C14,15 olefin.  Tian reported a one pot tandem selective 
vanadium catalyzed homoallylic epoxidation/ 5-endo-tet cyclization for the 22-hydroxy-
14,16-diene compound 3.125 in to give the 17-hydroxy lactone 3.128 in up to 62 % yield 
(Scheme 3.14).28 They also reported a 2 step process: m-CPBA mediated α-facial 
selective epoxidation to provide the epoxy acid 3.130 which was subjected to hydrogen 
peroxide in HCl/ethanol to afford the 14,15-dihydroxy-17-hydroxy lactone 3.131 in 68 % 
yield over 2 steps.35 The difference between these two reactions is the need for strong 
acidic conditions to promote cyclization in the case of epoxide 3.130, where on the other 
hand cyclization readily takes place even in basic conditions for the allylic epoxides 
OH
RO X
3.90 R = TBS, X= O























a) 20 mol % of tetrafluoroacetophenone, 3.118, 0.6 equiv. Oxone, DMM:ACN: 0.05 M Na2B4O7 10H2O
buffer in 4 x 10-4 EDTA 1.5:1:1.6, 61 % b) 30 mol % VO(acac), TBHP 62% 3.128.
3.126 R = TBS, X= O
3.127 R = MOM X =H,H
3.104 R = TBS, X= O














3.127.  At first glance it would appear that both of these reactions were formed through a 
Baldwin forbidden 5-endo-tet cyclization.  In fact there have been reports of such 
transformations with all examples proceeding with inversion of stereochemistry, and the 
success of the cyclizations is highly dependent on the electronic nature of the epoxide.36 
In most cases the endo-tet cyclization reactions of epoxides are facilitated by electron 
donating groups adjacent to the epoxide, with successful control over endo cyclizations 
being observed with allylic, propargylic, β-sulfonyl, and α-silyl epoxides.36 The 
phenomena is further supported by the work of Dai and coworkers where 5-endo-tet 
cyclizations were not observed with 2° epoxides lacking a donating substituent, however, 
the desired cyclization achieved after transforming the substrate to an allylic epoxide.37 
Another report has shown CSA promoted 5-endo-tet cyclizations of non activated 2° did 
not occur.  However, when pTSA was used cyclization took place with complete 
retention of stereochemistry as a result of double inversion.38 From these results it 
appears that the cyclization of the allylic epoxy acid 3.127 could occur through a 5-endo-
tet cyclization.  In the case of Tian’s 14,15-dihydro-22-hydroxy epoxide 3.130, 5-endo-
tet cyclization does not occur, instead the epoxide most likely undergoes nucleophilic 
opening to give the 16,17 diol intermediate 3.132, followed by acid catalyzed 
lactonization to give 3.131. 
The dienone side product 3.124 mentioned above, is obtained through 
decarboxylation of allylic epoxide 3.120 (Figure 3.15).  A similar thermal 
decarboxylation was observed with β,γ-epoxy acids to give allylic alcohols.39  In the 
current case, the decarboxylation of the 5,6-epoxy-3-enoic acid is the first example of this 
transformation and is believed to be enhanced by the boronate which has been previously 
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shown to catalyze decarboxylations.40 Fragmentation of D-ring peroxo adducts were 
observed by Heathcock during their [4+2] singlet oxygen cycloadditions to diene 3.133 
(Figure 3.15).27d The β-peroxo adduct upon formation at room temperature quickly 
underwent Grob fragmentation cleaving the C17-20 bond while simultaneously opening 




Figure 3.15 Fragmentation reactions of D-ring diene oxidation products 
3.2.6 Titanium Alkylidenation 
As mentioned earlier in the chapter, the addition of titanium carbenes to lactones 
provides exocyclic enol ethers in good yields with moderate to good stereoselectivities.  
Coupling of the side chain to the bisnorcholanic lactones via Takeda reaction was 
originally proposed over Takai alkylidenation due to the easier access of bis-phenylthio 
acetals than the 1,1-dihalogenated substrates.  Both the Takai and Takeda alkylidenations 
favor formation of Z-enol ethers with diastereoselectivies for Takai olefinations being 
superior.  The majority of Takeda olefinations have been performed on minimally 

























rigidity of the bisnorcholanic lactones was believed to be sufficient to enhance the 
selectivity for Z-enol ethers.  Besides the question of alkylidenation stereoselectivity, 
there was also the question of whether or not diastereoselective epoxidation of the Z- enol 
ether could provide the 23-(R)-hydroxy compounds either through substrate or reagent 
mediated control.  Finally, could stereoselective spiroketalization of 23-hydroxy-22-
hemiketals provide the desired natural non-anomeric C22-(S)-stereochemistry?  Prior to 
the successful synthesis of the 17-hydroxy-bisnorcholanic lactone 3.104 the non-
functionalized 3,12-bis-TBS 14,15-dihydro lactone 3.135 was used as a model substrate 
to test these hypotheses (Scheme 3.15).    
The original side chain precursor 3.136 used to evaluate the alkylidenation was 
synthesized in two steps and 60 % yield from (R)-glycidol and represents the side chain 
necessary for synthesis of 25-epi-cephalostatin North 1 (Scheme 3.15).  The reaction of 
lactone 3.135 with 1.5 equivalents of in situ generated titanium alkylidene, from bis 
thioacetal 3.136 and bis cyclopentadienyl titanium(II)dichloride provided approximately 
48 % of the desired enol ether 3.137 (Scheme 3.14).  Complete diastereoselectivity was 
observed denoted by a single triplet at 4.04 ppm believed to be the Z-isomer based on 




Scheme 3.15 Model Takeda lactone alkylidation results 
The major drawback to the Takeda reaction was isolating of the enol ether 
products due to the large amounts of triethylphosphite present and its sensitivity to 
chromatography.  The exocyclic enol ethers rearrange to endocyclic enol ethers and acid 
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mediated acetonide deprotection results in premature spiroketalization.  The original 
authors utilized excess aqueous FeCl3 which turned out to be problematic with the  
dimethylketal side chain.2a Furthermore, the original NaOH work up led to markedly 
lower yields which were recouped by quenching the reactions with a non-aqueous 
mixture of t-butanol as a proton source with pyridine as buffer which were removed 
under vacuum.  Increasing to 3 equivalents of the titanium carbene resulted in complete 
conversion of the lactone, diastereoselectively providing enol ether 3.136 in 
approximately 68 % yield.  The regiochemistry however was 4:1 by 1H NMR.  
Successful coupling was achieved on the model substrate to provide the desired enol 
ethers with complete stereoselectivity in moderate yields. 
With the enol ether in hand, epoxidation was examined, and m-CPBA was 
originally screened for its bulky size and ready availability.  Addition of m-CPBA to enol 
ether 3.137 gave the desired hydroxy-hemiketal 3.138 but also resulted in over-oxidation 
(Scheme 3.15).  The high reactivity of the epoxide toward nucleophiles led to 40 % 
cleavage of the enol ether with 1.2 equivalents of m-CPBA regenerating lactone 3.145 
along with aldehyde 3.148 which is believed to arise from non-nucleophilic Grob 
fragmentation of intermediate 3.147.  DMDO mediated oxidation of enol ether 3.137 
provided the hydroxy-hemiketal 3.138 in 73 % yield as a single diastereomer, which was 
stereochemically undetermined.  Downfield shifting through benzoylation of the C23 
alcohol provided confirmation of a single diastereomer.  Catalytic CSA in MeOH 
resulted in formation of the spiroketal 3.145 through sequential acetonide deprotection/ 
cyclization of 3.139.  However, competitive silyl deprotection led to a complex mixture.  
Catalytic AcOH led to incomplete acetonide deprotection.  Looking for selective 
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deprotection of the acetonide in the presence of the TBS ether, catalytic BiCl3 in CH3CN/ 
water was screened.41 The reaction of 3.139 with BiCl3 provided 60 % deprotection and 
29 % cyclization by 1H NMR.  Non-cyclized deprotected tetrol 3.144 was also obtained, 
and surprisingly, all products showed complete loss of the C23 benzoate.  The chemical 
shifts are consistent with those reported previously and suggest the natural 22-(S)-[5,5] 
spiroketal was obtained but was not confirmed.42 The loss of the C23 benzoate most 
likely involved attack of the C23-benzoate on oxonium ion 3.140 giving the more 
stabilized bridged oxonium ion 3.141.  Hydrolysis of the bridged oxonium ion leads to 
either reformation of the C23 benzoate 3.139 or to the Prevost Woodward reaction 
providing the highly unstable C22-hemi benzoate 3.142 which readily hydrolysis to the 
hemiketal 3.143.   
The 14,15-dihydro model studies supported the alkylidentaion strategy as an 
effective method for the synthesis of C23 hydroxy spiroketals (given further 
optimization).  The compatibility of the 14,15 olefin and the structural changes associated 
with the presence of the olefin also needed to be evaluated, and the Δ14-15-bisnorcholanic 
lactone was next examined (Figure 3.16).  Titanium carbenes can undergo metathesis 
with olefins, however, the bis cyclopentadienyl titanium carbenes are usually compatible 
with highly substituted olefins due to the bulkiness and high oxophilicity of the titanium 
carbene.  The real concern was whether or not the enol ether products 3.149 would 
undergo E-ring opening to reform the D-ring diene 3.151 given the propensity of these 
structures to open and the high reactivity of the enol ether.  The rearrangement would not 




Figure 3.16 Possible rearrangement of Δ14-15 enol ether alkylidenation products 
The side chain fragments 3.155 and 3.159 were required for the synthesis of the 
desired 26,27-dihydroxy North 1 analog and 3.155 was synthesized in 6 steps and 25 % 
overall yield from TRIS 3.152 (Scheme 3.17).  2,2-Dimethyl-5-oxo-1,3-dioxane 3.153 
was synthesized from TRIS following the reported procedure.43 Wittig olefination with 
methyltriphenylphosphonium bromide and n-BuLi followed by mCPBA oxidation gave 
epoxide 3.154 in 45 % yield over two steps.  Nucleophilic addition of bis-
phenylthiomethyl lithium to epoxide 3.155 followed by silyl protection of the resulting 
alcohol with TMSOTf provided the 26,27-dihydroxy fragment in 92 % yield for the two 
steps.  The high volatility of the 5-oxo-1,3-dioxane 3.153 lowered the yield substantially 
and a more effective method for the synthesis of the dihydroxy fragment was sought.  
Silylation of dihydroxy acetone dimer 3.156 with chloro t-butyldiphenyl silane gave bis 
silyl protected dihydroxy acetone 3.152 in 97 % yield.  Following the steps used in the 
synthesis of the dioxolane fragment 3.155, provided the desired fully protected dihydroxy 





Scheme 3.16 Synthesis of bis-phenylthioacetal side chains 
With the dihydroxy fragments in hand, Takeda alkylidenation of the Δ14-15 lactone 
was examined.  Treatment of lactone 3.72 with the bis thioacetal 3.155  resulted in less 
than 49 % yield of a 1:1 mixture of endocyclic enol ether 3.161  and the exocyclic enol 
ether 3.159 and (Z:E) of 7:1 (Scheme 3.18).  Surprisingly no E-ring opening diene 
products were detected.  With the ability to synthesize the unsaturated model enol ether 
3.161 the optimization of the desired 17-hydroxy-Δ14-15-bisnorcholanic lactone was 
undertaken.  Coupling of the more stable bis thioacetal side chain fragment 3.159 with 
the lithium salt of 17-hydroxylactone 3.104 failed to provide 3.164 under the standard 
conditions.  Switching to the magnesium salt resulted in the formation of 12 % of the 
desired enol-ether by 1H NMR.  Protection of the carbinol with TMSOTf provided 
lactone 3.162 in 82 % yield.  Alkylidentaion of lactone 3.162 with bis thioacetal 3.159 
continuously provided < 10 % of the desired product by 1H NMR.   
Although the unoptimized alkylidenations on the less functionalized lactone 
showed great promise and provided evidence for accessing α-hydroxy spiroketals through 
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the Takeda reaction, the higher functionalized lactones were not as promising and other 
avenues to provide the enol ethers were explored.   
 
Scheme 3.17 Bisnorcholanic Takeda alkylidenation coupling results 
With the lack of success in the other strategies (proceeding sections), the Takeda 
reaction was revisited, not on the lactone however, but on diene methyl ester 3.105, 
which is formed quantitatively from the addition of trimethylsilyldiazomethane to diene 
acid 3.90 (Scheme 3.19).  The Takeda alkylidenation was not originally screened on the 
methyl ester due to the aforementioned low diastereoselectivities typically obtained.  The 
diene methyl ester has the advantage of being less sterically congested than the lactone 
and smoother coupling with bis-thioacetal 3.159 was expected with reduced 
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diastereoselectivity.  Takeda alkylidination of methyl ester 3.105 with bis-thioacetal 
3.159 gave the desired methyl enol ether 3.165 in an unoptimized yield of 24 %.  While 
the initial yield was low, the diastereoselectivity was excellent providing only the Z-
isomer.  The formation of a single isomer from Takeda alkylidenation is rare and is a 
consequence of substrate control.  Sharpless asymmetric dihydroxylation of methyl enol 
ether 3.165 with AD-mix-α was attempted to generate the α-hydroxy ketone 3.166.  
However, asymmetric dihydroxylation failed to provide the desired product after running 
for 30 days at which time active oxidant was still present.  The lack of reactivity is due to 
the steric bulk of the silyl protecting groups.  Attempts to stereoselectively epoxidize 
3.165 in the presence of the diene were not successful nor was the selective deprotection 
of the C25 TMS, again attributed to the bulk of the silyl protecting groups.   
 
 



































With access to the diene methyl ester achievable in 2 operations, 7 steps and 43 % 
overall yield as a single diastereomer from hecogenin acetate 1.14, the final synthesis of 
the protected 26,27-dihydroxy North 1 analog can potentially be synthesized with a 
longest linear sequence of 12 steps.  The synthesis of this key intermediate is a great step 
toward realization of the alkylidenation “plug and play” strategy. 
The strategy’s future success requires smaller protecting groups like the di-t-
butylsilylene fragment 3.167 in order for catalytic asymmetric chemoselective oxidations 
of the enol ether to be achieved (Figure 3.17).  The di-t-butylsilylene has advantages over 
the acetonide as 1,3-protected triols are less susceptible to 1,2 migrations under acidic 
conditions which may pose problems during spiroketalization.  Although unknown, the 
1,3-protection of glycerol is predicted to be very high yielding unlike the acetonide 
reaction also due to the preference for the 1,3-arrangement.  A less sterically demanding 
protection scheme potentially allows for the easier synthesis of the α-hydroxy ketone 
through two possible pathways.  Pathway A centers around maintaining C25 hydroxyl 
protection as either dimethylsilyl or trimethylsilyl ether allowing Sharpless44 asymmetric 
dihydroxylation or Jacobsen epoxidation45 to provide the desired α-hydroxy ketone 
3.170.  Pathway B introduces the free C25 hydroxyl group which can be utilized for OH 
directed Yamamoto epoxidation of the homoallylic enol ether.46 The drawback to using 
the C25 hydroxy to access the α-hydroxy ketone 3.173 is the premature cyclization to 
hemiacetal 3.173 potentially subverting the C23-OH positive control element required for 
formation of the natural spiroketal.  If a mixture of hemiketals or formation of the wrong 
hemiketal stereochemistry occur then E-ring cyclization upon Zn/AcOH mediated 
peroxide reduction of adduct 3.173 will generate the correct stereochemistry at C16 but 
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the potential stereocontrol at C22 could be lost.  However, the formation of the α-
peroxide adduct, 3.173, upon [4+2] cycloaddition of singlet oxygen to diene 3.169 is 
expected to be more diastereoselective than for hydroxy ketone 3.171 (vide supra).  
Conversely, pathway A benefits over B by maintaining C25 protection, which will allow 
for E-ring cyclization to give hemiketal 3.164 prior to F-ring spiroketalization increasing 
the potential for C23-OH directed formation of the desired natural C22-(S) 










3.2.7 Olefin Metathesis Approach 
In 2011 Schrock and Hoveyda published a highly effective method for catalytic Z-
selective olefin cross metathesis of enol ethers (Figure 3.18).47 Molybdenum catalyst 
3.175 provides Z-enol ethers in > 95 selectivity with yields ranging from 58-77 %.  
Schrock’s catalyst 3.176 was also highly active leading to 80 % conversion in 10 min 
with little selectivity (48:52 Z:E).   
 
 
Figure 3.18 Schrock, Hoveyda and Fürstner developments on molybdenum catalyzed 
cross metathesis 
The asymmetric molybdenum catalyst 3.175 used in the study was not 
commercially available; however, the steric demand of the lactone and side chain 
warranted the use of Schrock’s original more active molybdenum catalyst 3.176 in light 
of the high stereoselectivity observed during titanium alkylidination.  The problem with 
using the Schrock catalyst is its high sensitivity to air and moisture, often requiring using 
a glove box.  Fürstner addressed this problem in 2011 by discovering chelation of 
Schrock’s catalyst with 2,2-bipyridine rendered the catalyst inactive and air stable for 
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extended periods of time.48 The catalyst could therefore be weighed on the bench top and 
reactivated in situ with zinc chloride.   
In light of these recent findings, the question of whether or not the desired Z-enol 
ether 3.164 could be provided through cross metathesis of enol ether 3.178 and side chain 
olefin 3.179 was raised (Figure 3.19).  In Grubb’s classification of olefins, 1,1-
disubstituted olefins fall under Type IV for both the Schrock and Grubbs’ 2nd generation 
catalysts which are considered spectators in olefin cross metathesis, but are known to be 
active in ring closing metathesis.49 Furthermore Grubbs catalysts have been shown to be 
ineffective for the cross metathesis of enol ethers, however, Hoveyda has recently 
developed a new ruthenium catalyst that is highly active in CM for enol ethers.50 Enol 
ethers as a whole have yet to be classified in terms of cross metathesis and α-substituted 
enol ethers which are active in RCM have yet to be explored in CM, so are they 
considered Type III or IV?51 The homoallylic alkene 3.179 is classified as a Type I olefin 
which exhibits rapid homodimerization giving products that are consumable.  However, 
the bulk of the silyl protecting groups may render them to be Type II class which exhibit 
slow homodimerization and the products are non-consumable, or Type III, which do not 
exhibit homodimerization.    
 
 
Figure 3.19 Olefin metathesis coupling strategy 
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Access to enol ether 3.164 through olefin CM required the synthesis of enol ether 
3.178 and side chain olefin 3.179 (Figure 3.19).  Enol ether 3.178 could be realized 
through methylenation of bisnorcholanic lactones by either Tebbe, Takeda, Petasis or 
Takai reactions.  While the Tebbe reaction has been the most utilized in total synthesis, 
the Petasis and Takai methylenation have seen considerable use and have several 
advantages over the Tebbe reaction.  The Petasis reagent is milder, higher yielding and 
far less Lewis acidic reducing the possibility of rearrangements that often accompany 
Tebbe reactions.  The titanium Schrock carbene precursor, bis-cyclopentadienyl dimethyl 
titanium (Petasis reagent) is easily prepared, stored, and fairly air and moisture stable.  
The activated carbenes upon liberation of methane are easily thermally generated in situ 
and result in fewer waste products than the Takai counterpart.  Although the Takai 
titanium(II) carbene is less sterically demanding than the Petasis reagent, the Petasis was 
chosen over Tebbe, Takai and Takeda for the aforementioned reasons.   
In 2005 Burke’s methylenation of a 5,5-fused α-substituted lactone resulted in 
quantitative formation of the enol ether and the conditions employed were the point of 
departure.52 Using the reported conditions, methylenation of dihydro lactone 3.135 
resulted in 60 % conversion as a 1:1 mixture of the desired enol ether 3.180 and the 
isomerized endo product 3.181 after 72 h, (Table 3.5 Entry 1). Switching to dioxane 
resulted in no reaction after 12 hours.  Toluene alone was an excellent solvent giving 
nearly complete conversion in 3 hours and 63 % yield of the desired exocyclic enol 
(Entry 3).  Running the reaction under microwave assistance led to complete conversion 
and 73 % yield giving only the desired exocyclic enol ether in 30 min (Entry 4).  There is 
only one report describing the use of microwave assistance for the acceleration of the 
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Petasis reaction.53 Increasing the reaction temperature to 150 °C reduced the reaction 
time to 10 min and provided 3.180 (R = H) 77 % yield (Entry 5).  Applying the model 
conditions to the fully functionalized lactone 3.162 gave the desired product in 68 % 
yield and increased reaction time of 30 min with the bulkier substrate (Entry 6).  
 
Table 3.5 Optimization of Petasis lactone methylenation 
 
Synthesis of side chain 3.179 was relatively straightforward starting from 
protected dihydroxy acetone 3.157 (Scheme 3.19).  The addition of allyl magnesium 
bromide to ketone 3.157 followed by silyl protection with TMSOTf and 2,6-Lutidine 
gave the desired product 3.179 in 94 % yield for the two steps.  The allylation reaction 
could also be achieved under aqueous conditions with indium powder and allyl bromide 
in THF/H2O at room temperature providing the same yield for the 2 steps.  The catalytic 
 














90b  60 72 1:1 58 
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100 0.16 3.180  only 77 






100 0.5 3.180  only 68 
a) combined isolated yields b) sealed tube c) 22-lactol isolated from sgc d) 300 Watt microwave with 
external temperature sensor 
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indium/ Mn/ TMSCl one pot allylation/ silylation, however, gave only 51 % of the 
desired compound 3.179 plus 12 % of the unprotected alcohol.   
 
 
Scheme 3.19 Synthesis of allyl side chain 
With both coupling partners in hand, the metathesis reaction was investigated and 
the stabilized Schrock molybdenum catalyst was prepared according to Fürstner’s 
procedure.  The original conditions reported for the CM of simple vinyl ethers required 
excess amounts of the enol ether to minimize erosion of stereochemistry by re-
consumption of the product.  There was reduced risk of this scenario occurring with the 
two bulky substrates and excess alkene was utilized as it was the more accessible 
fragment.  The CM reaction of non-functionalized enol ether 3.180 and alkene 3.179 with 
reactivated Schrock’s catalyst led to no reaction after 24 hrs (Scheme 3.20).  Crude 
1HNMR of the reaction mixture, taking care not to affect the substrates during work-up, 
confirmed that CM did not take place to any extent.  It also confirmed that 
homodimerization of the alkene had not occurred either, but complete isomerization to 
endocyclic ether 3.181 was observed.  Increasing the catalyst load to 10 % and longer 
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reaction times had no effect.  These results suggest that the catalyst reacted with the enol 
ether preferentially as expected, but could not perform the CM with the bulky alkene 
because of the bulkiness of the coupling partners or the activated carbene was never 
formed leading only to isomerization of the enol ether.   
 
 
Scheme 3.20  Olefin cross metathesis coupling results 
Potentially, the activated lactone carbene was formed and that constant off and on 
cycling sequestered the catalyst accounting for the lack of homodimerization, product 
3.183.  Although under the given set of conditions the reaction was not successful, less 
bulky substrates or temporary tethering of the alkene (3.184 and 3.185) thereby switching 
to RCM could provide the desired product 3.186 (Figure 3.20).  Ring closing metathesis 
of small, medium and macrocyclic rings has been utilized in the synthesis of many 
natural products.54 Furthermore, Rainier nicely showed tandem Takai mediated 
methylenation/RCM was effective in forming cyclic six membered enol ethers from 
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lactones.55  In the case of 3.184 entropy will play a significant role on the feasibility of 
the tandem reaction.  Though not investigated here, the possibility is intriguing and worth 
mentioning.   
 
 
Figure 3.20  Proposed tethered ring closing metathesis 
3.2.8 Halo Enol Ether Strategy 
The failed Takeda and CM strategies required the development of a new 
approach.  Keeping the strategy focused around the enol ether, it was envisioned that the 
lactone could be converted a mono or bis-halo enol ether 3.188 which would serve two 
purposes; stabilization of the enol ether toward isomerization, and provide functionality 
suitable for coupling of the side chain through nucleophilic opening of the epoxide 3.189 




























Figure 3.21 Forward halo enol ether strategy 
Two approaches to the formation of the halo enol ethers were taken.  The first 
approach was the dichloromethylenation of lactone 3.187 known to occur effectively with 
BrCCl3 or CCl4 and either HMPT at low temperatures or PPh3 at high temperatures.
56 
Starting with the model lactone 3.135 the reaction of bromotrichloromethane and HMPT 
at -40 °C did not provide the dichloro alkene 3.188, rather the desilylation of the C3-
carbinol was observed in 81 % yield (Table 3.6, Entry 1).  Thinking higher temperatures 
were required for the reaction to occur, PPh3 and CCl4 or BrCCl3 were screened (Entries 
2-7).  The reaction did not proceed in refluxing THF or dioxane (Entry 3-4).  Taking a 
lead from the Petasis optimization, microwave assisted dichloromethylenation was 
attempted.  Triphenylphosphine and CCl4 or BrCCl3 at 150 °C did not lead to the desired 
product (Entries 4-7).  Under neat conditions, 24 equivalents of CCl4, a mixture 3-chloro 
3.194 and 3-hydroxy lactones 3.193 were formed (Entry 4).  With 500 equivalents of 


































Mitsunobu reaction (Entry 5).  Addition of sodium bicarbonate or polyvinyl pyridine to 
neutralize any acid, completely eliminated the chlorination side reactions (Entries 6-7).  
Polyvinyl pyridine also completely eliminated the C3 deprotection, however, only 
starting lactone 3.135 was recovered (Entry 7).  
Table 3.6 Attempted synthesis of 1,1 dichloro enol ethers 
 
The second method involved iodination of preformed enol ether from the Petasis 
reaction (Scheme 3.21).  Iodonium di-sym-collidine perchlorate (IDCP) and 
trifluoromethanesulfonate salt (IDCT) have been effective for the synthesis of β-iodo 
enol ethers (Scheme 3.21).57 Reaction of enol ether 3.180 with 1.1 equivalents of IDCP 
resulted in 72 % conversion and 52 % yield of monoiodide 3.195aH with a Z:E of 5.9:1 
(Table 3.7, Entry 1).  Increasing to 1.5 equivalents of IDCP resulted in 100 % conversion 
while producing both mono and diiodo compounds 3.195aH and 3.195bI in 17:83 and a 
Z:E of 15:1 for monoiodide 3.195bH (Entry 2).  Switching to IDCT, 1.1 equivalents gave 
 







1 HMPT 2.2 Br 5 CH2Cl2 -40 - 25 16 4.OH only 81 
2 PPh3 4 Cl 24 THF 78 12 NR - 
3 PPh3 8 Cl 24 Dioxane 101 16 NR - 
4 PPh3 4 Cl 24 Neat 150 MW 0.5 4.C1 + 4.OH - 
5 PPh3 8 Cl 500 Neat 150 MW 0.5 4.Cl 83 % 
6b PPh3 4 Br 10 Dioxane 150 MW 0.5 4.OH 80 % 
7c PPh3 4 Br 24 THF 150 MW 1 NR - 


















89 % conversion and 59:41 ratio of products (Entry 3).  Given the difficulty in controlling 
the selectivity, the reaction was driven toward complete formation of the diiodide for the 
fully functionalized bisnorcholanic lactone 3.180b.  Furthermore, as mentioned earlier, 
the alkoxy β-substituted alkenyl lithium species are known to be more stable when an α-
halide is present, making them less susceptible to β-elimination.58 Running the reaction 
with 2.1 equivalents of IDCT provided 100 % conversion and 66 % yield of diiodo 
3.195bI.  With the bis iodo-enol ethers in hand, coupling of the side chain through 
nucleophilic opening of epoxide 3.158 was attempted with both the 3.195aH:3.195aI 
mixture and 3.195bI (Scheme 3.22).  Lithium halogen exchange was achieved with t-
BuLi resulting in monolithium species for both 3.195aH:3.195aI mixture and 3.195bI; 
however, nucleophilic addition to the epoxide 3.158 was not observed.  Addition of 
HMPA, and or excess MgBr2 to facilitate oxirane opening did not improve the reaction.  
In the case of 3.195bI the mono iodide 3.195bH was recovered along with a small 
amount of starting material suggesting the exchange did not go to completion.  The crude 
NMR from the reaction of 3.195aH:3.195aI showed the formation of monoiodide, but 
the exocyclic enol ether was not recovered.  The endocyclic enol ether was believed to 





Scheme 3.21 Results of halo enol ether coupling 
Table 3.7 Iodination of exocyclic enol ethers 
 
3.2.9 Nucleophilic Addition Coupling Strategy 
The bisnorcholanic lactone also posed the possibility of coupling side chain 
through addition of alkyl nucleophiles directly to the lactone.  Previous work in the Fuchs 
group signaled the difficulty of adding nucleophiles to even the simplest bisnorcholanic 
Entrya Substrate Reagent Conv. 
(%)b 
Mono:Di Z:E Yield (%)c
1 R = H,  
14,15 dihydro 
IDCP 72 Mono 
only 
5.9:1 52 
2 R = H,  
14,15 dihydro 
IDCPd 100 17:83 15:1 61 
3 R = H,  
14,15 dihydro 
IDCT 89 59:41 8.9:1 - 
4 R = OTMS,  
Δ14-15 
IDCTe 100 Di only - 66 
a) 1.1 equivalents of IDC are added to a solution of enol ether in CH2Cl2 at 0 °C b) calculated from 
crude NMR c) combined yields d) 1.5 equivalents e) 2.1 equivalents  
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lactones (unpublished results).  The first strategy examined small metalated alkyne 
nucleophiles.  Retrosynthetically, the C26,27 dihydroxy North 1 spiroketal 3.197 was 
designed to be accessed through spiroketalization of 3.198 upon selective oxidation for 
the alkene to install the C23 carbinol (Figure 3.22).  The cis-alkene 3.198 would be 
accessed through selective reduction of alkynyl hemiketal 3.199 which could be formed 
in two possible ways.  Path A, alkynyl hemiketal 3.199 would be generated by sequential 
nucleophilic additions; addition of trimethylsilyl acetylene to lactone 3.104 followed by 
the addition of resulting alkyne 3.200 to 5-oxo-1,3-dioxolane 3.153.  In pathway B the 
alkynyl hemiketal 3.199 would arrive directly from the nucleophilic addition of the 
metalated alkyne 3.201 to lactone 3.104.  
 
 


































Prior to the completion of the synthesis of lactone 3.104, model studies were 
performed on the bisnorcholanic lactone 3.72 (Scheme 3.22).  Addition of lithium 
trimethylsilylacetylide to lactone 3.72 provided an inseparable 2:1 mixture of lactol 3.202 
and keto diene 3.203 in 54 % yield.  The opening of the lactol did not proceed in the 
traditional manner, instead the formation of oxonium ion 3.210 led to cleavage of the C16 
C-O bond providing allyl carbonium ion 3.211 which upon deprotonation provides the 
diene 3.203 (Figure 3.23).  Considering the mechanism involved, the reaction must have 
taken place during work-up.  Addition of thionyl chloride to the mixture increased the 
conversion of the hemiketal to the diene-one.  PPTS also increased the formation of the 
diene but also resulted in the loss of C3 TBS protecting group (Scheme 3.23).  Attempts 
to increase the overall yield of hemiketal or diene-one had limited success.  Meanwhile, 
preformed acetylide 3.204 failed to undergo nucleophilic addition to lactone 3.72.  The 
addition of lithium trimethylsilylacetylide to 17-hydroxy lactone 3.104 resulted in only 
minor formation of the lactols.  The difficulty of nucleophilic addition to the lactones 
continued, as all attempts to add vinyl anions to the lactone provided no more than 10 % 
yield, although the addition of alkyl anions to the C12 deoxy-17-hydroxy-lactones 3.208 
in up to 73 % yield have been reported.59 The presence of the C12-TBS protected 
carbinol and the 14,15 olefin must alter the steric interaction of the incoming nucleophile 
with the C13- methyl suggesting that nucleophiles prefers to add from the α face when 


































































Figure 3.23 Alkyne-lactone to dienone mechanism 
 Utilization of bisnorcholanic lactones as the linchpin for the convergent syntheses 
of cephalostatin analogs has presented many challenges and quirky reactivity.  The 
underlying cause for the quirkiness and resistance of higher functionalized bisnorcholanic 
lactones toward both large and small nucleophiles, is the same driving force responsible 
for the unprecedented stereoselectivity seen during Takeda alkylidenation.  The strong 
substrate control observed for the diene methyl ester has breathed new life into the 
titanium alylidenation strategy for the synthesis of α-hydroxy spiroketals.  With the right 
side chain coupling fragment, the methyl enol ether promises to be a diverging point for 
the synthesis of an array of cephalostatin and ritterazine analogs.  This was further 
bolstered by the ability to synthesize the key diene methyl ester intermediate in 46 % 
yield from hecogenin acetate in a single operation and 7 steps, even with a noneconomic 
reduction/reoxidation sequence.  The further development an efficient method for the 
chemoselective oxidative cleavage of 12-oxo-steroidal spiroketals will only strengthen 
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Appendix A – Experimental 
 
General Procedures 
All reactions were run under N2 or Ar atmosphere unless otherwise stated, all 
glassware was flame dried under N2, and all syringes were oven dried overnight before 
use.  All solvents used were distilled and dried before use over CaH2 (dichloromethane, 
toluene and acetonitrile), over sodium/benzophenone (THF and Et2O), or dried on 
Grubbs column (methanol).  Commercially available solvents EtOAc and CH3CH2CN 
were used as is, while DMSO and DMF were stored over 4 Å molecular sieves.  All 
purchased reagents were used without prior purification unless otherwise specified. 
All reactions were monitored by Thin Layer Chromatography using 60 F-254 
plates (EM reagents, 0.25 mm) and TLC plates were visualized under UV lamp (254 nm) 
and with either p-anisaldehyde stain (PAA: 1350 mL absolute ethanol, 50 mL 
concentrated H2SO4, 37 mL p-anisaldehyde), permanganate stain (1% wt. KMnO4 and 
2% Na2CO3 in water), iodine (30 % iodine on  silica gel) or dinitrophenylhydrazine (12g 
of 2,4-dinitrophenylhydrazine, 60 mL conc. sulfuric acid, and 80 mL water in 200mL 
95% ethanol).  Purifications by flash chromatography were run with 60 Å silica gel (230-
400 mesh) using hexanes/EtOAc systems unless otherwise mentioned.  
All intermediates were characterized by 1H NMR, 13C NMR or 19F NMR when 
needed using a Varian Inova 300 instrument (300 MHz, 1H; 75 MHz, 13C) or a Bruker 
arx400 instrument (400 MHz, 1H; 100 MHz, 13C); all NMR experiments were run in 
deuterated solvents and references to residual solvent peaks (residual CHCl3 at 7.26 ppm 
on 1H spectra and at 77.16 ppm on 13C spectra)  CHDCl2 (5.32 ppm 
1H spectra and at 
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54.00 on 13C spectra), C6HD5 (7.15 ppm 
1H spectra and at 128.06 ppm on 13C spectra) or 
C3HD5O (2.05 ppm 
1H spectra and at 206.26 ppm on 13C spectra). Peak multiplicities in 
1H NMR, when reported, are abbreviated as s (singlet), d (doublet), t (triplet), q (quartet), 
p (pentet), dd (doublet of doublet), dt (doublet of triplet), dq (doublet of quartet), ddd 
(doublet of doublet of doublet) m (multiplet), and/or b (broad).  
All melting points were measured using SRS Optimelt capillary automated 
melting point system.  All MS experiments were run by the Purdue Campus Wide Mass 
Spectrometry Facility using low/high resolution electronic ionization (EI), electrospray 
ionization (ESI), or atmospheric pressure photo ionization (APPI) techniques.  All 




Experimental and Spectral Assignments 
 
Optimized Preparation of 23-oxo-Rockogenin Acetate 2.67 
 
The preparation of the ketone 2.67 is the optimization of the previously reported 
procedure.1 To a solution of rockogenin acetate 2.4 (1 mmol) and t-BuONO (5 mmol) in 
acetic acid (10 mL), was added BF3•OEt2 dropwise for 20 minutes at ambient 
temperature.  After 10 minutes of stirring, water (50 mL) was added to the reaction 
mixture resulting in the formation of a white precipitate, which contained the crude 
product mixture.  The white solid was collected by filtration, washed with water, 
dissolved in with EtOAc, dried over sodium sulfate, filtered and concentrated.  To the 
crude product was added 40% formic acid in ethanol (0.1 M) and the solution was heated 
at 60 °C for 4 hrs.  The mixture was diluted with 200 mL of water, transferred to a 
separatory funnel and extracted with EtOAc (3 x 100 mL).  The combined organic 
extracts were washed with water (2 x 100 mL), sodium bicarbonate (100 mL) and brine.  
The organic layer was dried over sodium sulfate, filtered and concentrated under vacuum 
to give an off-white solid.  The crude solid was diluted in 6:1 Hex:EA and purified 
through silica gel chromatography giving white semi-crystalline solid in 90 % yield.  1H 
and 13C NMR are in agreement with reported literature values.1 
                                                 
1Lee, S.; Fuchs, P. L. Canadian Journal of Chemical, 2006, 84, 1442-1447. 
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Kinetic Resolution of C23-(R)-Hydroxy Spiroketals 
 
Preparation of 12-benzyloxy-23(R),26-diol 2.79.  In a 100 mL round-bottomed 
flask was placed a 2:1 mixture of hydroxy spiroketals 2.78(R):2.78(S) 5.6 g, 9.42 mmol) 
and 3.0 equiv. (relative to major isomer) triethylsilane (3.0 mL, 18.9 mmol) in CH2Cl2 
(63 mL) to give a colorless solution.  The reaction was cooled to 0 °C and boron 
trifluoride diethyl etherate 2.2 equiv. (relative to major isomer) (1.75 mL, 13.8 mmol) 
was added dropwise over 5 min to give a colorless solution.  The reaction was stirred at 0 
°C until the C23-(R) alcohol 2.78(R) was nearly consumed at which time the reaction was 
quenched with saturated sodium bicarbonate.  The aqueous layer was extracted with 
CH2Cl2 (3 x 50 mL), and the combined organic layers were washed with brine (50 mL).  
The organic layer was dried over Na2SO4, filtered and concentrated to give 5.6 g of off-
white solids.  Short plug silica gel chromatography afforded 3.38 g of diol, (5.66 mmol, 
90 % yield, based on major isomer) as a 12.3:1 mixture of 2.79(R):2.79(S).  1H NMR 
(400 MHz, Chloroform-d) δ 8.01 (d, J = 7.6 Hz, 2H), 7.54 (t, J = 7.3 Hz, 1H), 7.43 (t, J = 
7.6 Hz, 2H), 4.80 (dd, J = 11.2, 4.6 Hz, 1H), 4.66 (tt, J = 10.8, 4.9 Hz, 1H), 4.36 (td, J = 
7.7, 5.0 Hz, 1H), 3.92 – 3.78 (m, 1H), 3.53 (td, J = 11.1, 4.6 Hz, 1H), 3.36 (dd, J = 10.9, 
7.5 Hz, 1H), 3.29 (dd, J = 8.4, 4.1 Hz, 1H), 3.24 (brs, 2H), 2.19 (p, J = 6.8 Hz, 1H), 1.99 





Preparation of 12-Acetoxy-23(R,-26-diol 2.81(R).  In a 50 mL round-bottomed 
flask was placed a 4:1 mixture of hydroxy spiroketals 2.80(R):2.80(S) (1.25 g, 3.19 
mmol) and 3.0 equiv. (relative to major isomer) triethylsilane (1.53 mL, 9.57 mmol) in 
CH2Cl2 (31.9 mL) to give a colorless solution.  The reaction was cooled to 0 °C  and 
boron trifluoride diethyl etherate 2.2 equivalents (relative to major isomer) (0.89 mL, 
7.02 mmol) was added dropwise over 5 min to give a colorless solution.   The reaction 
was stirred at 0 °C until the C23-(R) alcohol 2.80(R) was nearly consumed at which time 
the reaction was quenched with saturated sodium bicarbonate.  The aqueous layer was 
extracted with CH2Cl2 (3 x 20 mL), and the combined organic layers were washed with 
brine (25 mL).  The organic layer was dried over Na2SO4, filtered and concentrated to 
give 1.26 g of off-white solids.  Short plug silica gel chromatography afforded 947.1 mg 
of 2.81(S) (1.77 mmol, 75 % yield) and 300 mg of a mixture of 2.80(S)/2.80(R) (4.9:1, 
0.56 mmol, 24 % yield).  A diastereomeric  ratio of > 19:1 2.81(R): 2.81(S) was 
obtained.  1H NMR (400 MHz, Chloroform-d) δ 4.65 (tt, J = 11.0, 4.9 Hz, 1H), 4.54 (dd, 
J = 11.3, 4.6 Hz, 1H), 4.34 (td, J = 7.7, 5.1 Hz, 1H), 3.90 – 3.81 (m, 1H), 3.57 (td, J = 
10.1, 9.5, 4.4 Hz, 1H), 3.38 (ddd, J = 12.2, 7.6, 4.7 Hz, 1H), 3.32 (dd, J = 8.3, 4.1 Hz, 
1H), 2.03 (s, 3H), 1.99 (s, 3H), 0.99 (d, J = 6.6 Hz, 3H), 0.91 (d, J = 6.8 Hz, 3H), 0.88 (s, 
3H), 0.82 (s, 3H). 13C NMR (101 MHz, CDCl3) δ 170.75, 92.97, 83.07, 81.62, 73.51, 
71.78, 68.75, 65.07, 60.50, 55.31, 52.80, 45.37, 44.61, 44.30, 38.72, 36.70, 35.70, 34.78, 
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34.32, 33.92, 33.56, 31.84, 31.75, 31.66, 28.43, 27.40, 26.76, 21.53, 21.15, 19.86, 18.09, 




Preparation of C23(S),26-Diol 2.81(S).  In a 25 mL round-bottomed flask was 
placed C23-(S)-hydroxy-spiroketal 2.80(S) (300 mg, 0.056 mmol) and 3.0 equiv. 
triethylsilane (268 μL, 1.68 mmol) in CH2Cl2 (7.5 ml) to give a colorless solution.  The 
reaction was cooled to 0 °C  and boron trifluoride diethyl etherate 3.0 equiv. (213 μL, 
1.68 mmol) was added dropwise over 5 min to give a colorless solution and stirred at 0 
°C until the starting material was consumed (approximately 36 hrs) at which time the 
reaction was quenched with saturated sodium bicarbonate.  The aqueous layer was 
extracted with CH2Cl2 (3 x 5 mL), and the combined organic layers were washed with 
brine (5 mL).  The organic layer was dried over Na2SO4, filtered and concentrated to give 
0.3 g of off-white solids.  Short plug silica gel chromatography afforded 2.81(S) (250 mg, 
0.468 mmol, 83 % yield) as a white solid. 1H NMR (400 MHz, Chloroform-d) δ 4.64 (tt, 
J = 11.0, 4.9 Hz, 1H), 4.54 (dd, J = 11.2, 4.6 Hz, 1H), 4.34 (td, J = 7.7, 5.1 Hz, 1H), 3.71 
(dt, J = 8.5, 4.0 Hz, 1H), 3.56 – 3.43 (m, 2H), 3.28 (dd, J = 8.5, 4.3 Hz, 1H), 2.01 (s, 3H), 
1.99 (s, 3H), 0.94 (d, J = 6.8 Hz, 6H), 0.88 (s, 3H), 0.82 (s, 3H).  13C NMR (101 MHz, 
CDCl3) δ 170.51, 170.39, 92.53, 83.07, 81.29, 73.26, 69.25, 67.27, 64.07, 60.26, 55.05, 
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52.55, 45.01, 44.35, 38.68, 36.44, 35.45, 34.16, 34.08, 33.67, 32.30, 31.54, 31.42, 28.19, 
27.15, 26.51, 21.28, 18.43, 17.39, 14.08, 11.99, 11.59.  C31H50O7  ESI:HRMS M+Na 
Expected 557.3454  Found 557.3452. 
 
Preparation of tert-Butyldimethylsilyl Protected Homoallylic Alcohol 2.95 
 
i)  In a 5 mL round-bottomed flask was placed 2.81(R) (100 mg, 0.19 mmol) and 
2,6-lutidine (54.5 µl, 0.47 mmol) in CH2Cl2 (1870 µl) to give light yellow solution.  The 
reaction was cooled to 0 °C and tert-butyldimethylsilyl trifluoromethane sulfonate (94 µl, 
0.411 mmol) was added dropwise over 5 min and was allowed to run for 1 hr.  The 
reaction was quenched with methanol and concentrated under vacuum to give the crude 
bis-t-butyldimethylsilylated diol as an oil.   
ii)   In a 5 mL round-bottomed flask was placed the crude protected diol and 
methanol (7.57 µl, 0.19 mmol) in CH2Cl2 (1.87 mL) to give a colorless solution and 
cooled to 0 °C.  To the reaction was added CSA (4.34 mg, 0.019 mmol) and stirred at 0 
°C until the bis-TBS compound had been consumed.  The reaction mixture was quenched 
with the addition of saturated sodium bicarbonate and extracted with CH2Cl2 (3 x 5 mL), 
washed with brine and dried over sodium sulfate.  The crude sample was passed through 
a silica gel pad and concentrated by vacuum to give 2.93 in 93 % yield as an off-white 
solid.   
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iii) In a 10 mL round-bottomed flask was placed the crude alcohol 2.93 and 2-
nitro-phenylseleno cyanate (0.085 g, 0.37 mmol) in THF (0.94 mL) and the reaction was 
cooled to 0 °C to give a yellow solution.  Tributylphosphine (0.057 g, 0.28 mmol) was 
added slowly over 5 min and the reaction was allowed to warm to room temperature and 
continued to stir until the alcohol was consumed (2 hours).  After which time pyridine 
(0.076 mL, 0.94 mmol) was added followed by hydrogen peroxide (0.029 mL, 0.94 
mmol) and stirred at room temperature until the selenoxide intermediate had disappeared 
(16 hours).  The reaction was quenched with sodium bicarbonate and extracted with Et2O 
(3 x 5 mL) followed by washes with 5% HCl, saturated sodium bicarbonate, and brine.  
The organic layer was concentrated, added to a silica gel column and eluted with 5:1 
Hex:EA to give 103 mg of a 2.95 as a white solid (0.163 mmol, 87 % yield over 3 steps).  
1H NMR (400 MHz, Chloroform-d) δ 4.90 – 4.78 (m, 2H), 4.70 – 4.59 (m, 1H), 4.54 (dd, 
J = 11.2, 4.6 Hz, 1H), 4.33 (td, J = 7.8, 5.0 Hz, 1H), 3.93 – 3.80 (m, 1H), 3.33 (dd, J = 
8.3, 4.8 Hz, 1H), 2.01 (s, 3H), 1.98 (s, 3H), 1.75 (s, 3H), 1.00 (d, J = 6.7 Hz, 3H), 0.88 (s, 
9H), 0.81 (s, 3H), 0.06 (s, 6H).  HRMS ESI: [M+Na]; Expected 653.4213 for 










Preparation of Homoallylic Alcohol 2.96   
 
In a 10 mL round-bottomed flask was placed diol 2.81(R) (854 mg, 1.60 mmol) 
and 2-nitrophenyl seleno cyanate (540 mg, 2.40 mmol) in tetrahydrofuran (1.6 mL) to 
give a yellow solution which was cooled to 0 °C.  Tri-n-butylphosphine (985 µl, 3.99 
mmol) was added dropwise over 5 min, allowed to slowly warm to room temperature and 
continued to stir until the diol was consumed (2 hours).  Pyridine (646 µl, 7.99 mmol) 
and hydrogen peroxide (245 µl, 7.99 mmol) were added to the reaction and stirred until 
the intermediate selenoxide had been consumed (16 hours).  The reaction was quenched 
with sodium bicarbonate and extracted with Et2O (3 x 5 mL) followed by 5% HCl wash, 
saturated sodium bicarbonate wash, and brine wash.  The solution was dried over 
magnesium sulfate, concentrated and added to a silica gel column and eluted with 2:1 
Hex:EA to give 2.96 as a yellowish solid (776 mg, 1.50 mmol, 94 % yield).  1H NMR 
(400 MHz, Chloroform-d) δ 4.90 (s, 1H), 4.84 (s, 1H), 4.66 (tt, J = 11.0, 4.9 Hz, 1H), 
4.56 (dd, J = 11.3, 4.6 Hz, 1H), 4.35 (td, J = 7.7, 4.9 Hz, 1H), 3.88 (dt, J = 10.3, 3.5 Hz, 
1H), 3.36 (dd, J = 8.3, 4.8 Hz, 1H), 2.34 (dd, J = 14.2, 2.8 Hz, 1H), 2.04 (s, 3H), 2.01 (s, 
3H), 1.77 (s, 3H), 1.02 (d, J = 6.7 Hz, 3H), 0.90 (s, 3H), 0.83 (s, 3H).  13C NMR (101 
MHz, CDCl3) δ 170.53, 142.38, 113.37, 92.10, 82.96, 81.38, 73.31, 69.77, 64.71, 55.13, 
52.58, 45.06, 44.39, 41.82, 36.49, 35.49, 34.46, 34.14, 33.71, 31.56, 31.45, 28.22, 27.20, 
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26.56, 22.20, 21.37, 19.50, 12.03, 11.68. HRMS ESI: [M+Na]; Expected 539.3348 for 
C31H48NaO6, Found 539.3345.  
 
Chlorosulfenylation Product 2.131 
 
 To an aluminum foil wrapped 10 mL round bottom flask was added NCS (1.2 
equivalents, 14.3 mg, 0.107 mmol) in CH2Cl2 (890 μL) and the reaction was cooled to -20 
°C.  Benzenethiol (1.1 equivalents, 10.08 μL, 0.098 mmol) was added dropwise and the 
reaction was stirred at temperature for 30 min.  The reaction was cooled to -50 °C and 
alkenyl-hemiketal 2.129 46 mg (.089 mmol) in CH2Cl2 (890 μL) was added to the 
phenylsulfenyl chloride solution dropwise over 5 min and the reaction was stirred for 1 
hour.  The reaction was quenched with the addition of saturated Na2S2O3 and allowed to 
warm to room temperature.  The solution was extracted with CH2Cl2 (3 x 5 mL), washed 
with 5 % HCl (5 mL) followed by water (2 x 5 mL) and brine.  The organic layer was 
dried over sodium sulfate and concentrated to give an off-white solid.  The crude product 
was purified by silica gel chromatography ( gradient elution 5:1- 3:1 Hex:EA) to give 
2.131 29.1 mg (0.044 mmol, 50 %) of white solids.  1H NMR (300 MHz, Chloroform-d) 
δ 7.41 (d, J = 7.2 Hz, 2H), 7.33 – 7.24 (m, 2H), 7.20 (dd, J = 8.6, 5.9 Hz, 1H), 4.67 (ddt, 
J = 12.6, 8.1, 4.7 Hz, 3H), 3.90 – 3.69 (m, 1H), 3.39 (s, 2H), 2.02 (s, 3H), 2.01 (s, 6H), 
1.62 (s, 6H), 1.25 (s, 3H), 0.83 (s, 6H).  Crude 13C NMR showed the presence of the 
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hemiketal at 115.0 ppm and a lack of ketone chemical shift. LRMS ESI: [M+H] Expected 
661.33 for C37H54ClO6S, Found 661.33. 
 
PhSeBr Mediated Oxysulfenylation 2.133  
 
In a 25 mL round-bottomed flask was placed 1,2-diphenyldisulfide (37.7 mg, 0.17 
mmol) in CH3CN (8640 µl) to give a yellow solution (0.02 M) which was cooled to 0 °C.  
Bromine (7.12 µl, 0.14 mmol) was added dropwise to give an orange solution and stirred 
at temperature for 30 min.  The reaction mixture was cooled to -40 °C and 2.132 (100 
mg, 0.173 mmol) was added in a single shot.  The reaction was maintained at temperature 
until the reaction was deemed complete by TLC (12 hr).  The reaction was diluted with 
ether and quenched by the addition of saturated sodium thio sulfite at 0 °C.  The solution 
was extracted with diethyl ether (3 x 10 mL), washed with water (2 x 5 mL) followed by 
brine.  The organic layer was dried over magnesium sulfate, filtered and concentrated to 
give a yellowish solid.  The crude product was purified on silica gel chromatography 
eluting with 6:1 Hex:EA to give 2.133 (84 mg, 0.12 mmol, 71 % yield) as a white fluffy 
solid.  1H NMR (300 MHz, Chloroform-d) δ 8.03 (ddt, J = 9.6, 8.0, 1.4 Hz, 2H), 7.67 – 
7.51 (m, 1H), 7.51 – 7.36 (m, 2H), 7.26 (s, 4H), 7.21 – 7.04 (m, 1H), 5.12 – 4.93 (m, 1H), 
4.70 (dt, J = 11.3, 6.4 Hz, 1H), 4.01 – 3.79 (m, 1H), 3.24 – 3.16 (m, 0.4H), 3.04 (d, J = 
12.8 Hz, 1H), 2.96 (d, J = 12.4 Hz, 1H, 2.93 (d, J = 12.8 Hz, 1H) 2.76 (d, J = 12.4 Hz, 
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1H), 2.38 (dd, J = 5.3, 2.3 Hz, 1H), 2.05 (s, 1H), 2.02 (s, 3H), 1.58 (s, 1.5H), 1.29 – 1.22 
(m, 3H), 1.15 (d, J = 2.4 Hz, 1.5H), 1.11 (s, 1.5H), 1.03 (s, 1.5H), 0.86 (d, J = 4.9 Hz, 
3H). 13C NMR (75 MHz, CDCl3) δ 217.03, 216.77, 180.48, 170.70, 165.39, 165.21, 
138.29, 137.92, 133.13, 133.00, 130.94, 130.75, 129.54, 129.07, 128.83, 128.47, 125.66, 
125.45, 82.80, 82.55, 81.81, 81.19, 80.87, 80.36, 80.07,  73.42, 65.93, 65.36, 52.13, 
49.21, 48.92, 47.02, 44.65, 44.51, 38.57, 38.33, 38.15, 36.59, 36.40, 36.13, 35.72, 33.84, 
33.18, 33.08, 31.62, 31.51, 31.21, 28.52, 28.31, 27.30, 26.80, 26.68, 26.03, 21.53, 17.08, 
16.63, 12.16, 12.06, 11.95. LRMS ESI: [M+Na]; Expected 709.35 for C42H54NaO6S, 
Found 709.35. 
 
Oxyselenylation Product 2.139 
 
In a 1 mL vial was placed alkenyl-hemiketal 2.132 (10 mg, 0.017 mmol) and 
triethylamine (2.89 µl, 0.021 mmol) in CH3CN (173 µl, 0.1 M) to give a colorless 
suspension.  The reaction was cooled to 0 °C and phenyl selenium bromide (8.15 mg, 
0.035 mmol) was added giving a red solution.  The reaction temperature was maintained 
below 10 °C and quenched after 1 hr with sodium bisulfite and diluted with ether.  The 
mixture was extracted with diethyl ether (3 x 1 mL) and the combined organic layers 
were washed with water followed by brine.  The organic layer was dried over magnesium 
sulfate, filtered and concentrated to give a yellowish fluffy solid.  The crude product was 
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purified by silica gel chromatography to give keto-furan 2.139 (8.11 mg, 0.011 mmol, 64 
% yield) as a fluffy white solid. 1H NMR (300 MHz, Chloroform-d) δ 8.16 – 7.92 (m, 
2H), 7.69 – 7.36 (m, 5H), 7.26 (s, 3H), 5.18 – 4.95 (m, 1H), 4.70 (tt, J = 11.1, 5.0 Hz, 
1H), 3.91 (tt, J = 11.5, 6.2 Hz, 1H), 3.17 – 2.89 (m, 1.5 H), 2.79 (d, J = 11.8 Hz, 1H), 
2.02 (s, 3H), 1.25 (s, 3H), 1.20 (s, 1H), 1.15 (s, 3H), 1.12 (s, 1H), 1.06 (s, 3H), 0.87 (s, 
3H), 0.82 (d, J = 7.1 Hz, 3H).  LRMS ESI: [M+Na]; Expected 757.29 for C42H54NaO6Se, 
Found 757.30. 
 
 C23-Functionalized Oxyselenylation Product 2.141 
 
To a suspension of  silver trifluoroacetate (13.87 mg, 0.063 mmol) and CH2Cl2 
(314 µl, 0.1 M) in a 1 mL vial at 0 °C was added phenyl selenium bromide (14.82 mg, 
0.063 mmol) to give a white suspension.  After 30 minutes the suspension was cooled to -
78 °C and 23-acetoxy-alkenyl-hemiketal 2.140 (52.3 µl, 0.031 mmol) was added 
dropwise as a 0.6 M solution.  The reaction was complete within 1 hr and quenched with 
sodium sulfite, diluted with CH2Cl2 and extracted with CH2Cl2 (3 x 1 mL).  The 
combined organic layers were dried over sodium sulfate, filtered and concentrated to give 
a fluffy white solid.  The crude product was purified by silica gel chromatography to give 
a 3:1 mixture of 23-acetoxy keto-furans 2.141 (52.3 µl, 0.031 mmol) in 29 % yield as a 
fluffy white solid.  1H NMR (400 MHz, Chloroform-d) δ 8.03 (t, J = 9.3 Hz, 2H), 7.67 – 
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7.30 (m, 5H), 7.30 – 7.07 (m, 3H), 5.06 (dd, J = 10.9, 4.8 Hz, 0.6 H), 4.97 (dd, J = 11.0, 
4.9 Hz, 0.2 H), 4.86 (d, J = 6.9 Hz, 1H), 4.70 (tt, J = 11.3, 5.4 Hz, 0.8 H), 3.92 – 3.77 (m, 
1H), 3.15 (d, J = 12.7 Hz, 0.15H), 3.04 (d, J = 11.9 Hz, 0.60H), 2.96 (d, J = 12.6 Hz, 
0.15H), 2.74 (d, J = 12.0 Hz, 0.60H), 2.54 (s, 0.60H), 2.48 (d, J = 3.0 Hz, 0.15 H), 2.30 
(dd, J = 17.9, 7.0 Hz, 1H), 2.04 (s, 1H), 2.01 (s, 3H), 1.39 (s, 2H), 1.27 (s, 0.45H), 1.25 
(s, 2H), 1.24 (s, 2H), 1.15 (s, 1H), 1.13 (s, 2H), 1.07 (s, 1H), 0.92 (d, J = 7.1 Hz, 2H), 
0.86 (s, 2H), 0.84 (s, 1H). 
 
Preparation of BOC Protected Homoallylic Alcohol 2.148   
 
In a 25 mL round-bottomed flask was placed homoallylic alcohol 2.96 (1 g, 1.94 
mmol) and DIPEA (0.34 mL, 1.94 mmol) in CH2Cl2 (9.68 mL) to give a colorless 
solution which was cooled to 0 °C.  Di-tert-butyl dicarbonate (1.12 mL, 4.84 mmol) and 
DMAP (1.18 g, 9.68 mmol) were added to the reaction which was stirred for 24 hrs at 
room temperature.  The reaction was quenched with water and stirred for 15 min at which 
time the reaction mixture was transferred to separatory funnel and extracted with diethyl 
ether (3 x 10 mL).  The organic layers were combined and washed with 1 N HCl, (2 x 10 
mL), followed by saturated sodium bicarbonate (20 mL) and brine (20 mL).  The organic 
layer was dried over magnesium sulfate and concentrated under vacuum to give a white 
solid.  The crude product was passed through a short silica gel plug eluting with 8:1 
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Hex:EA to give 1.17 g (98 % yield) of BOC protected homoallylic alcohol 2.148.  The 
product was carried to the next step without further purification. 1H NMR (400 MHz, 
Chloroform-d) δ 4.99 (dt, J = 8.2, 5.0 Hz, 1H), 4.80 – 4.72 (m, 2H), 4.65 (tt, J = 10.9, 5.0 
Hz, 1H), 4.54 (dd, J = 11.3, 4.6 Hz, 1H), 4.31 (td, J = 7.7, 4.7 Hz, 1H), 3.41 (dd, J = 8.2, 
5.5 Hz, 1H), 2.38 – 2.25 (m, 2H), 1.99 (d, J = 1.5 Hz, 6H), 1.74 (s, 3H), 1.43 (s, 9H), 
0.97 (d, J = 6.8 Hz, 3H), 0.90 (s, 3H), 0.82 (s, 3H).  HRMS ESI: [M+Na]; Expected 
639.3872 for C36H56NaO8, Found 639.3873. 
 
Preparation of Cyclic-Iodocarbonate 2.149   
 
Following Johnson’s2 modification of the procedure reported by Bartlett3;  in a 50 
mL round-bottomed flask was added Boc-homoallylic alcohol 2.148 (1.17 g, 1.62 mmol) 
in propionitrile (16.2 mL) and cooled to -40 °C to give a colorless solution.  Iodine (3 
equiv., 1.230 g, 4.85 mmol) was quickly added and the reaction stirred at -40 °C until the 
Boc-homoallylic alcohol was deemed consumed by TLC (30 min).  The mixture was 
partitioned between 50 mL of 20 % Na2S2O3/saturated NaHCO3 and 50 mL of diethyl 
ether.  The organic layer was collected and washed with saturated aqueous NaCl (50 mL), 
dried over MgSO4, and evaporated to give 1.25 g of a yellowish solid which contained a 
                                                 
2 Johnson, W. S.; Chan, M. F. Journal of  Organic Chemistry 1985, 50, 2598-2600. 
3 Bartlett, P. A.; Meadows, J. D.; Brown, E. G.; Morimoto, A.; Jernstedt, K. K. Journal of Organc 
Chemistry 1982, 47, 4013-4018. 
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small amount of the Ritter byproduct.  The crude product was taken to the next step 
without further purification.  1H NMR (400 MHz, Chloroform-d) δ 4.66 (tt, J = 11.0, 4.9 
Hz, 1H), 4.57 (dd, J = 11.2, 4.6 Hz, 1H), 4.39 (m, 2H), 3.44 (t, J = 7.3 Hz, 1H), 3.37 (s, 
1H), 2.30 (dd, J = 14.3, 3.1 Hz, 1H), 2.04 (s, 3H), 2.00 (s, 3H), 1.65 (s, 3H), 1.38 (s, 1H), 
1.33 (s, 1H), 1.08 (d, J = 6.7 Hz, 3H), 0.88 (s, 3H), 0.83 (s, 3H).  13C NMR (101 MHz, 
CDCl3) δ 170.79, 170.69, 148.33, 89.63, 83.98, 81.30, 80.90, 73.48, 64.49, 55.37, 52.76, 
45.07, 44.58, 36.71, 35.71, 35.22, 34.44, 33.90, 31.78, 31.62, 28.40, 27.40, 26.77, 24.76, 
21.57, 19.67, 14.66, 12.23, 11.84.  HRMS ESI: [M+Na]; Expected 709.3538 for 
C32H47INaO8, Found 709.3537. 
 
Preparation of 25-Epoxy-23-Methyl Carbonate 2.154   
 
In a 50 mL round-bottomed flask was added iodo carbonate 2.153 (1.11 g, 1.62 
mmol) in 9:1:1 MeOH (13.21 mL):THF (1.45 mL):Water (1.47 mL)  to give a 0.1 M 
colorless solution.  Potassium carbonate (0.23 g, 1.70 mmol) was added in 3 portions 
over 1 hr giving a suspension, and the reaction was stirred at room temperature until the 
cyclic carbonate was deemed consumed by crude NMR (1.5 hr).  The reaction was 
diluted with diethyl ether 20 mL, extracted with diethyl ether (3 x 10 mL), washed with 
saturated NaCl, dried over MgSO4, and concentrated to give 2.154 as a white solid; 
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which was taken to the next step without further purification.  1H NMR (400 MHz, 
Chloroform-d) δ 4.96 (dt, J = 8.4, 4.2 Hz, 1H), 4.65 (tt, J = 10.9, 4.9 Hz, 1H), 4.54 (dd, J 
= 11.2, 4.7 Hz, 1H), 4.31 (td, J = 7.8, 5.0 Hz, 1H), 3.79 (s, 3H), 3.44 (dd, J = 8.5, 4.5 Hz, 
1H), 2.60 (d, J = 4.6 Hz, 1H), 2.56 (d, J = 4.6 Hz, 1H), 2.02 (s, 3H), 2.00 (s, 3H), 1.36 (s, 
3H), 1.33 (s, 3H), 0.97 (d, J = 6.7 Hz, 3H), 0.88 (s, 3H), 0.83 (s, 3H).  13C NMR (101 
MHz, CDCl3) δ 170.77, 170.67, 155.56, 90.28, 83.44, 81.47, 75.62, 73.50, 64.27, 55.27, 
55.01, 53.16, 52.76, 45.18, 44.59, 37.25, 36.68, 35.70, 35.08, 34.33, 33.91, 31.67, 28.96, 
28.41, 27.40, 26.74, 21.86, 21.56, 18.98, 12.22, 11.75. HRMS ESI: [M+Na]; Expected 
613.3352 for C33H50NaO9, Found 613.3351. 
 
Preparation of 16-Hydroxy-23-Methyl Carbonato-25-Epoxide 2.150   
 
In a 100 mL round-bottomed flask was placed epoxide 2.154 (0.95 g, 1.62 mmol), 
1,1,1-trifluoroacetone (0.72 mL, 8.08 mmol), EDTA (0.24 g, 0.81 mmol) and sodium 
bicarbonate (2.17 g, 25.8 mmol) in 1.5:1 acetonitrile (19.38 mL):water (Ratio: 1.000, 
12.92 mL) giving a colorless suspension.  The reaction was cooled to 5 °C and oxone 
(4.96 g, 8.08 mmol) was added portionwise over 3 hrs and the reaction was maintained at 
5 °C  until the starting material was deemed consumed by 1H NMR. The reaction was 
diluted with diethyl ether (20 mL), extracted with diethyl ether (3 x 10 mL), washed with 
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saturated NaCl, dried over MgSO4, and concentrated to give a white solid; which was 
taken to the next step without further purification.  1H NMR (300 MHz, Chloroform-d) δ 
5.03 (dt, J = 8.5, 4.4 Hz, 1H), 4.74 – 4.58 (m, 2H), 3.96 (dd, J = 8.6, 4.4 Hz, 1H), 3.80 (s, 
3H), 2.62 (d, J = 4.4 Hz, 1H), 2.58 (d, J = 4.5 Hz, 1H), 2.01 (s, 3H), 2.00 (s, 3H), 1.37 (s, 
3H), 1.02 (d, J = 6.7 Hz, 3H), 0.86 (s, 3H), 0.83 (s, 3H). HRMS ESI: [M+H] Expected 
607.3482 for C33H51O10, Found 607.3481. 
 
Preparation of Keto-Furan 2.159  
 
i) In a 50 mL round-bottomed flask was placed crude epoxy-hemiketal 2.150 
(0.98 g, 1.62 mmol) and CH2Cl2 (16 mL, 0.1 M) to give a colorless solution.  PPTS (162 
mg, 0.65 mmol) was added and the reaction stirred at 0 °C for 24 hrs while monitored by 
1H NMR.  The reaction was quenched with saturated sodium bicarbonate and extracted 
with CH2Cl2 (3 x 5 mL), washed with sodium bicarbonate (2 x 5 mL) and brine.  The 
organic layer was dried over sodium sulfate, filtered and concentrated to give the crude 
alkoxy-keto-furan as a fluffy off-white solid.    
ii) In a 25 mL round-bottomed flask was placed crude alcohol 2.151 (0.98 g, 1.62 
mmol) and imidazole (0.22 g, 3.2 mmol) in DCE (8.0 mL) to give a colorless solution.  
The solution was cooled to 0 °C and TBS-Cl (0.37 g, 2.42 mmol) was added and the 
reaction was stirred at room temperature until the starting alcohol was consumed.  The 
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reaction was quenched with methanol, diluted with saturated sodium bicarbonate (20 
mL), extracted with CH2Cl2 (3 x 10 mL), washed with 1 N HCl (10 mL), saturated 
sodium bicarbonate (10 mL), brine (10 mL) and dried over sodium sulfate.  The organic 
layer was concentrated under vacuum to give the crude protected ketofuran as a white 
solid.  The crude solid was purified by silica gel chromatography to give 455 mg of 
ketofuran 2.151 as a white solid in 39 % yield over five steps from BOC-homoallylic 
alcohol 2.148. 1H NMR (400 MHz, Chloroform-d) δ 4.97 (dt, J = 6.6, 2.0 Hz, 1H), 4.67 
(ddt, J = 16.4, 11.0, 4.9 Hz, 2H), 3.98 (dd, J = 11.2, 2.2 Hz, 1H), 3.73 (s, 3H), 3.46 (d, J 
= 9.2 Hz, 1H), 3.31 – 3.21 (m, 1H), 2.42 (d, J = 2.8 Hz, 1H), 2.29 – 2.19 (m, 2H), 2.00 (s, 
3H), 1.99 (s, 3H), 1.14 (s, 3H), 0.95 (s, 3H), 0.85 (s, 9H), 0.83 (s, 3H), 0.00 (s, 6H). 13C 
NMR (101 MHz, CDCl3) δ 216.96, 170.72, 170.08, 155.30, 85.51, 83.72, 82.72, 80.43, 
73.42, 68.07, 64.61, 54.71, 52.03, 49.24, 47.06, 44.48, 39.56, 38.15, 36.51, 36.33, 35.67, 
33.84, 33.06, 31.61, 28.30, 27.31, 26.56, 25.93, 25.72, 21.64, 21.53, 18.27, 15.78, 12.15, 












Preparation of Keto-Furan 2.160   
 
i) In a 5 mL round-bottomed flask was placed crude epoxy-hemiketal 2.150 (440 
mg, 0.73 mmol) in CH2Cl2 (2430 µL, 0.1 M) to give a colorless solution.  PPTS (73.2 
mg, 0.29 mmol) was added and the reaction stirred at 0 °C for 24 hrs while monitored by 
1H NMR.  The reaction was quenched with saturated sodium bicarbonate and extracted 
with CH2Cl2 (3 x 5 mL), washed with sodium bicarbonate (2 x 5 mL) and brine.  The 
organic layer was dried over sodium sulfate, filtered and concentrated to give the crude 
alkoxy-keto-furan 2.151 as a fluffy off-white solid.   
ii) In a 5 mL round-bottomed flask was placed crude alcohol 2.151 (440 mg, 0.73 
mmol) and triethylamine (300 µL, 2.18 mmol) in CH2Cl2 (2430 µL) to give a colorless 
solution.  The reaction mixture was cooled to 0 °C and benzoyl chloride (127 µL, 1.092 
mmol) followed by DMAP (17.79 mg, 0.15 mmol) were added to the solution and the 
reaction was allowed to warm to room temperature slowly.  The reaction was quenched 
with water and extracted with CH2Cl2 (3 x 5 mL), washed with sodium bicarbonate (2 x 5 
mL) and brine.  The organic layer was dried over sodium sulfate, filtered and 
concentrated to give a fluffy off-white solid.  The crude product was purified by silica gel 
chromatography to give 26-benzoyloxy-16-keto-23-methylcarbonato-22,25-furan 2.160 
(0.430 g, 0.604 mmol, 83 % yield) and 55 % overall yield from Boc-homoallylic alcohol 
2.148).  1H NMR (400 MHz, Chloroform-d) δ 8.15 – 7.86 (m, 2H), 7.55 – 7.49 (m, 1H), 
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7.40 (t, J = 7.7 Hz, 2H), 5.02 (dt, J = 6.6, 2.4 Hz, 1H), 4.71 (dd, J = 10.9, 4.7 Hz, 1H), 
4.68 – 4.59 (m, 1H), 4.24 (d, J = 11.0 Hz, 1H), 4.11 (d, J = 10.7 Hz, 1H), 2.37 (d, J = 2.8 
Hz, 1H), 1.99 (s, 4H), 1.97 (s, 3H), 1.30 (s, 1H), 1.26 (s, 3H), 0.95 (s, 3H), 0.81 (s, 3H). 
13C NMR (101 MHz, CDCl3) δ 216.56, 170.58, 169.94, 166.15, 155.15, 132.96, 130.17, 
129.77, 128.34, 85.58, 81.95, 81.63, 80.39, 73.33, 68.97, 64.57, 60.37, 54.78, 53.50, 
52.01, 49.18, 46.97, 44.44, 40.54, 38.12, 36.31, 35.60, 33.77, 33.02, 31.56, 28.85, 28.23, 
27.24, 26.52, 25.94, 21.42, 21.04, 15.86, 14.22, 12.06, 11.90. HRMS ESI: [M+Na]; 
Expected 733.3563 for C40H54NaO11, Found 733.3564. 
 
Formation of C16 Silyl Enol Ethers 2.166a/b and C-Silylation Side Products 2.165a/b 
In a 10 mL round-bottomed flask was placed 2.159 (174.9 mg, 0.24 mmol) and 
triethylamine (220 µL, 1.58 mmol) in dichloromethane (3465 µL, 0.07 M) to give a 
colorless solution.  Triethylsilyl trifluoromethanesulfonate (247 µL, 1.092 mmol) was 
added dropwise over 10 min and stirred at room temperature for 6 hours until complete 
by TLC.  The reaction was quenched with methanol and diluted with saturated sodium 
bicarbonate.  The solution was extracted with diethyl ether (3 x 5 mL), washed with 
sodium bicarbonate and brine.  The organic layer was dried over magnesium sulfate, 
filtered and concentrated to give an off-white solid.  TLC of the crude mixture indicated 4 
products, which were purified through silica gel chromatography by gradient elution 6:1 - 
3:1 Hex:EA giving two mixtures.  The desired silyl enol ether 2.166a (87 mg, 0.104 
mmol, 42.9 % yield) was isolated as mixture with minor amounts of C15-enol ether, 
2.166b.  The C-silylation side product 2.165a (89.4 mg, 0.107 mmol, 44 % yield) was 





2.166a/b: (2.166a is the major isomer) 1H NMR (400 MHz, Chloroform-d) δ 4.92 
(tt, J = 6.9, 3.1 Hz, 1H), 4.81 (dd, J = 10.7, 5.0 Hz, 1H), 4.63 (tt, J = 10.9, 4.9 Hz, 1H), 
3.72 (d, J = 2.2 Hz, 3H), 3.58 – 3.44 (m, 1H), 3.35 (d, J = 9.6 Hz, 1H), 2.02 (s, 3H), 1.84 
(s, 2H), 1.20 (s, 3H), 0.97 (s, 3H), 0.95 (s, 9H), 0.93 (s, 6H), 0.81 (d, J = 3.2 Hz, 3H), 
0.61 (dq, J = 12.9, 7.9 Hz, 14H), 0.51 (t, J = 8.0 Hz, 3H), 0.02 (d, J = 2.7 Hz, 6H). 13C 
NMR (101 MHz, CDCl3) δ 172.92, 170.57, 155.43, 149.62, 126.55, 84.51, 82.97, 82.29, 
79.04, 73.01, 68.33, 54.59, 53.53, 52.86, 52.09, 48.05, 44.83, 40.34, 36.43, 35.81, 34.21, 
33.51, 32.47, 31.37, 28.54, 27.63, 27.11, 25.97, 25.24, 22.27, 21.67, 18.31, 15.94, 15.76, 
13.69, 12.15, 7.77, 7.27, 7.22, 6.91, 6.85, 6.67, 6.53, 6.40, 5.74, 5.71, 3.71, 3.68, -5.32, -
5.47.  LRMS ESI: [M + Na] 857, [M + K] 873 HRMS ESI : [M + Na] 857.5031 Expected 








2.165a/b: (2.165a is major product) 1H NMR (400 MHz, Chloroform-d) δ 4.96 
(dt, J = 6.8, 1.9 Hz, 1H), 4.69 (dd, J = 10.9, 4.6 Hz, 1H), 4.62 (dq, J = 10.8, 5.4, 4.8 Hz, 
1H), 3.97 (dd, J = 11.2, 2.2 Hz, 1H), 3.72 (s, 3H), 3.45 (d, J = 9.3 Hz, 1H), 3.25 (d, J = 
9.2 Hz, 1H), 2.41 (d, J = 2.9 Hz, 1H), 2.29 – 2.18 (m, 2H), 2.00 (s, 3H), 1.82 (s, 2H), 
1.13 (s, 3H), 0.98 – 0.88 (m, 16H), 0.84 (s, 9H), 0.81 (s, 3H), 0.58 (q, J = 7.9 Hz, 9H), -
0.00 (s, 6H).  13C NMR (101 MHz, CDCl3) δ 216.93, 172.88, 170.04, 155.28, 85.49, 
83.69, 82.70, 80.43, 77.36,  72.82, 68.06, 64.60, 54.67, 52.04, 49.23, 47.05, 44.53, 39.56, 
38.13, 36.49, 36.37, 35.67, 34.05, 33.06, 31.62, 28.32, 27.54, 26.55, 25.90, 25.69, 22.22, 
21.62, 18.24, 15.76, 12.15, 11.99, 7.18, 3.63, -5.41, -5.55.  LRMS ESI: [M + Na] 857, [M 











Formation of 17-α-(Triethylsilyl)oxy-keto-Furan 2.167 
 
In a 10 x 100 mm culture tube was placed 2.166a (74.1 mg, 0.089 mmol) and 
sodium bicarbonate (112 mg, 1.33 mmol) in acetonitrile (600 µL): 0.05 M sodium borate 
buffer with 1 x 10-4 EDTA (400 µL) 3:2 ratio at 0.089 molar to give a colorless solution.  
The reaction mixture was cooled to 5 °C and 1,1,1-trifluoroacetone (47.6 µL, 0.53 mmol) 
was added followed by oxone added in 3 portions over 1 hr.  The reaction was quenched 
with saturated sodium sulfite, and diluted with diethyl ether.  The solution was extracted 
with diethyl ether (3 x 5 mL), washed with water, sodium bicarbonate and brine.  The 
organic layer was dried over magnesium sulfate, filtered and concentrated to give an off 
white solid.  The crude product was purified through silica gel chromatography to 
provide alpha-siloxy-keto-furan 2.167 (32 mg, 0.038 mmol, 42 % yield) as a white fluffy 
solid.  1H NMR (400 MHz, Chloroform-d) δ 5.37 (s, 1H), 5.19 – 5.07 (m, 2H), 4.64 (tt, J 
= 10.9, 4.9 Hz, 1H), 4.55 – 4.42 (m, 1H), 3.76 (s, 3H), 3.53 (d, J = 9.1 Hz, 1H), 3.29 (dd, 
J = 9.0, 1.1 Hz, 1H), 2.45 – 2.18 (m, 3H), 2.01 (s, 3H), 1.84 (s, 3H), 1.31 (s, 3H), 0.94 (q, 
J = 9.2, 8.6 Hz, 16H), 0.86 (s, 9H), 0.83 (s, 3H), 0.60 (q, J = 7.9 Hz, 6H), -0.01 (s, 6H). 
13C NMR (101 MHz, CDCl3) δ 213.81, 172.91, 169.66, 155.14, 88.22, 85.83, 82.60, 
72.89, 72.85, 68.01, 54.93, 51.70, 51.36, 44.50, 40.07, 38.79, 36.77, 36.42, 35.63, 34.10, 
32.94, 31.71, 28.39, 27.59, 26.36, 25.91, 25.33, 22.28, 21.96, 18.29, 15.37, 12.21, 11.60, 
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7.23, 3.76, 3.69, 0.13, -5.36, -5.55.  HRMS ESI: [M+Na]; 873.4980 Expected for 
C45H78O11SiNa; 873.4979 Found. 
 
Preparation of C16-Alcohol 2.168 
 
In a 1 mL vial was placed ketone 2.159 (20 mg, 0.028 mmol) and cerium (III) 
chloride (6.84 mg, 0.028 mmol) in THF (142 µL): MeOH (71.1 µL) to give a colorless 
suspension and stirred at room temperature for 30 min.  Sodium borohydride (1.57 mg, 
0.042 mmol) was added portionwise over 15 min and continued to stir at room 
temperature for 3 hrs.  The reaction mixture was quenched with 5 % HCl at 0 °C and was 
quickly extracted once the bubbling ceased with diethyl ether (3 x 1 mL).  The combined 
organic fractions were washed with sodium bicarbonate (2 x 1 mL), and brine.  The 
organic layer was dried over magnesium sulfate, filtered and concentrated to give the 
crude alcohol as a white fluffy solid.  The crude product was purified by silica gel 
chromatography to give 2.168 (14.5 mg, 0.020 mmol, 73 % yield) as a white solid.  1H 
NMR (300 MHz, Chloroform-d) δ 4.95 (dt, J = 7.8, 5.0 Hz, 1H), 4.67 (tt, J = 10.8, 5.1 
Hz, 1H), 4.55 (dd, J = 10.8, 4.7 Hz, 1H), 4.32 (q, J = 7.3, 6.7 Hz, 1H), 3.92 (dd, J = 7.7, 
5.7 Hz, 1H), 3.77 (s, 3H), 3.53 (d, J = 9.8 Hz, 1H), 3.42 (d, J = 9.9 Hz, 1H), 3.27 (b, 1H), 
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2.11 – 2.05 (m, 1H), 2.01 (s, 3H), 2.00 (s, 3H), 1.25 (s, 3H), 1.24 (s, 3H), 0.98 (s, 3H), 
0.97 (s, 3H), 0.88 (s, 9H), 0.81 (s, 3H), 0.03 (s, 6H).   
 







In a 10 mL round-bottomed flask was placed hecogenin acetate 1.14 (200 mg, 
0.42 mmol) and boron trifluoride diethyl etherate (270 µL, 2.12 mmol) in AcOH (4230 
µL) to give a white suspension.  Sodium nitrite (29.2 mg, 0.42 mmol) was added 
followed by Iron(III) chloride (340 mg, 2.12 mmol) and to give a deep red solution and 
the reaction was continued until no change was apparent by TLC.  The reaction solution 
was poured onto ice and stirred for 2 hours until all of the nitrite was consumed.  The 
white precipitate produced was collected by filtration giving a wet solid which was 
dissolved with CH2Cl2 and transferred to a separatory funnel with.  The organic layer was 
washed with water, sodium bicarbonate (3 x 100 mL) and brine.  The organic layer was 
dried over sodium sulfate and concentrated under vacuum to give off white powdery 
solid.  The crude product was added to a silica gel column and eluted with 3:1 Hex:EA Rf 
= 0.20  to give 12-oxo-acetoxy-bisnorcholanic lactone 3.9 (100 mg, 0.25 mmol, 58 % 
yield) as a white flaky solid.  1H NMR (400 MHz, Chloroform-d) δ 4.84 (td, J = 7.8, 4.6 
Hz, 1H), 4.61 (tt, J = 11.2, 4.9 Hz, 1H), 2.60 – 2.48 (m, 2H), 2.45 – 2.30 (m, 2H), 2.20 
(dd, J = 14.4, 5.0 Hz, 1H), 1.97 (s, 3H), 1.54 (dt, J = 13.0, 3.5 Hz, 1H), 1.33 (d, J = 7.6 
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Hz, 4H), 1.01 (s, 3H), 0.88 (s, 3H). 13C NMR (101 MHz, CDCl3) δ 212.38, 180.79, 
170.59, 80.88, 73.01, 55.72, 55.52, 53.92, 50.83, 44.41, 37.28, 36.69, 36.26, 36.14, 34.11, 
33.71, 32.40, 31.35, 27.99, 27.16, 21.41, 17.27, 13.82, 11.87. HRMS ESI: [M+Na]  
425.2303 Expected for C24H34NaO5; 425.2302 Found. 
 
Synthesis of 12,22-bis-Lactone 3.12 
 
In a 10 mL round-bottomed flask was placed hecogenin acetate 1.14 (100 mg, 
0.21 mmol) and acetic acid (60.6 µL, 1.06 mmol) in CH2Cl2 (2115 µl) 0.1 molar to give a 
colorless solution.  m-CPBA (90 mg, 0.53 mmol) was added portionwise  over 30 min 
and the reaction was stirred at room temperature until all the hecogenin had been 
consumed.  The reaction was diluted with water and extracted with CH2Cl2 (3 x 5 mL) 
and the combined organic layers were washed with sodium bisulfite, saturated sodium 
bicarbonate, and brine.  The organic layer was dried over sodium sulfate, filtered and 
concentrated to give a yellowish solid.  The crude product was purified on silica gel 
chromatography to give 3.12 (75 mg, 0.180 mmol, 85 % yield) as a white solid.  1H NMR 
(400 MHz, Chloroform-d) δ 4.90 (td, J = 8.1, 4.3 Hz, 1H), 4.67 (tt, J = 11.5, 4.8 Hz, 1H), 
2.86 – 2.75 (m, 2H), 2.67 (d, J = 8.0 Hz, 1H), 2.59 (dt, J = 15.0, 7.3 Hz, 1H), 2.45 (dd, J 
= 14.0, 12.1 Hz, 1H), 2.01 (d, J = 0.8 Hz, 3H), 1.59 (td, J = 13.8, 4.4 Hz, 1H), 1.44 (s, 
3H), 1.35 (d, J = 7.6 Hz, 3H), 0.80 (s, 3H). 13C NMR (101 MHz, CDCl3) δ 179.91, 
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173.93, 170.75, 85.34, 72.93, 59.84, 55.19, 55.10, 50.28, 43.57, 38.35, 36.79, 36.69, 
36.54, 36.53, 35.52, 33.87, 32.15, 28.03, 27.34, 21.52, 17.31, 16.65, 11.61.  
 







 The title compound was synthesized in accordance with the reported procedure.4 
To a mixture of AcOH (60 mL) and H2SO4 (concentrated) (0.9 mL) was added I2 (0.49 g, 
1.9 mmol) and the resulting solution was stirred for 30 min at room temperature. 3-
acetoxy-rockogenin 3.13 (8.4 g, 19.4 mmol) was added and the mixture was further 
stirred for 10 min. CH3CO3H (118.4 mL, 118 mmol, 1 M in AcOH) was added dropwise 
over 1 hr. After 4 h, the reaction was saponified with 5 N NaOH (pH =13) at room 
temperature overnight.  The crude product was collected by filtration and dried in vacuo.  
Flash chromatography (CH2Cl2:MeOH 10:1) provided 3.14 (6.0 g, 85%) as a white solid.  
Mp 252- 253 °C.  
1H NMR (400 MHz, Chloroform-d) δ 4.93 (td, J = 7.8, 4.7 Hz, 1H), 
3.58 (tt, J = 11.0, 4.8 Hz, 1H), 3.36 (dd, J = 11.1, 4.7 Hz, 1H), 2.76 (qd, J = 7.6, 1.3 Hz, 
1H), 2.28 (ddd, J = 13.3, 7.8, 6.6 Hz, 1H), 1.33 (d, J = 7.6 Hz, 3H), 0.83 (s, 3H), 0.77 (s, 
3H). 13C NMR (101 MHz, CDCl3) δ 181.45, 82.26, 78.10, 69.82, 57.87, 52.65, 52.30, 
46.23, 44.33, 39.52, 37.56, 36.89, 36.59, 35.14, 33.52, 32.32, 31.41, 30.90, 29.81, 28.10, 
17.22, 13.87, 11.91, 11.82, 8.33. 
                                                 





 1H NMR (300 MHz, pyridine-d5): d 4.88 (br s, 1H), 3.89 (br s, 1H), 3.64 (br s, 
1H), 2.97 (d, 1H, J = 11.4 Hz,), 2.65 (d, 1H, J = 4.5 Hz), 2.17 - 2.13, (m, 2H), 2.07- 2.03 
(m, 1H), 1.23 (d, 3H, J = 7.2 Hz), 0.82 (s, 3H), 0.71 (s, 3H). 13C NMR (75 MHz, 
pyridine-d5): d 181.0,82.5, 70.7, 68.1, 58.8, 54.2, 54.0, 52.4, 42.4, 41.6, 38.0,37.7, 36.5, 
36.1, 33.8, 33.4, 33.1, 32.1, 20.6, 17.7, 13.6, 13.5. HRMS ESI: [M+Na]; 385.2354 
Expected for C22H34NaO4; 385.2355 Found. 
 
Preparation of Hecogenin-C12-Dioxolane 3.15 
 
In a 250 mL round-bottomed flask was placed hecogenin acetate 1.14 (5 g, 10.58 
mmol) and ethane-1,2-diol (1.74 mL, 31.7 mmol) in toluene (105 mL) to give a colorless 
solution.  p-Toluenesulfonic acid monohydrate (0.20 g, 1.06 mmol) was added, the flask 
was fitted with a Dean-Stark trap and a condenser.  The reaction was heated at reflux for 
4 hrs, after which the reaction was cooled and quenched with the addition of saturated 
sodium bicarbonate.  The solution was extracted with CH2Cl2 (3 x 100 mL), washed with 
water (3 x 100 mL), saturated sodium bicarbonate and brine.  The organic layer was dried 
over sodium sulfate, filtered and concentrated to give off-white solids.  The crude product 
was purified by short-plug silica gel chromatography to give 3.15 (5.47 g, 10.58 mmol, 
100 % yield) as a white solid.  1H NMR (400 MHz, Chloroform-d) δ 4.65 (tt, J = 11.0, 
4.9 Hz, 1H), 4.35 (dt, J = 8.8, 6.9 Hz, 1H), 4.07 – 3.93 (m, 2H), 3.93 – 3.74 (m, 2H), 3.46 
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(ddd, J = 11.0, 4.3, 1.9 Hz, 1H), 3.35 (t, J = 10.9 Hz, 1H), 2.31 (dd, J = 9.0, 7.1 Hz, 1H), 
2.00 (s, 3H), 0.93 (d, J = 6.9 Hz, 3H), 0.90 (s, 3H), 0.82 (s, 3H), 0.77 (d, J = 6.4 Hz, 3H). 
13C NMR (101 MHz, CDCl3) δ 170.79, 112.99, 109.53, 80.38, 73.67, 66.97, 65.37, 64.27, 
63.82, 52.94, 52.52, 51.26, 48.25, 44.56, 42.36, 36.64, 35.50, 34.54, 34.01, 31.72, 31.52, 
30.75, 30.42, 28.93, 28.57, 27.48, 21.56, 17.27, 14.72, 13.95, 12.23. 
 
Formation of bis-Lactone 3.20 
 
In a 10 mL round-bottomed flask was placed hecogenin acetate 1.14 (0.5 g, 1.06 
mmol), iodine (0.027 g, 0.11 mmol), and H2SO4 (0.059 mL, 1.11 mmol) in AcOH (3.47 
mL) to give a purple solution.  The solution was stirred at room temperature for 30 min, 
at which time, sodium periodate (1.36 g, 6.35 mmol) was added portionwise over 15 min 
and the reaction was stirred overnight.  TLC at t = 18 h showed the reaction was 
incomplete with approximately 45 % SM remaining.   After 18 h the reaction was diluted 
with 20 mL of water, cooled to 5 °C and quenched with saturated sodium sulfite 20 mL.  
The reaction mixture was transferred to separatory funnel, extracted with ethyl acetate (3 
x 15 mL) and the combined organic layer was washed with H2O, saturated NaHCO3, and 
saturated NaCl.  The organic layer was dried over Na2SO4, filtered and concentrated to 
give a brown solid.  The crude product mixture was added to a silica gel column (eluted 
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with a 5:1 to 2:1 Hex:EA gradient).  Two products were isolated 3.21 as off-white solid 
32 mg 6 % and 3.20 180 mg 26 % as a white solid.    
3.20 90% pure by 1H NMR (400 MHz, Chloroform-d) δ 5.83 (td, J = 7.8, 4.2 Hz, 
1H), 4.65 (tt, J = 11.2, 5.1 Hz, 1H), 4.59 (ddd, J = 11.0, 3.8, 1.4 Hz, 1H), 3.34 (t, J = 10.9 
Hz, 1H), 3.18 (qd, J = 7.3, 2.3 Hz, 1H), 2.43 (dd, J = 3.5, 1.3 Hz, 1H), 2.17 (dd, J = 13.7, 
5.1 Hz, 1H), 2.09 (dd, J = 15.9, 4.2 Hz, 1H), 2.00 (s, 3H), 1.97 (dd, J = 7.3, 2.3 Hz, 1H), 
1.85 (dd, J = 11.2, 3.8 Hz, 1H), 1.23 (d, J = 7.3 Hz, 3H), 0.92 (s, 3H), 0.89 (d, J = 6.8 Hz, 
3H).  13C NMR (101 MHz, CDCl3) δ 214.25, 174.75, 171.04, 170.69, 73.19, 69.87, 
69.07, 56.38, 56.32, 54.30, 53.86, 44.55, 41.65, 38.14, 37.78, 36.37, 36.30, 34.29, 33.81, 








3.21 95 % pure by 1H NMR (400 MHz, Chloroform-d) δ 4.66 (ddt, J = 16.3, 11.1, 
5.0 Hz, 1H), 4.43 (td, J = 7.6, 4.5 Hz, 1H), 4.25 (t, J = 3.1 Hz, 1H), 3.56 (ddd, J = 11.1, 
5.0, 1.7 Hz, 1H), 3.44 (t, J = 11.2 Hz, 1H), 2.44 – 2.32 (m, 2H), 2.19 (dd, J = 14.2, 5.0 
Hz, 1H), 2.01 (s, 3H), 1.30 (d, J = 6.9 Hz, 3H), 1.09 (s, 3H), 0.91 (d, J = 2.3 Hz, 3H), 
0.82 (d, J = 6.6 Hz, 3H). 13C NMR (101 MHz, CDCl3) δ 213.38, 170.72, 107.02, 80.08, 
73.26, 67.02, 56.98, 55.98, 55.72, 55.51, 55.44, 44.83, 44.54, 39.95, 37.72, 36.39, 36.19, 




Preparation of 3-(t-Butyldimethylsilyl)oxy-12-oxo-Bisnorcholanic Lactone 3.51 
 
i) In a 250 mL round-bottomed flask was placed diol 3.14 (6.7 g, 18.48 mmol) 
and imidazole (3.15 g, 46.2 mmol) in ClCH2CH2Cl (185 mL) to give a colorless solution 
which was cooled to 0 °C.  TBS-Cl (3.34 g, 22.18 mmol) was added to give a white 
suspension and stirred until the reaction was deemed complete by TLC (4 hrs).  The 
reaction was quenched with methanol, and diluted with saturated sodium bicarbonate.  
The resulting solution was extracted with CH2Cl2 (3 x 100 mL), washed with brine, and 
dried over sodium sulfate.  The dry organic layer was concentrated to give the crude 
product as a off-white solid.  The crude product was passed through a short silica plug to 
give 3.50 (6.8 g) as a white solid; which was used directly in the next step without further 
purification.   
 
Swern Oxidation  
3-(t-Butyldimethylsilyloxy)-12-oxo-bisnorcholanic lactone 3.51.  In a 250 mL 
round-bottomed flask was added oxalyl chloride (3.82 mL, 43.6 mmol) in CH2Cl2 (145 
mL) and cooled to -78 °C to give a colorless solution.  To the solution, DMSO (6.19 mL, 
87 mmol) was added dropwise over 5 minutes and the solution was stirred for 1 hour; at 
which time crude 12-hydroxy-bisnorcholanic lactone 3.50 (36.3 mL, 14.53 mmol) was 
added dropwise as a (1M DCM solution) and stirred for 30 minutes.  TEA (18.23 mL, 
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131 mmol) was then added and the reaction was allowed to slowly warm to -30 °C.  The 
reaction was quenched by the addition of saturated sodium bicarbonate solution, 
extracted with CH2Cl2 (3 x 75 mL), washed with water and brine.  The organic layer was 
dried over sodium sulfate and concentrated to give an off white solid which was purified 
by silica gel chromatography (eluting with 6:1 Hex:Ea) to give 12-oxo-bisnorcholanic 
lactone 3.51 (5.64 g, 11.88 mmol, 82 % yield).  1H NMR (400 MHz, Chloroform-d) δ 
4.88 (td, J = 7.7, 4.7 Hz, 1H), 3.52 (tt, J = 10.4, 4.9 Hz, 1H), 2.58 (d, J = 7.7 Hz, 3H), 
2.30 – 2.20 (m, 1H), 1.38 (d, J = 7.5 Hz, 3H), 1.10 (d, J = 6.2 Hz, 2H), 1.05 (s, 3H), 0.89 
(s, 3H), 0.86 (s, 9H). 13C NMR (101 MHz, CDCl3) δ 212.87, 180.93, 81.01, 71.70, 55.95, 
55.87, 54.22, 50.96, 44.86, 38.46, 37.50, 36.79, 36.32, 34.28, 32.55, 31.73, 31.63, 28.29, 
26.03, 18.34, 17.40, 13.94, 12.12, -4.46.  HRMS ESI: [M+Na]; 497.3063 Expected for 
C28H46NaO4Si; 497.3062 Found. 
 
TPAP Oxidation 
 ii) In a 250 mL round-bottomed flask, was placed crude 12-hydroxy-
bisnorcholanic lactone 3.50 (6.8 g, 14.26 mmol), in 1:1 MTBE (70 mL): phosphate buffer 
(pH = 9.5 70 mL) followed by dropwise addition of CH2Cl2 to give a colorless solution. 
To the colorless solution, TPAP (0.05 g, 0.14 mmol) was added and stirred for five 
minutes.  To the blackish suspension sodium hypochlorite (30.6 mL, 21.39 mmol) was 
added dropwise over 1.5 h and stirred for another 12 hours.  The reaction was quenched 
with saturated Na2S2O3 and the aqueous layer was back extracted with CH2Cl2 (3 x 75 
mL).  The combined organic layers were washed with water (2 x 25 mL) and brine.  The 
organic layer was dried over Na2SO4, filtered through Celite and concentrated to give 7.1 
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g of the crude ketone as an off-white solid.  The crude ketone was purified by silica gel 
chromatography and (eluted with 5:1 hexane: EtOAc) to give 3.51 (6.09 g, 12.84 mmol, 
94 % yield).  
 
Preparation of 3-(t-Butyldimethylsilyl)oxy-14,15-Dehydro-12-Trifluoroacetoxy-
Bisnorcholanic Lactones 3.64 and 3.76 
 
 
i) In a 5 mL 10 x 100 mm culture tube was placed 12-oxo-lactone 3.51 (50 mg, 
0.105 mmol) in argon sparged CH2Cl2 (2630 µL).  The ketone was irradiated with 300 
nm in a Rayonet until the starting material was consumed by 1H NMR. The crude 
aldehyde 3.57 was obtained by concentrating under vacuum.  
ii) In a 5 mL round bottomed flask was placed crude aldehyde 3.53 (50 mg, 0.105 
mmol) and 2,6-di-tert-butyl-4-methylpyridine (21.63 mg, 0.105 mmol) in CH2Cl2 (2633 
µL).  The reaction mixture was cooled to -78 °C and 2,2,2-trifluoroacetic 
trifluoromethanesulfonic anhydride (TFAT) (25.9 mg, 0.105 mmol) was added dropwise 
and the reaction was maintained at temperature until the starting aldehyde was deemed 
consumed by TLC.  The reaction was quenched with methanol, and diluted with saturated 
sodium bicarbonate.  The resulting solution was extracted with CH2Cl2 (3 x 5 mL), 
washed with brine, and dried over sodium sulfate.  The dry organic layer was 
concentrated to give the crude product as an off-white solid.  The crude product was 
purified by silica chromatography to give a white solid with 3.64 and 3.76 as a 1:1 
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inseparable mixture (39.1 mg, 0.068 mmol, 65 % yield).  1H NMR (400 MHz, 
Chloroform-d) δ 5.59 (t, J = 2.3 Hz, 1H), 5.33 (dd, J = 7.2, 2.5 Hz, 1H), 4.95 (td, J = 7.6, 
3.3 Hz, 1H), 4.87 (dd, J = 12.4, 4.5 Hz, 1H), 4.70 (dd, J = 11.7, 4.6 Hz, 1H), 4.12 (q, J = 
7.1 Hz, 0H), 3.56 (tp, J = 10.5, 5.0 Hz, 2H), 3.01 (dd, J = 17.7, 7.8 Hz, 1H), 2.40 (dd, J = 
7.2, 3.0 Hz, 2H), 2.22 (dd, J = 7.3, 1.4 Hz, 1H), 2.04 (s, 0H), 1.57 (s, 3H), 1.29 (d, J = 7.5 
Hz, 3H), 1.26 (d, J = 7.6 Hz, 3H), 1.11 (d, J = 5.9 Hz, 6H), 0.88 (d, J = 1.2 Hz, 24H), 
0.74 (s, 3H), 0.05 (d, J = 1.7 Hz, 13H). 13C NMR (101 MHz, CDCl3) δ 160.43, 135.66, 
130.28, 119.57, 85.76, 85.65, 84.91, 81.66,  71.72, 58.57, 55.00, 52.66, 51.57, 50.24, 
45.17, 44.53, 44.15, 38.55, 38.40, 38.04, 37.49, 37.33, 37.10, 36.60, 36.13, 34.32, 33.89, 
31.75, 29.80, 29.62, 28.56, 28.02, 26.39, 26.06, 24.50, 18.38, 17.65, 16.89, 16.29, 15.96, 
12.97, 12.20, -4.43.  19F NMR (376 MHz, CDCl3) δ -76.68, -76.79. HRMS ESI: [M+Na]; 
497.3063 Expected for C28H46NaO4Si; 497.3062 Found. 
 
Preparation of 3,12-bis-(t-Butyldimethylsilyl)-oxy-14,15-Dehydro-Bisnorcholanic 
Lactones 3.66 and 3.72   
 
i) In a 50 mL pear shaped flask was placed 12-oxo-lactone 3.51 (650 mg, 1.36 
mmol) in argon sparged CH2Cl2  (26 mL) 0.05 M.  The ketone was irradiated with 300 
nm light in a Rayonet until the starting material was consumed by 1H NMR.  The crude 
aldehyde 3.57 was obtained by concentrating under vacuum and was used without further 
purification.   
ii) In a 25 mL round-bottomed flask was placed crude aldehyde 3.57 (650 mg, 
1.36 mmol) and DTBMP (700 mg, 3.41 mmol) in CH2Cl2 (13.6 mL, 0.1 M).  The 
reaction mixture was cooled to 0 °C and tert-butyldimethylsilyl trifluoro-
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methanesulfonate (0.69 mL, 3.00 mmol) was added dropwise over 15 min, after which 
the reaction was stirred at 0 °C until the starting aldehyde was deemed consumed by 
TLC.  The reaction was quenched with methanol, and diluted with saturated sodium 
bicarbonate.  The resulting solution was extracted with CH2Cl2 (3 x 15 mL), washed with 
brine, and dried over sodium sulfate.  The filtered dry organic layer was concentrated to 
give the crude products as an off-white solid.  The crude products were purified by silica 
chromatography to give 3.66 (125 mg, 0.21 mmol, 15 % yield) and 3.72 (460 mg, 0.79 
mmol, 58% yield; plus 9 % of 8,14-dehydro compound  3.78) each as a white solids. 
 
 
3,12α-bis-(t-butyldimethylsilyl)oxy-14,15-dehydro-bisnorcholanic lactone 3.66  
(124 mg, 0.21 mmol, 15 % yield): 1H NMR (400 MHz, Chloroform-d) δ 5.45 (t, J = 2.1 
Hz, 1H), 5.28 (dd, J = 7.5, 2.3 Hz, 1H), 3.72 (t, J = 2.7 Hz, 1H), 3.54 (tt, J = 10.5, 4.9 Hz, 
1H), 2.72 (dd, J = 7.5, 5.1 Hz, 1H), 2.59 (qd, J = 7.3, 5.0 Hz, 1H), 2.15 (t, J = 11.3 Hz, 
1H), 1.87 – 1.75 (m, 1H), 1.56 (s, 2H), 1.30 (d, J = 7.4 Hz, 3H), 1.05 (s, 3H), 0.88 (d, J = 
2.9 Hz, 18H), 0.83 (s, 3H), 0.05 (s, 12H).  HRMS ESI: [M+Na]; 588.4030 Expected for 









3,12-β-bis-(t-butyldimethylsilyl)oxy-14,15-dehydro-bisnorcholanic lactone 3.72 
(463 mg, 0.79 mmol, 58% yield; plus 9 % 8,14-dehydro-bisnorcholanic lactone 3.78) 1H 
NMR (400 MHz, Chloroform-d) δ 5.45 (t, J = 2.1 Hz, 1H), 5.29 (dd, J = 7.1, 2.4 Hz, 1H), 
3.53 (tt, J = 10.5, 4.8 Hz, 1H), 3.22 (dd, J = 11.1, 4.4 Hz, 1H), 2.68 (qd, J = 7.6, 3.1 Hz, 
1H), 2.36 (dd, J = 7.1, 3.1 Hz, 1H), 2.09 (q, J = 9.0, 6.9 Hz, 1H), 1.96 – 1.83 (m, 1H), 
1.33 (d, J = 7.4 Hz, 3H), 0.98 (s, 3H), 0.88 (d, J = 5.1 Hz, 18H), 0.85 (s, 3H), 0.06 – 0.02 
(m, 12H). 13C NMR (101 MHz, CDCl3) δ 180.88, 162.94, 117.54, 86.48, 80.10, 72.01, 
55.35, 54.24, 51.90, 44.71, 38.51, 37.85, 37.12, 35.92, 34.43, 31.93, 30.41, 29.79, 28.22, 
26.07, 25.99, 25.89, 18.40, 18.02, 17.84, 15.43, 12.25, -3.46, -4.43, -4.55.  HRMS ESI: 














Preparation of 3.90 through TFAT mediated lactone opening of 3.72:  In a 1 mL 
vial was added lactone 3.72 (20 mg, 0.034 mmol) and 2,6-di-tert-butyl-4-methylpyridine 
(10.46 mg, 0.051 mmol) in CH2Cl2 (340 µl, 0.1 M) to give a colorless solution that was 
cooled to -78 °C.  To the solution, 2,2,2-trifluoroacetic trifluoromethanesulfonic 
anhydride (16.71 mg, 0.068 mmol) was added dropwise over 30 min and the reaction was 
allowed to warm slowly to -40 °C over 2 hr.  The reaction was quenched cold with 
saturated sodium bicarbonate and the resulting solution was extracted with CH2Cl2 (3 x 1 
mL), washed with saturated ammonium chloride and brine.  The organic layer was dried 
over sodium sulfate, filtered and concentrated to give a dark oil.  The dienoic acid was 
purified by short plug chromatography with 2 % TEA on silica gel, all other side products 
were flushed of the column with 20 % ethyl acetate in hexanes and the desired carboxylic 
acid was eluted with 80% ethyl acetate in hexanes containing 2 % AcOH.  The fractions 
were collected and washed with sodium bicarbonate followed by saturated ammonium 
chloride solution and brine.  The organic layer was dried over sodium sulfate, filtered and 
concentrated to give 3.90 (18.00 mg, 0.031 mmol, 90 % yield) as a fluffy white solid.  Rf 
= 0.3 in 10 % EA in Hexanes.  1H NMR (400 MHz, CDCl3) δ 6.28 (d, J = 2.1 Hz, 1H), 
5.87 (t, J = 2.0 Hz, 1H), 3.85 (q, J = 7.1 Hz, 1H), 3.54 (tt, J = 10.7, 4.8 Hz, 1H), 3.07 (dd, 
J = 11.1, 4.2 Hz, 1H), 1.38 (d, J = 7.3 Hz, 3H), 1.03 (s, 3H), 0.92 (s, 9H), 0.88 (s, 12H), 
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0.52 (td, J = 12.1, 3.3 Hz, 1H), 0.05 (d, J = 3.4 Hz, 9H), 0.02 (s, 3H). 13C NMR (101 
MHz, CDCl3) δ 181.76, 157.94, 155.57, 126.54, 119.88, 78.23, 72.14, 59.53, 53.48, 
44.85, 38.56, 38.41, 37.63, 35.81, 34.78, 31.98, 31.72, 29.43, 28.48, 26.22, 26.09, 19.05, 
18.40, 18.36, 12.72, 12.58, -2.95, -4.22, -4.43. HRMS ESI: [M-H] 587.3951 Expected for 
C34H59O4Si2; Found 587.3952. 
 
Preparation of 3.90 via tandem Prins/ lactone opening of ene-al 3.57:   
To a 250 mL round-bottomed flask was added crude aldehyde 3.57 (5.00 g, 10.53 
mmol) and 2,6-lutidine (3.68 mL, 31.6 mmol) in CH2Cl2 (105 mL) to give a colorless 
solution that was cooled to 0 °C.  To this solution tert-butyldimethylsilyl trifluoro-
methanesulfonate (6.05 mL, 26.3 mmol) was added dropwise over 30 min and the 
reaction was allowed to warm to room temperature slowly while stirring for 18 h.  Excess 
silyl triflate was quenched with methanol and the mixture was concentrated to give a 
yellow oil.  The oil was dissolved in CH2Cl2:MeOH 2:1 at 0 °C for 30 min and stirred 
with 2 equivalents of acetic acid to provide the crude acid upon quenching with sodium 
bicarbonate,  extracting with CH2Cl2 (3 x 5 mL), and drying the organic layer over 
sodium sulfate.  The organic layer was concentrated and purified by short plug 
chromatography with 2 % TEA on silica gel, all other side products were flushed from 
the column with 20 % ethyl acetate in hexanes and the desired carboxylic acid was eluted 
with 80% ethyl acetate in hexanes containing 2 % AcOH.  The collected fractions were 
washed with sodium bicarbonate followed by saturated ammonium chloride solution and 
brine.  The organic layer was dried over sodium sulfate, filtered and concentrated to give 
dienoic acid 3.90 as fluffy white solid (3.2 g, 5.43 mmol, 51.6 % yield) as a single 
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diastereomer; Rf =0.3 in 10 % EA in Hexanes.  
1H NMR (400 MHz, CDCl3) δ 6.28 (d, J 
= 2.1 Hz, 1H), 5.87 (t, J = 2.0 Hz, 1H), 3.85 (q, J = 7.1 Hz, 1H), 3.54 (tt, J = 10.7, 4.8 Hz, 
1H), 3.07 (dd, J = 11.1, 4.2 Hz, 1H), 1.38 (d, J = 7.3 Hz, 3H), 1.03 (s, 3H), 0.92 (s, 9H), 
0.88 (s, 12H), 0.52 (td, J = 12.1, 3.3 Hz, 1H), 0.05 (d, J = 3.4 Hz, 9H), 0.02 (s, 3H). 13C 
NMR (101 MHz, CDCl3) δ 181.76, 157.94, 155.57, 126.54, 119.88, 78.23, 72.14, 59.53, 
53.48, 44.85, 38.56, 38.41, 37.63, 35.81, 34.78, 31.98, 31.72, 29.43, 28.48, 26.22, 26.09, 
19.05, 18.40, 18.36, 12.72, 12.58, -2.95, -4.22, -4.43.  HRMS ESI: [M-H] 587.3951 
Expected for C34H59O4Si2; Found 587.3952. 
 
Synthesis of 3β,12β-bis-(t-butyldimethylsilyl)oxy-14,15-Dehydro-17-Hydroxy-
Bisnorcholanic Lactone 3.104: Optimized Procedure: 
 
 
In a 50 mL round-bottomed flask was added 14,16-dienyl-bisnorcholanic acid 
3.90 (250 mg, 0.424 mmol), 2,2,2-trifluoro-1-(3-fluorophenyl)ethanone (0.011 mL, 0.085 
mmol) and sodium hydrogen carbonate (71.3 mg, 0.849 mmol) in 1.5:1 [DMM (8.94 
mL), acetonitrile (4.24 mL)]:[0.05 M Na2B4O7·10H2O in 4 x 10
-4 EDTA  pH = 10} (8.49  
mL) to give a final concentration of 0.02 M.  The colorless suspension was cooled to 0 °C 
to give, oxone (0.255 mmol, 1.415 mL 0.18 M in 4 x 10-4 EDTA solution) and potassium 
carbonate (1.415 mL, 2.122 mmol) were added by syringe pump through PTFE needles 
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over 1.5 h.  The reaction continued to stir at 0 °C until the starting material was 
consumed as judged by TLC (6:1 Hexanes:EtOAc, approximately 24 h).  Upon 
completion, the reaction was quenched with hexane, washed with 10 mL saturated 
Na2S2O3, and 10 mL saturated NaHCO3.  The organic layer was dried over Na2SO4, 
filtered and concentrated by rotary evaporator to give an opaque oil.  (TLC Rf 0.55 6:1 
Hexanes:EtOAc)  The crude product was purified by silica gel chromatography ( grdient 
elution 5-10 % EtOAc in Hexanes) to give 17-hydroxy-bisnorcholanic lactone 3.104 (157 
mg, 0.260 mmol, 61.3 % yield) as a white fluffy solid  1H NMR (400 MHz, CDCl3) δ 
5.40 (t, J = 1.8 Hz, 1H), 5.12 (t, J = 1.5 Hz, 1H), 4.24 (s, 1H), 3.98 (dd, J = 11.1, 4.7 Hz, 
1H), 3.54 (tt, J = 10.6, 4.9 Hz, 1H), 2.65 (q, J = 7.3 Hz, 1H), 2.07 (t, J = 10.5 Hz, 1H), 
1.39 (s, 1H), 1.25 (d, J = 7.2 Hz, 4H), 1.11 (s, 3H), 0.90 (s, 9H), 0.88 (s, 9H), 0.86 (s, 
3H), 0.12 (s, 6H), 0.05 (s, 6H). 13C NMR (101 MHz, CDCl3) δ 148.81, 136.76, 132.09, 
119.33, 87.39, 77.37,  75.77, 72.28, 55.41, 47.01, 44.71, 39.45, 38.63, 37.27, 35.66, 
31.92, 30.76, 28.46, 27.83, 26.08, 18.45, 18.16, 14.60, 12.40, 10.01, -4.10, -4.42, -4.68.  
LRMS [M+Na] 627 m/z, [2M+Na] 1231; HRMS ESI: [M+Na] 627.3877 Expected for 
C34H60NaO5Si2; Found 627.3872.  
 
Unoptimized Procedure:  
In a 25 mL round-bottomed flask was added 14,16-dienyl-bisnorcholanic acid 
3.90 (100 mg, 0.17 mmol), 2,2,2-trifluoro-1-(3-fluorophenyl)ethanone 4.41 μL, 0.085 
mmol), and tetrabutylammonium hydrogen sulfate (5.76  mg, 0.034 mmol) in 1.5:1 
[DMM (5.09 mL), acetonitrile (5.09 mL)]:[0.05 M Na2B4O7·10H2O in 4 x 10
-4 EDTA]  
(6.08  mL) to give a final concentration of 0.02 M.  The colorless suspension was cooled 
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to 0 °C and oxone (0.17 mmol, 1.07 mL 0.18 M in 4 x 10-4 EDTA solution) and 
potassium carbonate (117 mg, 0.85 mmol in 1.07 mL) were added by syringe pump 
through a PTFE needle over 1.5 h.  The reaction was continued to stir at 0 °C until the 
starting material was consumed as judged by TLC (6:1 Hexanes:EtOAc), approximately 
48 h.  Upon completion, the reaction was quenched with hexane, washed with 5 mL 
saturated Na2S2O3, and 5 mL saturated NaHCO3.  The organic layer was dried over 
Na2SO4, filtered and concentrated under vacuum to give an opaque oil.  (TLC Rf 0.55 6:1 
Hexanes:EtOAc)  The crude product was purified by silica gel chromatography (gradient 
elution 5-10 % EtOAc in Hexanes) to give 17-hydroxy-bisnorcholanic lactone 3.104 (50 
mg, 0.038 mmol, 48 % yield) as  a white fluffy solid.  1H NMR (400 MHz, CDCl3) δ 5.40 
(t, J = 1.8 Hz, 1H), 5.12 (t, J = 1.5 Hz, 1H), 4.24 (s, 1H), 3.98 (dd, J = 11.1, 4.7 Hz, 1H), 
3.54 (tt, J = 10.6, 4.9 Hz, 1H), 2.65 (q, J = 7.3 Hz, 1H), 2.07 (t, J = 10.5 Hz, 1H), 1.39 (s, 
1H), 1.25 (d, J = 7.2 Hz, 4H), 1.11 (s, 3H), 0.90 (s, 9H), 0.88 (s, 9H), 0.86 (s, 3H), 0.12 
(s, 5H), 0.05 (s, 6H). 13C NMR (101 MHz, CDCl3) δ 148.81, 136.76, 132.09, 119.33, 
87.39, 77.37,  75.77, 72.28, 55.41, 47.01, 44.71, 39.45, 38.63, 37.27, 35.66, 31.92, 30.76, 














Decarboxylation side product 3.124 was obtained as a white fluffy solid; TLC 
(1:6 EtOAc in hexanes Rf  0.75); fluffy white solid 15 mg, 0.027 mmol, 15.75 % yield) 1H 
NMR (400 MHz, CDCl3) δ 6.53 (d, J = 5.8 Hz, 1H), 6.25 (dd, J = 5.8, 1.6 Hz, 1H), 5.31 
– 5.23 (m, 1H), 3.53 (ddd, J = 15.7, 10.9, 6.4 Hz, 1H), 3.10 (dd, J = 11.6, 3.8 Hz, 1H), 
2.16 – 2.05 (m, 1H), 1.74 (d, J = 7.0 Hz, 3H), 1.66 (ddt, J = 18.6, 11.6, 3.7 Hz, 4H), 1.59 
(s, 2H), 1.57 – 1.11 (m, 11H), 1.08 (s, 4H), 1.03 (d, J = 6.3 Hz, 1H), 1.01 – 0.90 (m, 2H), 
0.87 (d, J = 4.7 Hz, 18H), 0.82 (d, J = 4.8 Hz, 1H), 0.78 (s, 3H), 0.67 (td, J = 12.1, 2.8 
Hz, 1H), 0.04 (s, 6H), -0.08 (s, 3H), -0.14 (s, 3H).; 13C NMR (101 MHz, CDCl3) δ 
148.80, 136.75, 132.08, 119.32, 87.39, 77.38,  75.77, 72.28, 55.41, 47.02, 44.71, 39.46, 
38.63, 37.27, 35.67, 31.92, 30.76, 28.47, 27.83, 26.11, 26.08, 18.45, 18.17, 14.61, 12.40, 
10.01, -4.09, -4.42, -4.68.; LRMS: ESI [M-H] 560, [M+H-H2O] 543; HRMS (ESI) 









Preparation of 3,12-bis-(tert-Butyldimethylsilyl)oxy-Bisnorcholanic Acid 3.135 
 
In a 50 mL round-bottomed flask was placed dihydroxylactone 3.14 (.96 g, 2.65 
mmol) and 2,6-lutidine (0.771 mL, 6.62 mmol) in ClCH2CH2Cl ( 26.5 mL) to give a 
colorless solution which was cooled to 0 °C.  Tert-butyldimethylsilyl trifluoro-
methanesulfonate (1.338 mL, 5.83 mmol) was added dropwise to give a white suspension 
and stirred until the reaction was deemed complete by TLC (1.5 hrs).  The reaction was 
quenched with methanol, and diluted with saturated sodium bicarbonate.  The resulting 
solution was extracted with CH2Cl2 (3 x 30 mL), washed with brine, and dried over 
sodium sulfate.  The dry organic layer was concentrated to give the crude product as an 
off-white solid.  The crude product was purified by silica gel chromatography to give 
deprotected diol 3.135 (1.456 g, 2.463 mmol, 93 % yield) as a white solid.   
 
Preparation of Enol Ether 3.137 Through Takeda Coupling 
 
In a 2 ml conical vial was placed bis(cyclopentadienyl)titanium dichloride (384 
µl, 0.569 mmol), magnesium (16.52 mg, 0.680 mmol)  and activated molecular sieves 
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which was connected to a vacuum and gently heated with a heat gun for one minute.  The 
flask was carefully back filled with argon and THF (689 μl, 1.48 M )  was added to give a 
dark red suspension.  Triethyl phosphite (189 mg, 1.137 mmol) was then added to give a 
green solution and the reaction was allowed to run until all of the magnesium was 
consumed giving a deep violet color (3 hrs).  Bis-phenylthioacetyl 3.136 (50 mg, 0.139 
mmol) was added as 0.5 M solution in THF and stirred for 15 min at which time 
bisnorcholanic lactone 3.135 (41.0 mg, 0.069 mmol) was added as a 0.5 M toluene 
solution and the reaction was stirred over night at 80 °C.  The reaction was cooled to rt 
and quenched with t-butanol and pyridine, diluted with hexane and passed through a 
Celite pipette column.  The filtered solution was then concentrated, reconstituted in 2 % 
DCM:Hex and passed through an neutral alumina column.  The neutral alumina column 
was repeated and the desired fractions were concentrated, partially purified by 2 % TEA 
silica gel chromatography (eluted under gradient elution 2% to 25% DCM in Hexanes) to 
give enol ether 3.137 as a white solid  (66.6 mg, 0.093 mmol, 67 % yield).  (66.6 mg, 
0.093 mmol, 67 % yield).  Crude 1H NMR (400 MHz, Benzende-d6) δ 4.73 – 4.57 (m, 
1H), 4.31 (t, J = 7.5 Hz, 1H), 3.94 (d, J = 8.0 Hz, 1H), 3.66 (d, J = 8.0 Hz, 1H), 3.60 (dd, 
J = 14.3, 8.7 Hz, 1H), 3.19 (dd, J = 10.8, 4.6 Hz, 1H), 3.01 (q, J = 7.2 Hz, 1H), 1.98 (dt, J 
= 13.8, 7.1 Hz, 1H), 1.46 (d, J = 9.8 Hz, 3H), 1.36 (s, 3H), 1.05 (s, 6H), 1.02 (s, 9H), 0.18 
– 0.03 (m, 6H).  13C NMR (101 MHz, C6D6) δ 165.43, 109.22, 89.61, 84.97, 82.15, 
81.16, 73.86, 72.28, 62.60, 54.25, 53.48, 47.19, 45.21, 39.15, 38.14, 37.32, 36.50, 35.63, 
35.48, 34.05, 32.42, 32.19, 31.04, 30.24, 28.90, 27.89, 27.79, 27.68, 27.53, 26.18, 25.49, 
24.75, 23.61, 21.09, 18.41, 18.25, 12.33, 9.09, 1.42, -3.25, -4.20, -4.28.  HRMS ESI: 
[M+H] 716.5231 Expected for C42H77O5Si2; Found 716.5229. 
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Synthesis of 3,12-bis(tert-Butyldimethylsilyl)oxy-23-Hydroxy-22-Hemiketal 3.138 
 
In a 1 mL vial was placed enol ether 3.137 (10 mg, 0.014 mmol) and sodium 
bicarbonate (5.86 mg, 0.070 mmol) in CH2Cl2 (127 µl) and the solution was cooled to -20 
°C.  Dimethyldioxirane (209 µl, 0.017 mmol) 0.08 M in CH2Cl2:Acetone was added and 
the reaction was stirred for 30 min at -20 °C.  The reaction was quenched with saturated 
sodium sulfite (0.5 mL) and extracted with CH2Cl2 (3 x 1 mL) filtered and concentrated 
to give a white fluffy solid.  The crude compound was purified by 2 % TEA silica gel 
chromatography (eluted under a 2% to 25% DCM in Hexanes gradient) to give 3,12-
bis(tert-butyldimethylsilyl)oxy-23-hydroxy-22-hemiketal 3.138 as a white solid (7.64 
mg, 10.17 µmol, 72.9 % yield).  1H NMR (400 MHz, Chloroform-d) δ 4.62 (td, J = 7.8, 
5.3 Hz, 1H), 4.02 – 3.97 (m, 1H), 3.84 (d, J = 8.5 Hz, 1H), 3.81 (d, J = 8.5 Hz, 1H), 3.53 
(tt, J = 10.3, 4.8 Hz, 1H), 3.36 (dd, J = 10.9, 4.5 Hz, 1H), 3.26 (s, 1H), 2.04 (s, 0H), 1.99 
(dd, J = 12.8, 6.5 Hz, 1H), 1.42 (s, 3H), 1.40 (s, 3H), 1.38 (s, 3H), 1.09 (d, J = 6.9 Hz, 
3H), 0.89 (s, 10H), 0.88 (s, 11H), 0.81 (s, 3H), 0.79 (s, 3H), 0.04 (s, 9H).  13C NMR (101 
MHz, CDCl3) δ 110.16, 109.61, 81.33, 81.25, 80.99, 75.50, 73.37, 72.21, 64.37, 54.98, 
53.42, 47.26, 45.14, 40.20, 38.66, 38.28, 37.26, 35.63, 34.36, 32.06, 31.77, 31.02, 29.86, 
28.73, 27.15, 27.04, 26.32, 26.10, 24.53, 18.45, 16.17, 12.51, 10.72, -2.60, -3.42, -4.41. 
HRMS ESI: [M+H] 751.5364 Expected for C42H79O7Si2; Found 751.5361.  
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In a 1 mL vial was placed 3,12-bis(tert-butyldimethylsilyl)oxy-23-hydroxy-22-
hemiketal 3.138 (7 mg, 9.32 µmol), triethylamine (2.60 µl, 0.019 mmol) and DMAP 
(0.057 mg, 0.466 µmol) in CH2Cl2  (93 µl).  The solution was cooled to 0 °C and benzoyl 
chloride (1.622 µl, 0.014 mmol) was added and the reaction was stirred for 2 h at 0 °C.  
The reaction was quenched with saturated sodium bicarbonate, extracted with CH2Cl2 (3 
x 1 mL), washed with brine and dried over sodium sulfate.  The organic layer was filtered 
and concentrated to give a white fluffy solid.  The crude compound was purified by  2 % 
TEA silica gel chromatography (gradient elution 2% to 25% DCM in Hexanes) to give as 
a 3,12-bis(tert-butyldimethylsilyl)oxy-23-benzoyl-22-hemiketal 3.139 a white solid (7 
mg, 8.18 µmol, 88 % yield).  1H NMR (400 MHz, Chloroform-d) δ 8.05 (d, J = 7.7 Hz, 
2H), 7.56 (t, J = 7.4 Hz, 1H), 7.52 – 7.34 (m, 3H), 5.37 (dd, J = 6.7, 3.4 Hz, 1H), 4.02 (d, 
J = 8.7 Hz, 1H), 3.73 (d, J = 8.6 Hz, 1H), 3.66 (dd, J = 6.2, 2.8 Hz, 0H), 3.53 (tt, J = 11.1, 
5.2 Hz, 2H), 3.34 (dd, J = 10.7, 4.5 Hz, 1H), 2.32 (dd, J = 15.4, 3.4 Hz, 1H), 2.25 – 2.18 
(m, 1H), 1.99 (dt, J = 14.1, 7.1 Hz, 2H), 1.90 (dd, J = 8.6, 6.1 Hz, 1H), 1.35 (s, 5H), 1.31 
(s, 2H), 1.08 (t, J = 6.2 Hz, 3H), 0.88 (s, 13H), 0.86 (s, 8H), 0.79 (s, 4H), 0.76 (s, 3H), 









In a 5 mL round-bottomed flask was added 3,12-bis-(tert-butyldimethylsilyl)oxy-
14,16-dienyl-22 bisnorcholanic acid 3.90 (200 mg, 0.340 mmol) in benzene (2.401 mL) 
and MeOH (686 µL) which was cooled to 0 °C to give a colorless solution (0.11 M).  To 
the solution was added (diazomethyl) trimethylsilane (255 µL, 0.509 mmol) to give a 
yellow color and was stirred for 1 h.  The reaction mixture was concentrated in vacuo and 
the resulting solid was passed through a short silica gel pad with 5 % CH2Cl2:Hex to give 
methyl 3,12-bis-(tert-butyldimethylsilyl)oxy-14,16-dienyl-bisnorcholonate 3.105 (205 
mg, 0.340 mmol, 100 % yield) as a fluffy white solid.  1H NMR (500 MHz, Benzene-d6) 
δ 6.44 (d, J = 2.2 Hz, 1H), 5.98 – 5.81 (m, 1H), 4.09 (q, J = 7.1 Hz, 1H), 3.55 (tt, J = 
10.4, 5.0 Hz, 1H), 3.36 (s, 3H), 3.16 (dd, J = 11.1, 4.2 Hz, 1H), 2.01 (tt, J = 11.5, 2.7 Hz, 
1H), 1.91 – 1.77 (m, 1H), 1.53 (d, J = 7.4 Hz, 3H), 1.22 (s, 3H), 1.03 (d, J = 4.9 Hz, 
18H), 0.68 (s, 3H), 0.12 (d, J = 2.9 Hz, 6H), 0.10 (s, 3H), 0.07 (s, 3H). 13C NMR (126 
MHz, Benzene-d6) δ 175.50, 157.52, 156.47, 126.98, 120.78, 78.60, 72.37, 59.85, 53.69, 
51.55, 44.98, 39.25, 39.10, 37.95, 36.05, 35.11, 32.60, 32.30, 29.88, 28.92, 26.60, 26.41, 
19.69, 18.74, 18.60, 13.22, 12.67, -2.66, -3.88, -3.98, -4.05.  HRMS ESI: [M+H] 









In a 50 mL round-bottomed flask was placed dihydroxy acetone dimer 3.156 (2 g, 
11.10 mmol) and imidazole (4.53 g, 66.6 mmol) in CH2Cl2 (27.8 ml) to give a colorless 
solution.  Tert-butyldiphenylsilyl chloride (11.98 ml, 46.6 mmol) was added at 0 °C and 
the reaction was allowed to slowly warm to 25 °C and stirred for 12 h.  The reaction 
mixture was quenched with saturated sodium bicarbonate 20 ml, extracted with CH2Cl2 
(3 x 20 ml), washed with saturated sodium bicarbonate (10 ml), washed with brine (10 
ml) and dried over sodium sulfate.  The crude product was purified by silica gel 
chromatography (10% EA in Hexanes) to give 1,3-bis-(tert-butyldiphenylsilyl)oxy 
acetone 3.157  (6.1 g, 10.76 mmol, 97 % yield) as a colorless oil.  1H NMR (400 MHz, 
Chloroform-d) δ 7.68 – 7.59 (m, 1H), 7.49 – 7.43 (m, 1H), 7.42 – 7.35 (m, 1H), 4.45 (s, 
1H), 1.06 (s, 2H).  13C NMR (101 MHz, CDCl3) δ 207.31, 135.58, 132.67, 130.04, 
127.95, 127.80, 68.66, 26.81, 26.69, 19.30. 
 





In a 25 mL round-bottomed flask was added methyltriphenylphosphonium 
bromide (473 mg, 1.323 mmol) in THF (4.41 mL) to give a white suspension which was 
cooled to 0 °C.  n-Butyllithium (0.512 mL, 1.279 mmol) was added dropwise to give a 
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deep yellow suspension after 30 min.  1,3-bis-(tert-butyldiphenylsilyl)oxy acetone 3.157 
(1.764 mL, 0.882 mmol) as a 0.5 M THF solution was added dropwise and the reaction 
was stirred at  0 °C for 4 h.  The reaction was quenched with 1 N HCl, diluted with 
diethyl ether, and extracted with diethyl ether (3 x 5 ml).  The combined organic layers 
were washed with water, sodium bicarbonate, brine and dried over magnesium sulfate.  
The organic layer was concentrated to give a yellow oil.  The crude product was purified 
on silica gel column (5 % EA in hexanes) to give alkene as a colorless oil  (438 mg, 
0.775 mmol, 88 % yield).  1H NMR (500 MHz, Chloroform-d) δ 7.68 – 7.54 (m, 8H), 
7.50 – 7.29 (m, 12H), 5.21 (dd, J = 2.6, 1.3 Hz, 2H), 4.18 (t, J = 1.4 Hz, 4H), 1.02 (s, 
18H). 
In a 10 mL round-bottomed flask was placed the purified terminal alkene (1.26 
ml, 0.354 mmol) and sodium bicarbonate (89 mg, 1.062 mmol) in CH2Cl2 (2.81 ml)  to 
give a colorless suspension.  The reaction was cooled to 0 °C over 20 min at which time 
m-CPBA (119 mg, 0.531 mmol) was added portionwise over 1 hour.  The reaction was 
allowed to slowly warm to room temperature and stirred until all of the starting material 
was consumed by TLC (10:1 Hex:EA Rf = 0.45).  The reaction mixture was diluted 
saturated NaHCO3, transferred to separatory funnel and extracted with CH2Cl2 (3 x 1 
mL).  The organic layers were combined, washed with saturated NaCl, dried over sodium 
sulfate and concentrated to give the crude mixture (206 mg) a colorless oil.  The crude 
product was purified by short silica gel column (eluted with 10:1 Hex:EA) to give the 
desired epoxide 3.158 203 mg (99 %) as a colorless oil.  1H NMR (400 MHz, CDCl3) δ 
7.82 - 7.64 (m, 8H), 7.59 - 7.31 (m, 12H), 3.95 (q, J = 11.3 Hz, 4H), 2.74 (s, 2H), 1.11 (s, 
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18H). 13C NMR (101 MHz, CDCl3) δ 135.76, 135.71, 133.37, 129.84, 127.84,  63.91, 
60.09, 48.86, 26.91, 19.43.MS ESI (M+H ) expected 580.28 and found 580.2829. 
 
Preparation of bis-Phenylthio Acetal 2.159 
 
In a 10 mL round-bottomed flask was added bis(phenylthio)methane (189 mg, 
0.813 mmol) in Tetrahydrofuran (2.031 ml) and cooled to -78 °C.  After 15 min n-
butyllithium (0.322 ml, 0.804 mmol) was added dropwise to give a yellow solution which 
was stirred for 1 h at -78 °C.  Epoxide 3.158 (0.813 ml, 0.406 mmol) was added dropwise 
as a 0.5 M solution in THF and the reaction was allowed to warm to 0 °C over 2 h.  The 
reaction was quenched with 1 N HCl, diluted with diethyl ether and extracted with 
diethyl ether (3 x 5 ml).  The combined organic layers were washed with water, sodium 
bicarbonate, brine and dried over magnesium sulfate.  The organic layer was concentrated 
to give a yellow oil and was purified on silica gel column eluting with 5 % EA in hexanes 
to the crude hydroxy-bis-thioacetal as a colorless oil and was used directly without 
further purification.  1H NMR (400 MHz, Chloroform-d) δ 7.84 – 7.33 (m, 30H), 4.88 – 
4.70 (m, 1H), 3.81 (dt, J = 10.1, 2.2 Hz, 3H), 3.74 (dt, J = 10.0, 2.1 Hz, 2H), 2.35 (dd, J = 
6.3, 1.7 Hz, 2H), 1.08 (d, J = 1.5 Hz, 18H). 
  In a 10 mL round-bottomed flask was placed crude hydroxy-bis-thioacetal  (330 
mg, .406 mmol) and 2,6-lutidine (0.095 ml, 0.812 mmol) in CH2Cl2 (2.030 ml) to give a 
colorless solution.  The solution was cooled to 0 °C and trimethylsilyl 
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trifluoromethanesulfonate (0.110 ml, 0.609 mmol) was dropwise over five minutes and 
the reaction was maintained at 0 °C for 3h.  The reaction was quenched with methanol, 
diluted with saturated sodium bicarbonate 5 ml, extracted with CH2Cl2 (3 x 5 ml) washed 
with saturated sodium bicarbonate (5 ml), brine (5 ml) and dried over sodium sulfate.  
The crude product was purified by silica gel chromatography to give trimethylsilyl 
protected bis-thioacetal fragment 3.159 (252 mg, 0.285 mmol, 70.1 % yield for two 
steps).  1H NMR (400 MHz, Chloroform-d) δ 7.93 – 7.83 (m, 8H), 7.63 (d, J = 7.4 Hz, 
4H), 7.36 – 7.27 (m, 12H), 7.09 (dt, J = 27.3, 7.4 Hz, 7H), 5.11 (t, J = 6.0 Hz, 1H), 4.23 




Bisnorcholanic Lactone 3.162 
 
 
In a 2 mL vial were added 3,12-di-tert-butyldimethylsiloxy-17-hydroxy-14,15-
dehydro- bisnorcholanic lactone 3.104 (103.6 mg, 0.171 mmol) and triethylamine (50.1 
µl, 0.360 mmol) in CH2Cl2 (856 µl) which was cooled to 0 °C to give a 0.2 M colorless 
solution.  After 15 min, trimethylsilyl trifluoromethanesulfonate (61.9 µl, 0.342 mmol) 
was added dropwise over 5 min and maintained at 0°C for 30 min, at which time the ice 
bath was removed and stirred at room temperature until the starting material had been 
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consumed (4 h TLC 6:1 Hexanes: EtOAc).  The reaction was cooled to 0 °C and excess 
trimethylsilyl triflate was quenched with methanol and stirred for 15 min.  The reaction 
mixture was concentrated to give a colorless oil and was purified by silica gel 
chromatography (under gradient elution 2 % EtOAc in Hexanes) to give 3,12-di-tert-
butyldimethylsiloxy-17-trimethylsiloxy-14,15-dehydro-bisnorcholanic lactone 3.162 (95 
mg, 0.140 mmol, 82 % yield).  TLC Rf = 0.72  6:1 Hexanes: EtOAc. 1H NMR (400 MHz, 
CD2Cl2) δ 5.41 (t, J = 2.5 Hz, 1H), 4.86 (d, J = 2.8 Hz, 1H), 4.10 (dd, J = 11.6, 4.6 Hz, 
1H), 3.97 (s, J = 1.8, 1.4 Hz, 1H), 3.73 (s, J = 2.9, 2.0 Hz, 1H), 3.57 (tt, J = 10.8, 4.8 Hz, 
1H), 2.92 (q, J = 7.5 Hz, 1H), 2.15 – 2.03 (m, 1H), 2.03 – 1.94 (m, 1H), 1.15 (d, J = 7.5 
Hz, 3H), 1.08 (s, 3H), 0.88 (s, 18H), 0.83 (s, 3H), 0.13 (s, 3H), 0.13 (s, 6H), 0.07 (s, 3H), 
0.06 (s, 3H), 0.04 (s, 6H).  13C NMR (101 MHz, CD2Cl2) δ 171.59, 163.83, 117.19, 
93.83, 90.30, 78.82, 72.48, 71.44, 58.49, 54.00, 50.63, 44.87, 42.37, 39.02, 37.70, 35.96, 
35.26, 32.42, 31.47, 30.24, 28.70, 26.24, 26.14, 19.45, 18.63, 18.41, 17.86, 12.29, 3.45, -





















In a 10 mL round-bottomed flask was placed bis(cyclopentadienyl)titanium 
dichloride (689 µl, 1.020 mmol), magnesium (25.4 mg, 1.045 mmol) and activated 
molecular sieves.  The flask was hooked to a vacuum and heated with a heat gun gently 
for one minute.  The flask was carefully back filled with argon and THF (689 μL) was 
added to give a dark red suspension 1.48 M.  Triethyl phosphite (357 µl, 2.040 mmol) 
was added to give a green solution and the reaction was allowed to run for 3 hrs until all 
of the magnesium was consumed and the reaction had a deep violet color.  1,1-bis 
thioacetal 3.159 (497 µl, 0.249 mmol) was added as 0.5 M solution in THF and stirred for 
15 min at which time diene methyl ester 3.105 (597 µl, 0.298 mmol) was added as 0.5 M 
THF solution and the reaction was stirred over night.  The reaction was quenched with t-
BuOH and triethylamine.  The reaction mixture was diluted with hexane and passed 
through a Celite column.  The filtered solution was then concentrated and reconstituted in 
2 % DCM:Hex and passed through an alumina column twice.  The desired fractions were 
concentrated and purified by 2 % TEA silica gel chromatography (eluted under gradient 
2% to 25% DCM in Hexanes) to give a white solid methyl enol ether 3.165 (76.8 mg, 
0.061 mmol, 24.62 % yield).  1H NMR (500 MHz, Benzene-d6) δ 7.94 – 7.77 (m, 9H), 
7.25 (pd, J = 5.2, 4.5, 1.6 Hz, 13H), 7.16 (d, J = 2.2 Hz, 3H), 6.29 (d, J = 2.1 Hz, 1H), 
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5.96 (t, J = 2.0 Hz, 1H), 5.08 (t, J = 7.1 Hz, 1H), 4.30 (s, 0H), 4.06 (dd, J = 24.7, 9.8 Hz, 
2H), 3.89 (dd, J = 9.6, 3.4 Hz, 1H), 3.86 (q, J = 6.9 Hz, 1H), 3.64 – 3.54 (m, 1H), 3.52 (s, 
3H), 3.17 (dd, J = 11.1, 4.2 Hz, 1H), 2.80 (qd, J = 14.8, 7.1 Hz, 2H), 2.10 – 1.99 (m, 1H), 
1.92 (dq, J = 12.6, 3.2 Hz, 1H), 1.69 (ddt, J = 12.9, 7.9, 4.2 Hz, 2H), 1.44 (d, J = 7.1 Hz, 
3H), 1.20 (d, J = 3.0 Hz, 18H), 1.07 (s, 3H), 1.05 (s, 7H), 1.02 (s, 9H), 0.75 (s, 3H), 0.44 
(td, J = 12.0, 3.4 Hz, 1H), 0.21 (s, 9H), 0.15 (d, J = 3.6 Hz, 6H), 0.10 (d, J = 1.9 Hz, 6H).  
13C NMR (126 MHz, CDCl3) δ 162.31, 159.57, 156.34, 136.25, 136.20, 134.23, 134.19, 
134.12, 129.93, 129.87, 129.32, 128.06, 127.29, 126.36, 120.52, 80.14, 79.18, 72.22, 
67.80, 67.69, 59.76, 58.39, 53.77, 44.86, 39.12, 37.81, 35.98, 35.89, 34.89, 32.44, 32.25, 
31.51, 29.77, 28.86, 27.30, 26.45, 26.21, 21.80, 19.67, 18.55, 18.42, 13.72, 12.53, 2.82, -
3.20, -3.75, -4.17, -4.24.   
 
Synthesis of Side Chain Homoallylic Alcohol Fragment 3.179 
 
In a 10 mL round-bottomed flask was placed 1,3-bis-(tert-butyldiphenylsilyl)oxy 
acetone 3.157 (200 mg, 0.353 mmol) and indium (64.8 mg, 0.564 mmol) in THF (3.150 
mL) and water (1.26 mL) to give an off-white suspension.  Allyl bromide (48.8 µl, 0.564 
mmol) was added and the reaction was stirred for 12 h.  The reaction was diluted with 
ether and filtered through Celite.  The biphasic mixture was extracted with diethyl ether 
(3 x 5 mL), washed with brine, dried over sodium sulfate and concentrated to give a 
yellow oil.  The crude product was taken to the next step without further purification.  In 
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a 10 mL round-bottomed flask was placed the crude homoallylic alcohol  (0.215 g, .353 
mmol) and 2,6-lutidine (0.123 mL, 1.059 mmol) in DCM (.53 mL) to give a yellow 
solution which was cooled to -78 °C.  Trimethylsilyl trifluoromethanesulfonate (0.128 
mL, 0.706 mmol) was added dropwise and stirred for 1 while letting the reaction warm 
slowly. The reaction was quenched with methanol, diluted with saturated sodium 
bicarbonate 20 mL, extracted with CH2Cl2 (3 x 5 mL), washed with saturated sodium 
bicarbonate (10 mL), brine (10 mL) and dried over sodium sulfate.  The crude product 
was purified by silica gel chromatography to give trimethylsilyl-homoallylic alcohol 
3.179 (0.226 g, 0.332 mmol, 94 % yield) as a clear oil.  1H NMR (400 MHz, Chloroform-
d) δ 7.71 (ddd, J = 6.5, 3.1, 1.5 Hz, 1H), 7.44 (dd, J = 7.3, 5.8 Hz, 0H), 7.38 (dt, J = 8.7, 
7.4 Hz, 1H), 5.81 (ddt, J = 17.1, 10.3, 7.1 Hz, 0H), 5.15 – 4.90 (m, 0H), 3.74 (d, J = 9.9 
Hz, 0H), 3.63 (d, J = 9.8 Hz, 0H), 2.47 (d, J = 7.4 Hz, 0H), 1.08 (s, 2H), 0.08 (s, 1H). 13C 
NMR (101 MHz, CDCl3) δ 135.89, 134.39, 133.75, 133.60, 129.68, 127.72, 117.42, 












Petasis Methylidenation of Bisnorcholanic Lactones: 
Representative microwave procedure: 
In a 20 mL microwave vial was placed bisnorcholanic lactone (97 mg, 0.164 
mmol) and 2.3 equivalents of bis-(cyclopentadienyl)-dimethyl titanium (377 µl, 0.377 
mmol) in 4:1 PhMe(656 µl):THF(164 µl) to give a red solution (0.2 M).  The reaction 
was heated to 150 °C in a 300 Watt microwave at 5 min intervals and stopped when 
deemed complete by TLC denoted by the absence of starting material.  The crude 
reaction mixture was concentrated and purified first by passing through a Celite pad 
eluting with 5 % diethyl ether in hexane, then passed through two successive 8 inch 
Brockmman III alumina columns (eluting with 1% DCM and TEA in hexane).  The 
desired fractions were combined and concentrated to give an off-white-yellow solid. 
 
 
22-enol ether 3.180 A from bisnorcholanic lactone 3.135. 1H NMR (400 MHz, 
CD2Cl2) δ 4.76 (td, J = 7.5, 4.4 Hz, 1H), 3.94 (s, 1H), 3.64 (s, 1H), 3.55 (dt, J = 10.9, 6.1 
Hz, 1H), 3.35 (dd, J = 10.9, 4.6 Hz, 1H), 2.86 (q, J = 7.3 Hz, 1H), 2.13 (dt, J = 13.0, 7.3 
Hz, 1H), 1.80 (d, J = 7.4 Hz, 1H), 1.17 (d, J = 7.2 Hz, 3H), 0.91 (s, 9H), 0.88 (s, 8H), 
0.81 (s, 3H), 0.76 (s, 3H), 0.07 (s, 3H), 0.06 (s, 3H), 0.04 (s, 6H).  13C NMR (101 MHz, 
CD2Cl2) δ 172.36, 85.88, 81.25, 76.98, 72.58, 63.06, 54.66, 54.00, 53.85, 47.50, 45.56, 
39.15, 38.47, 37.65, 36.01, 34.57, 34.08, 32.53, 31.26, 29.20, 26.29, 23.56, 18.65, 18.47, 
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14,15-dehydro-17-hydroxy-22-enol ether 3.180 B from 17-hydroxy-bisnorcholanic 
lactone 3.104. 1H NMR (400 MHz, Methylene Chloride-d2) δ 4.77 (dd, J = 2.2, 1.1 Hz, 
1H), 4.25 (s, 1H), 4.02 (d, J = 1.2 Hz, 1H), 3.97 (dd, J = 11.2, 4.8 Hz, 1H), 3.56 (tt, J = 
10.5, 4.8 Hz, 1H), 1.91 (q, J = 6.8 Hz, 1H), 1.54 (s, 3H), 1.30 (d, J = 1.0 Hz, 3H), 1.09 (s, 
3H), 1.04 (d, J = 6.8 Hz, 3H), 0.91 (s, 9H), 0.87 (s, 9H), 0.85 (s, 3H), 0.13 (s, 3H), 0.12 
(s, 3H).  13C NMR (101 MHz, CD2Cl2) δ 153.94, 120.27, 108.01, 93.34, 92.44, 77.37, 
72.32, 55.66, 47.83, 45.17, 38.94, 37.52, 36.43, 34.25, 32.40, 30.72, 29.61, 28.71, 26.20, 
26.16, 23.91, 18.59, 18.43, 13.64, 12.49, 8.29, -2.10, -4.34, -4.37.  HRMS: ESI [M+H] 








Preparation of 14,15-dehydro-17-trimethylsilyloxy-22-enol ether 3.180 C from 
3,12-di-tert-butyldimethylsilyloxy-17-trimethylsilyloxy-14,15-dehydro-bisnorcholanic 
lactone 3.162. 1H NMR (400 MHz, CD2Cl2) δ 5.41 (t, J = 2.5 Hz, 1H), 4.86 (d, J = 2.8 
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Hz, 1H), 4.10 (dd, J = 11.6, 4.6 Hz, 1H), 3.97 (s, J = 1.8, 1.4 Hz, 1H), 3.73 (s, J = 2.9, 2.0 
Hz, 1H), 3.57 (tt, J = 10.8, 4.8 Hz, 1H), 2.92 (q, J = 7.5 Hz, 1H), 2.15 – 2.03 (m, 1H), 
2.03 – 1.94 (m, 1H), 1.15 (d, J = 7.5 Hz, 3H), 1.08 (s, 3H), 0.88 (s, 18H), 0.83 (s, 3H), 
0.13 (s, 3H), 0.13 (s, 6H), 0.07 (s, 3H), 0.06 (s, 3H), 0.04 (s, 6H).  13C NMR (101 MHz, 
CD2Cl2) δ 171.59, 163.83, 117.19, 93.83, 90.30, 78.82, 72.48, 71.44, 58.49, 54.00, 50.63, 
44.87, 42.37, 39.02, 37.70, 35.96, 35.26, 32.42, 31.47, 30.24, 28.70, 26.24, 26.14, 19.45, 
18.63, 18.41, 17.86, 12.29, 3.45, -3.59, -3.86, -4.32. HRMS: ESI [M+H] Expected 
675.4660 for C38H71O4Si3, Found 675.4657. 
 
Synthesis of Alkynyl Hemiketal 3.202 and Dienylynyl-Ketone 3.203 
 
In a 1 mL vial were placed 14,15-dehydro-bisnorcholanic lactone 3.72 (20 mg, 
0.034 mmol) and trimethylsilylacetylene (12.39 µl, 0.088 mmol) in diethyl ether (170 µl) 
to give a colorless solution.  The reaction was cooled to – 78 °C over 15 min and n-
butyllithium (34.0 µl, 0.085 mmol) was added dropwise via syringe to give a colorless 
solution.  The reaction was stirred for 1 hr at – 78 °C when TLC showed the starting 
material was completely consumed.  The cooling bath was removed and the reaction was  
allowed to warm to 0°C at which time the reaction was quenched with saturated 
ammonium chloride 0.5 mL and further warmed to room temperature.  The reaction 
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mixture was transferred to a separatory funnel and extracted with diethyl ether (3 x 1 
mL). The combined organic layers were washed with H2O, saturated NaCl, dried over 
MgSO4, filtered through a cotton plug, and concentrated under vacuum to give an off-
white fluffy solid.  The crude product was purified by silica gel column (slurry packed 
with hexane and was gradient eluted with a 10:1 to 8:1 Hex:EA) to give a 2:1 mixture of 
3.202 and 3.203 12.6 mg in 54 % of as a white  fluffy solid.  1H NMR in CDCl3 is 
consistent with desired lactols and dienone 3.203.  Hemiketal 3.202 1H NMR (400 MHz, 
Chloroform-d) δ 5.43 (t, J = 2.2 Hz, 1H), 5.39 – 5.31 (m, 2H), 5.12 – 4.99 (m, 1H), 3.53 
(tt, J = 10.3, 4.8 Hz, 1H), 3.15 – 3.04 (dd, J = 11.1, 4.2 Hz, 1H), 2.50 (dt, J = 11.2, 8.4 
Hz, 1H), 2.29 (dd, J = 10.1, 7.1 Hz, 1H), 1.38 (s, 3H), 1.25 (d, J = 2.4 Hz, 3H), 0.95 (d, J 
= 9.7 Hz, 6H), 0.90 (d, J = 3.4 Hz, 9H), 0.88 (s, 9H), 0.85 (d, J = 2.5 Hz, 6H). 0.19 (d, J = 
2.1 Hz, 9H), 0.17 – 0.14 (s, 12H), 0.04 (d, J = 2.4, 1.2 Hz, 21H), 
 
 
Dien-ynyl-one 3.203.  1H NMR (400 MHz, Chloroform-d) δ 6.22 (d, J = 2.1 Hz, 
1H), 5.89 (t, J = 2.0 Hz, 1H), 4.04 (q, J = 7.1 Hz, 1H), 3.52 (ddt, J = 15.7, 10.3, 5.0 Hz, 
1H), 3.16 (dd, J = 11.2, 4.4 Hz, 1H), 1.11 (d, J = 7.1 Hz, 3H), 1.02 (s, 3H), 0.93 (s, 3H), 
0.90 (s, 18H), 0.19 (d, J = 2.1 Hz, 6H), 0.17 – 0.14 (s, 9H), 0.04 (d, J = 2.4, 1.2 Hz, 6H).  
13C NMR (101 MHz, CDCl3) δ 158.51, 154.32, 127.86, 120.10, 118.78, 89.38, 79.99, 
78.10,  72.10, 60.20, 59.50, 57.86, 53.45, 52.01, 47.79, 44.95, 44.85, 44.77, 38.58, 37.65, 
234 
 
37.08, 36.05, 35.86, 34.89, 34.10, 31.99, 31.78, 30.72, 30.11, 29.85, 29.45, 28.42, 26.31, 
26.09, 26.03, 18.41, 18.17, 15.08, 13.77, 13.14, 12.59, 12.31, -0.07, -0.62, -2.87, -3.90, -
4.12, -4.42.  MS ESI [M+H] not observed ESI [M+H – H20]; C39H68O3Si3 Expected = 
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